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Introduction: Vascular cells communicate through gap junctions, which are formed by connexin 
(Cx) proteins. Cx43 is expressed in both endothelial and smooth muscle cells. Studies have 
demonstrated alterations in gap junctions with atherosclerosis and hypertension, diseases that 
involve changes in mechanical forces. However, regulation of arterial gap junctions by 
mechanical forces has not been well understood. Methods: In the present study, ex vivo 
perfusion culture of rabbit thoracic aortas was used to investigate the regulation of Cx43 by 
pressure magnitude and pulsatility. After culturing for 6 or 24 h, the Cx43 protein and mRNA 
levels were detected by Western blot and real-time PCR, respectively. The Src inhibitor PP1 or 
NADPH oxidase inhibitor apocynin was added to the culture medium to study the molecular 
mechanisms in some experiments. Results: (1) An increase in the steady pressure level (from 80 
to 150 mmHg) significantly increased both mRNA and protein levels of Cx43 at 6 h, which were 
blocked by PP1. High steady pressure also upregulated Cx43 mRNA at 24 h, although the Cx43 
protein levels were similar. This pattern of steady pressure-induced regulation of Cx43 was not 
altered by the presence of pressure pulsatility or flow levels. (2) Cyclic stretch, elicited by 
pulsatile perfusion (mean: 80 mmHg, pulse: 30 mmHg, 192 cycles/min), decreased Cx43 protein 
for both 6 and 24 h, compared with steady stretch controls (mean: 80 mmHg, pulse: 0 mmHg). 
Concomitantly, levels of active and total Src were reduced by cyclic stretch at 24 h. PP1 in 
steady perfusion culture or apocynin in pulsatile perfusion culture eliminated the observed 
differences in Cx43 protein between cyclic and steady stretch. In addition, apocynin elevated 
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active and total Src in aortas under cyclic stretch at 24 h. The ratio of active to total Src was not 
significantly altered in any case. Conclusions: Both pressure magnitude and pulsatility regulate 
Cx43 expression. High pressure upregulates Cx43 mRNA and is time-independent. High 
pressure upregulates Cx43 protein and is time-dependent. Cyclic stretch downregulates Cx43 
protein and is time-independent. Src and NADPH oxidase may be involved in the signaling 
pathway. 
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1.0  INTRODUCTION AND SPECIFIC AIMS 
1.1 INTRODUCTION 
Cardiovascular diseases are the leading causes of morbidity and mortality in developed 
countries, which accounted for 36.3% of all deaths in the United States of America in 2004.1 
Atherosclerosis is a type of chronic and localized arterial lesion that produces thickening, 
hardening and restructuring of the arterial wall. Atherosclerosis can induce arterial stenosis, 
particularly coronary arterial stenosis. Coronary arterial stenosis reduces myocardial blood 
supply and may lead to ischemia, cardiac insufficiency and myocardial infarction. 
Atherosclerosis also causes stroke, and gangrene of the extremities. 
Atherosclerosis was thought to be a chronic inflammatory disease although the 
pathogenesis of atherosclerosis is still not completely understood.2, 3 Atherosclerosis is the result 
of a complex interaction between blood elements, disturbed flow, and vessel wall abnormality, in 
particular, endothelial dysfunction. Risk factors of atherosclerosis include a high blood lipid 
level, diabetes mellitus, hypertension, smoking, family history, genetic predisposition, etc. These 
risk factors may increase oxidative stress in vascular cells.1 Although these common risk factors 
are systemic in nature, atherosclerosis affects some specific vascular sites.2 Atherosclerosis 
occurs most in regions with geometric changes, such as curvature, branching and bifurcation. 
There has been positive correlation between plaque location and low oscillating wall shear stress 
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in the human carotid bifurcation.3 This correlation stimulated great interests in studying into the 
effects of flow on vascular endothelial cells (ECs).4-6 Vascular smooth muscle cells (VSMCs) 
maintain the structural integrity of blood vessels. VSMCs also play important roles in 
atherosclerosis.10, 11 Arterial cells in hypertension and vein grafts used for coronary bypass 
surgery are subjected to elevated forces. The process of adapting to the new mechanical milieu, 
remodeling, may contribute to the complications of hypertension and graft failure. Altered 
mechanical conditions may play roles in restenosis after stenting as well.7  
Mammalian cells can exchange small molecules with a molecular weight up to 1000 
Daltons (Da) through gap junctions, which are formed by connexin (Cx) molecules.8 Connexins 
are named by the predicted molecular weight in kiloDalton (kDa). Gap junctions coordinate 
vascular cells.9 In arteries, Cx37, Cx40 and Cx43 may be expressed in ECs, while Cx37, Cx40, 
Cx43 and Cx45 may be expressed in VSMCs.9 However, these connexin isotypes are not 
uniformly expressed in the vasculature. In general, ECs predominantly express Cx40 and Cx37, 
while arterial SMCs predominantly express Cx43.  
In vivo studies have shown that some diseases (e.g., atherosclerosis, hypertension) are 
associated with altered connexin expression. It is not clear, however, whether these changes in 
connexin expression contribute to the genesis and/or maintenance of the disease process. In 
addition, in vivo studies have not provided a unified picture of the link between the disease 
process (or the attendant changes in mechanical milieu) and connexin expression. For example, 
transgenic mice with reduced Cx43 expression had fewer atherosclerotic lesions following the 
administration of high-fat diet.10 In contrast, transgenic mice with smooth muscle cell-specific 
knockout of Cx43 had thicker neointima following vascular injury.11 Similarly, vascular 
connexin expression was variably altered in hypertensive rats, depending on the hypertension 
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model.19, 20 Taken together, the in vivo studies indicate that regulation of vascular connexin 
expression is multifactorial and therefore, it is difficult to tease out the effects of mechanical 
milieu alone from these data. 
In vitro cell culture studies have been conducted as well to investigate regulation of 
vascular gap junctions by mechanical factors. These mechanical factors, specifically flow (shear 
stress) and pressure /wall stress/stretch, regulate gap junctions. For example, unidirectional and 
bidirectional (oscillatory) shear stress modulate the Cx43 protein level in ECs.12 Shear stress 
spatial gradients also upregulates Cx43 expression in aortic ECs.13 Cyclic circumferential stretch, 
but not pressure, increased Cx43 protein in ECs.12 Twenty percent static stretch of cultured 
VSMCs increased Cx43 messenger ribonucleic acid (mRNA) and protein.14 Although these in 
vitro cell culture studies have provided useful information, the results can be questioned for at 
least two reasons: (1) lack of the native three-dimensional architecture with appropriate 
combination of multiple vascular wall components (ECs, VSMCs, extracellular matrix proteins), 
and (2) changes in EC and VSMC phenotypes in in vitro cell culture. Therefore, the effects of 
mechanical factors on vascular gap junctions observed in in vitro studies may not reflect the case 
in vivo. 
We utilized the approach of ex vivo culture of intact arteries to study regulation of gap 
junctions by mechanical factors in order to avoid some of the above-mentioned problems related 
to in vivo animal and in vitro cell culture studies. Specifically, ex vivo culture of arteries enabled 
us to maintain the native vascular architecture and composition and rigorously control the 
mechanical milieu of interest. In the present study, we primarily examined the link between 
pressure (both steady and pulsatile) and vascular connexin expression (both mRNA and protein). 
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1.2 SPECIFIC AIMS 
The overall hypothesis is that arterial gap junctions are regulated by mechanical factors. This 
hypothesis was investigated through the following two specific hypotheses and corresponding 
aims. 
 
Hypothesis 1: Arterial gap junctions are regulated by the mean pressure level. 
Specific Aim 1a: To characterize regulation of Cx43 expression (both gene and protein) by 
the steady pressure level. 
Specific Aim 1b: To examine whether pressure pulsatility affects the regulation of Cx43 
expression (both gene and protein) by the mean pressure level. 
Specific Aim 1c: To begin investigation of potential mechanisms underlying the steady 
pressure level-induced regulation of Cx43 expression. 
Ex vivo culture of rabbit descending thoracic aortas (DTA) was carried out under high 
(150 mmHg) or low (80 mmHg) steady pressure to characterize regulation of Cx43 
expression (Specific Aim 1a). Two culture durations (6 and 24 h) were explored to 
investigate the dynamics of this regulation. To examine the effects of pressure 
pulsatility on the regulation of Cx43 by the steady pressure level (Specific Aim 1b), the 
same experiments were repeated with the addition of a fixed level of pulsatile pressure 
(30 mmHg) to both high and low mean pressures. Finally, potential mechanisms 
underlying the steady pressure-induced regulation of Cx43 expression (Specific Aim 
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1c) were studied by investigating aspects of cell phenotype changes and certain 
signaling molecules (e.g., p27, Src, beta-catenin).  
 
Hypothesis 2: Arterial gap junctions are regulated by cyclic stretch induced by pulsatile 
pressure. 
Specific Aim 2a: To characterize regulation of Cx43 expression (both gene and protein) by 
pulsatile pressure. 
Specific Aim 2b: To examine whether the pulsatile pressure-induced regulation of Cx43 
expression (both gene and protein) is primarily mediated by cyclic stretch. 
Specific Aim 2c: To begin investigation of potential mechanisms underlying the regulation 
of Cx43 expression by cyclic stretch. 
To characterize regulation of Cx43 expression, ex vivo culture of DTAs were carried 
out under two conditions with the same mean pressure (80 mmHg): zero pulse pressure 
(i.e., steady condition) and 30 mmHg pulse pressure (Specific Aim 2a). This level of 
pulse pressure induced significant cyclic stretch of cultured aortas. Two culture 
durations (6 and 24 h) were explored to investigate the dynamics of this regulation. To 
examine whether cyclic stretch was the primary mediator of the pulsatile pressure-
induced regulation of Cx43 expression (Specific Aim 2b), the same experiments were 
repeated with aortas cultured under a higher mean pressure level (150 mmHg); at this 
level of mean pressure pulsatile pressure did not induce significant cyclic stretch of the 
aorta.15 Finally, potential mechanisms underlying the pulsatile pressure-induced 
regulation of Cx43 expression (Specific Aim 2c) were studied by investigating aspects 
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of cell phenotype changes and certain signaling molecules (e.g., p27, Src, reactive 
oxygen species, Akt). 
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2.0  BACKGROUND 
Because of the prominent roles of mechanical forces in vascular physiology and pathology, 
effects of forces on vascular cells and transduction of forces into biochemical signals by vascular 
cells will be briefly reviewed.  
2.1 MECHANOTRANSDUCTION OF VASCULAR ENDOTHELIAL CELLS 
Being the inner layer of blood vessels, ECs are subject to viscous wall shear stress because of 
flowing blood. Blood pressure is applied to ECs directly as well. ECs are cyclically stretched due 
to the intermittent pumping of the heart. Vascular ECs are a transducer and integrator of both 
humoral and mechanical conditions. ECs actively synthesize and secrete many substances to 
maintain the homeostasis of the vasculature. The effects of flow, pressure and stretch (strain) on 
ECs will be reviewed. 
2.1.1 Mechanotransduction of flow by vascular endothelial cells 
Blood flow is very complex.16 Blood flow is laminar in straight parts of large and medium-
caliber arteries. However, disturbed flow occurs in regions with changing geometries, such as 
curvature, branching, and bifurcation. Doppler ultrasound and magnetic resonance imaging have 
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been used to measure blood flow in large arteries. To date, the patterns of disturbed flow are hard 
to be characterized. Generally, the disturbed flow has low mean wall shear stress with large 
amplitude and reverses flow direction during some portion of the period (oscillatory flow). 
Flow regulates gene expression of ECs, and this regulation depends on flow patterns.21-23 
Laminar flow induces genes that are protective to vascular cells. In contrast, disturbed flow 
activates genes that may induce dysfunction of ECs. For example, the expression of the 
monocyte chemotactic protein-1 (MCP-1) is increased by disturbed flow. 
The mechanisms of flow transduction by ECs are not completely known even though 
some mechanosensors of flow in ECs have been revealed. The cell membrane and some 
membrane proteins have the preference as mechanosensors. These proteins include receptor 
tyrosine kiases,17 integrins,18 G protein-coupled receptors and G proteins,19 intercellular 
junctional proteins,20 and ion channels.28 The membrane glycocalyx may also be the sensor.21 
Flow regulates shape and orientation of ECs. ECs align in the direction of blood flow in 
the straight part of arteries,22 which depends on a mechanosensory complex comprised of platelet 
endothelial cell adhesion molecule-1 (PECAM-1), vascular endothelial cell cadherin (VE-
cadherin) and vascular endothelial growth factor receptor 2 (VEGFR2).20 In contrast, ECs have 
little orientation at branching sites where the flow patterns are disturbed. ECs subjected to 
oscillatory flow have a polygonal morphology similar to that of static controls.23 
Under a chronic change in flow, blood vessels undergo structural remodeling via 
endothelium-dependent mechanisms.24 Endothelial caveolin-1 and caveolae are required for this 
remodeling.25 The ATP-gated P2X4 ion channels26 and the p47phox-dependent NADPH 
Oxidases27 are also necessary. Furthermore, caveolae participate in β1 integrin-mediated 
mechanotransduction of shear stress.28  
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One major achievement of vascular biology in the last two decades is the discovery that 
ECs secrete the vasorelaxant nitric oxide (NO). NO is a free radical gas diffusing rapidly from 
ECs to adjacent cells. Its vasodilation function is through activating soluble guanylate cyclase, 
which generates cGMP, and ultimately leading to activations of a variety of downstream 
effectors. NO plays a pivotal role in vascular biology and pathobiology. NO is the most potent 
vasodilator secreted in the vasculature. It also inhibits lipid oxidation, platelet aggregation and 
leukocyte adhesion to ECs and suppresses VSMC proliferation and migration. NO regulates the 
balance between cell proliferation and cell death because it is either proapoptotic or antiapoptotic. 
NO is generated through the enzyme nitric oxide synthase (NOS). ECs express endothelial nitric 
oxide synthase (eNOS, or NOS3). ECs may also express the neuronal (nNOS) and inducible 
isoforms (iNOS) of this enzyme. 
NOS is a multi-domain enzyme consisting of an N-terminal oxygenase domain with 
binding sites for heme, L-arginine, and tetrahydrobiopterin, and a reductase domain bound by 
FMN, FAD, NADPH, and calmodulin. Two identical subunits form one functional eNOS 
complex. eNOS is myristoylated and palmitoylated. 
Shear stress regulates the gene expression level of eNOS both in vivo29 and in vitro,30 
even though eNOS is constitutively expressed in ECs. Bovine aortic ECs had more eNOS 
mRNA after exposure to 3 h of steady laminar flow. Laminar flow increased eNOS mRNA level 
through two mechanisms: a transient increase in eNOS transcription followed by a prolonged 
stabilization of eNOS mRNA molecules.31 The initial activation of transcription was via c-
Src/Ras/Raf/ ERK1/2. The long-term stabilization of eNOS mRNA was also through c-Src, but 
was independent of Ras and ERK. The effect of flow on eNOS mRNA stability was further 
found to be related to 3' polyadenylation of the eNOS mRNA.32 Laminar flow increased 
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expression of eNOS transcripts with longer poly(A) tails, which extended the half life of eNOS 
mRNA from 6 h in static cells to 18 h in sheared cells. 
Flow increases NO production by regulating eNOS activation. Flow-dependent 
phosphorylation of bovine eNOS-Ser1179 was mediated by a PKA and/or AMP-activated protein 
kinase-dependent mechanism, and increased the eNOS activity.33, 34 PECAM-1, VEGFR2, the 
Scaffolding protein Gab1, the tyrosine phosphatase SHP2, and the receptor tyrosine kinase Tie2 
were mechanotransducers that lead to the activation of eNOS in response to flow.42-45 Another 
mechanism of the flow-induced activation of eNOS was through recruiting heat-shock protein 90 
(Hsp 90) to eNOS.35  
One of the exciting findings recently is the discovery that the zinc finger-containing 
transcription factor, lung Kruppel-like factor (KLF2) has crucial roles in regulating vascular 
structure and function.36-38 Human umbilical vein endothelial cells (HUVECs) exposed to 
sustained laminar flow had increased expression of KLF2, which was mediated by nucleolin.50, 51 
However, disturbed flow decreased KLF2 expression both in vivo and in vitro.39 KLF2 was 
involved in the laminar flow-induced increase in eNOS transcription,36 beneficial effects of 
statins,40 endothelial thrombotic function,41 inhibition of protease-activated receptor-1 
expression,42 and TGF-β signaling.43 It was further found that KLF2 acted as a central 
transcriptional switch point between the quiescent and activated states of adult ECs. 
Proteins that are specifically activated by disturbed flow may be play roles in 
atherosclerosis. In an effort to identify the PKC isoforms that were expressed at regions with 
disturbed flow in vivo, PKCzeta was found to be more active among a few PKC isoforms 
expressed in ECs at regions with disturbed flow.44 Oscillatory flow activated NADPH oxidase to 
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generate more superoxide45 through upregulating the bone morphogenic protein 4 (BMP-4).46 In 
contrast, laminar flow inhibited BMP-4 via PKA.47 
2.1.2 Mechanotransduction of pressure/stretch by vascular endothelial cells 
It should be pointed out that although I use pressure/stretch here, pressure and stretch are not the 
same. ECs are subjected to pressure/stretch as well. Depending on the pulsatility of the pressure 
and the rigidity of the substrate used to culture ECs, ECs may be compressed by the applied 
pressure or be stretched as well. Pressure/stretch regulates structure and function of ECs. Some 
molecular mechanisms have been identified. 
Pressure may promote or inhibit EC growth depending on the level, pulsatility and 
duration of the applied pressure. Low sustained hydrostatic pressure up to the level of 
physiologic pressure in vivo increased proliferation of bovine pulmonary artery ECs (BPAECs) 
cultured on rigid substrates via basic fibroblast growth factor (bFGF),48 and of HUVECs by 
activating αV integrins.49 However, a higher static pressure (>80 mmHg) caused degeneration of 
ECs.50 By contrast, pulsatile pressure (140/100 mmHg) inhibited apoptosis.51  
Sustained static pressure may induce cytoskeleton remodeling and changes in 
morphology of ECs.48 However, this effect was not observed using a pulsatile pressure.51  
Pressure may affect the synthetic activity of ECs. High static pressure increased the 
release of endothelin-1 (ET-1),52 prostacyclin,53 and interleukin-6 (IL-6) in ECs.54  
Pulsatile pressure mediates the endothelial barrier function.55 The change in permeability 
of HUVECs induced by pulsatile pressure depends on the pressure level. Exposure of HUVECs 
to a high pulsatile pressure (140/100 versus 60/20 mmHg at 1 Hz) reduced significantly the 
transendothelial permeability to albumin. Furthermore, this effect occurred concomitantly with 
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the redistribution of the intracellular tight junction protein zona occludens-1 (ZO-1) and 
remodeling of actin stress fibers. 
Cyclic stretch changes the cytoskeleton organization and orientation of ECs. Arterial ECs 
in vivo align along the flow direction, which is coincidentally perpendicular to the cyclic stretch 
direction. Although the alignment of ECs with the flow direction does not require cyclic 
stretch,56 circumferential stretch may increase the sensitivity of ECs to shear stress.57 ECs 
cultured in vitro also aligned perpendicular to the uniaxial stretching direction via the kinase 
Rho58 and focal adhesion kinase (FAK).59 Concomitantly, c-jun N-terminal kinase (JNK) was 
activated.60 However, equibiaxial cyclic stretch did not reorientate ECs,60 although both uniaxial 
and biaxial stretches increased the amount of actin stress fibers.60 The actin stress fibers of ECs 
in intact arteries can realign toward the circumferential direction if the arteries are stretched 
axially and there is no flow.73  
The regulation of the gene expression of HUVECs by pulsatile pressure was studied 
using microarray techniques.61 Pulsatile pressure modulated the expression of 14 genes which 
encoded some mechanosensitive proteins for homeostasis (tissue plasminogen activator), cell 
adhesion (integrin α2), and signaling (Rho B, cytosolic phospholipase A2). Vascular endothelial 
growth factor (VEGF)-C and TGF-β2 were found to be pulsatile pressure-sensitive as well. 
Cyclic stretch may increase the expression of some marker proteins of VSMCs in ECs.62 
The mRNA levels of SM22-α, α-smooth muscle actin (α-SMA), caldesmon-1, smooth muscle 
myosin heavy chain (SMMHC), and calponin-1 were increased in cyclically stretched HUVECs 
as compared with static controls. On the other hand, the mRNA levels of two EC-specific 
markers, von Willebrand factor (vWF) and VEGFR2, were downregulated. Furthermore, the 
protein levels of SM22-α and α-SMA were also increased. Surprisingly, cyclic stretch also 
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significantly increased network formations on Matrigel (frequently used to measure the 
endothelial angiogenesis capability) by ECs,63 although cyclic stretch seemed to 
transdifferentiate ECs to VSMCs. 62  
Stretch activates a number of proteins in ECs. Activation of eNOS by cyclic stretch was 
bi-phasic and mediated by two distinct pathways.64 Cyclic stretch enhanced Akt-dependent 
antiapoptosis capability in ECs.65 The superoxide production by NADPH oxidase was increased 
in cyclically stretched ECs.66  
2.2 MECHANOTRANSDUCTION OF VASCULAR SMOOTH MUSCLE CELLS 
 VSMCs are not directly exposed to a significant level of flow in healthy blood vessels. However, 
when there are injuries and denudation of ECs, VSMCs may directly experience fluid shear. 
VSMCs can also be exposed to fluid shear because of an interstitial flow induced by the 
transmural pressure differential.67 A few studies have demonstrated the effects of flow on 
VSMCs. 
2.2.1  Mechanotransduction of flow by vascular smooth muscle cells 
There was a rise in cytosolic Ca2+ ion concentration in VSMCs responding to an increase in 
flow.68 VSMCs contracted when the shear stress was larger than the threshold value (11 
dyne/cm2).69 This response was dependent on the Rho-kinase pathway. The transient receptor 
potential ion channel protein M7 (TRPM7) was accumulated rapidly to the plasma membrane 
upon flow.70 Interestingly, ECs showed a low level of TRPM7-like current, which was not 
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increased by flow. Flow also increased NO production by nNOS in VSMCs.71 The increased 
level of NO reduced activation of matrix metalloproteinase (MMP)-2, resulting in a significant 
flow-induced inhibition of VSMC migration.72 
Flow may induce endothelial transdifferentiation from VSMCs.73 Flow increased the 
mRNA levels of EC markers such as PECAM-1, vWF, and VE-cadherin, accompanied by the 
decreased mRNA levels of VSMC markers (α-SMA, calponin-1, SMMHC, and transgelin). 
Protein levels of PECAM-1 and vWF were also significantly increased by flow. 
2.2.2  Mechanotransduction of pressure/stretch by vascular smooth muscle cells 
The main mechanical factors applied to VSMCs are pressure and the accompanied stretch/strain. 
These factors mediate the structure and function of VSMCs, which have been extensively 
investigated. 
Pressure/stretch regulates differentiation and phenotypes of VSMCs. In healthy adult 
arteries, VSMCs are at a fully differentiated, contractile phenotype with a very small rate of 
proliferation. However, a synthetic phenotype may be induced by vascular injuries, excessive 
stimulation of growth factors, and pressure/stretch. A certain level of pressure/stretch is required 
to maintain a differentiated, contractile phenotype of VSMCs. The protein levels of high-
molecular-weight caldesmon and filamin, two molecular markers of contractile VSMCs, were 
maintained in rabbit aortas perfused under an intraluminal pressure of 80 mmHg for 3 days.74 
However, the rates of synthesis of several proteins (α-SMA, calponin, SM22α, tropomyosin, and 
desmin) in unstretched veins were significantly lower than those in stretched veins. This process 
was mediated through actin polymerization.75 VSMCs that were stretched equibiaxially exhibited 
an increase in the expression of VSMC differentiation markers, and this process was mediated by 
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Notch/Cp-binding factor 1 (CBF-1)/recombination signal sequence-binding protein-Jκ (RBP-Jκ) 
signaling.76 
Pressure/stretch regulates proliferation and apoptosis of VSMCs. Human aortic smooth 
muscle cells cultured at 160 mmHg atmospheric pressure had a nearly four fold increase in cell 
proliferation compared to controls. However, static pressure may also reduce proliferation if the 
pressure is too high (200 mmHg).77 Vein grafts and cyclically stretched SMCs underwent 
apoptosis.78 The signaling pathways leading to apoptosis include p38 mitogen-activated protein 
kinase (p38 MAPK),78 β1 integrin/Rac/p53,79 Ras/Rac/p38 MAPK/NF-κB/IL6,80 Notch 
receptor,94 and hedgehog.81 
Pressure/stretch mediates a number of pathways involved in many processes of VSMCs, 
which will be reviewed individually. These include FAK, mitogen-activated protein kinase 
(MAPK) cascade, NF-κB pathway, MMPs, and NADPH oxidase. 
FAK. Focal adhesions are sites where cells connect with extracellular matirx (ECM).82 A 
number of signaling and structural proteins are concentrated at focal adhesions. Therefore, focal 
adhesions can integrate environmental stimuli and mediate the two-way crosstalk between ECM 
and cells. Focal adhesions are reorganized under stimulation of vascular cells by mechanical 
factors. Integrin proteins are one of the key sensors of force/deformation at focal adhesions. 
Integrins are activated and clusterred by mechanical forces. FAK is one of the non-receptor type 
tyrosine kinases and its activities are regulated through phosphorylation. FAK is activated 
following integrin activation. Tyrosine phosphorylation of FAK was increased by stretch in 
rabbit pulmonary arteries.97 Phosphorylation of specific amino acids in FAK was also studied 
using ex vivo culture of rabbit descending thoracic aortas.83 Tyrosine phosphorylation of FAK 
was significantly increased by high steady pressure (150 mmHg) as compared with the 80 mmHg 
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controls. Inhibition of Src (with the inhibitor PP2) and integrin (using RGD peptide) dampened 
total FAK phosphorylation in vessels cultured at 150 mmHg. In contrast, cyclic stretch generated 
by pulsatile perfusion did not induce significant FAK phosphorylation relative to non-pulsatile 
controls with the same mean pressure at 80 mmHg. 
MAPK. The MAPK cascade includes three different pathways which are activated by 
various stimuli and initiate distinct cellular responses. One is mediated by ERK1/2, whose 
activation leads to the activity of some regulatory proteins in the cytoplasm and nuclei. The other 
two are JNK and p38. All these three pathways can be activated by mechanical forces to regulate 
gene expression, protein synthesis and function. ERK1/2 and JNK were activated in cyclically 
stretched VSMCs84 and in rat arteries by acute hypertension.85 High steady pressure (150 mmHg) 
and 10% cyclic stretch also activated ERK1/2 as compared with normal steady pressure (80 
mmHg) using an ex vivo method.86, 87 However, the mechanisms of activating ERK by high 
steady pressure and pulsatility differ. Integrin and Src kinase-mediated FAK activations were 
involved in high steady pressure-induced activation of ERK,83 while reactive oxygen species 
(ROS) mediated the latter.87 Cyclic stretch also activated p38.87 
NF-κB. NF-κB is a transcription factor, and is found in all cell types. NF-κB belongs to 
the category of "rapid-acting" transcription factors, because it is present in cells in an inactive 
state and does not require new protein synthesis to be activated. Inactive NF-κB is sequestered in 
the cytoplasm by the inhibitor protein, IκB, which is phosphorylated and degraded upon 
activation of the NF-κB pathway. Released NF-κB is translocated into the nucleus where it 
transcribes a large range of genes implicated in inflammation, but also genes related to apoptosis 
repression and survial.  
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Mechanical factors can activate NF-κB. Cyclic stretch activated NF-κB in human 
coronary SMCs in vitro through stimulating superoxide production.88 In contrast, NF-κB was not 
activated by pulsatile perfusion of intact arteries.83 Higher steady pressure was more effective to 
activate NF-κB in arteries, which was important to cell survival under increased stress.89 
Blocking nuclear translocation of NF-κB increased apoptotic cells induced by high steady 
pressure. However, activation of NF-κB was not sufficient to prevent apoptosis in veins used for 
coronary bypass which underwent arterial perfusion conditions.80 ROS induced by high 
intraluminal pressure activated NF-κB.90 Transforming growth factor alpha (TGF-α) was needed 
for stretch-induced activation of NF-κB and consequent vascular remodeling.90 
MMP. MMPs, a family of endoproteinases which have at least 25 members, require the 
ion zinc in their active sites. The activity of MMPs is suppressed by one of four endogenous 
tissue inhibitors of MMPs (TIMPs). MMPs are classified into collagenases, gelatinases, 
stromelysins, membrane type, and other MMPs according to their substrate specificity, sequence 
similarity, and structure.91 MMPs have overlapping activities against a variety of ECM, and non-
ECM components, such as growth factor binding proteins or latent growth factors. Therefore, 
MMPs are involved in many processes, such as proliferation, apoptosis, differentiation, and 
migration of cells in tissues. MMPs regulate modeling and remodeling in response to altered 
hemodynamic conditions and injuries in cardiovascular system.  
Mechanical forces regulate MMPs of VSMCs. The gelatinases, MMP-2 and MMP-9, 
were mostly studied among vascular MMPs. The nature of the applied strain may mediate MMP-
2 and MMP-9 differently. Static strain increased the gene expression and protein levels of MMP-
2 and MMP-9 in human saphenous vein SMCs in vitro, while cyclic strain did the opposite.92 
These effects, however, were not observed in another study.93 Cyclic stretch induced more 
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mRNA and proenzyme of MMP-2 in aortic SMCs via ROS generated by NADPH oxidase. In 
intact veins, arterial conditions reduced the latent MMP-2 and MMP-9 levels compared to 
matched veins. This reduction was caused by increased degradation because the synthesis of 
MMP-2 and MMP-9 was actually increased in arterial condtions.94 Contrary to this ex vivo study, 
arterialization of canine jugular veins in vivo upregulated MMP-9, MMP-2 and MT1-MMP 
accompanied by TIMP-2 downregulation.95 Longitudinal stretch of veins increased the level of 
pro-MMP-9, active MMP-2, and integrin αv, which is the receptor of active MMP-2.96 Integrin 
αvβ3 binds to the C-terminus of MMP-2 and this binding is stable in the presence of the 
detergent sodium dodecyl sulfate (SDS).97 Arterial MMP-2 and MMP-9 may be regulated 
differently by pressure.98 Porcine coronary arteries subjected to normal transmural pressure 
(100 mmHg) had significantly more active MMP-2 relative to those under high pressure (200 
mmHg) and zero-pressure controls for 2 days, regardless of the flow condition.98 However, 
arteries subjected to high pressure had more MMP-9 than arteries maintained at normal pressure 
and zero-pressure controls, also regardless of the flow level. In contrast, mouse carotid arteries 
maintained at low pressure (10 mmHg) had a stronger MMP-2 activity as compared to arteries at 
normal pressure (80 mmHg) for 3 days.99 Under high pressure (150 mmHg), both MMP-2 and 
MMP-9 activities were induced. Further, high pressure induced MMP-9 contributed to the 
increased distensibility. Similarly, MMP-9 was important for arterial geometric remodeling and 
SMC migration.100 In DOCA-salt hypertensive rats, MMP-2 expression and activity in aortas 
were increased.101 Cyclic bending for 4 h down-regulated MMP-1 gene expression in porcine 
femoral arteries.102 To date, differential regulation of MMPs in intact blood vessels by cyclic and 
steady stretch has not been reported. 
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To have a more complete view of MMP regulation by mechanical forces, the effects of 
stretch on MMPs in ECs are discussed here.103 Equibiaxial cyclic strain (0-10% strain, 60 
cycles/min) stimulated the MMP-2 gene expression and activity through the G protein Gβγ, 
receptor tyrosine kinase, Shc, p38- and ERK-dependent pathway in bovine aortic ECs.104 In 
addition to MMP-2, MMP-14 was also upregulated at both gene expression and protein levels by 
cyclic stretch through JNK and tumor necrosis factor-α (TNF-α) in HUVECs.105 Static stretch 
also increased the mRNA and protein levels of MMP-2 in skeletal muscle microvascular ECs 
through JNK, while ERK and ROS did not regulate MMP-2.106 Cyclic stretch increased the 
mRNA level of MT1-MMP in rat microvascular EC through the transcription factor Egr-1.107 
NADPH oxidase. ROS are oxygen-derived small molecules, including superoxide, 
hydroxyl, peroxyl, ozone, singlet oxygen, and hydrogen peroxide. ROS interact with a variety of 
molecules, such as proteins, lipids, carbohydrates, and nucleic acids. Therefore, ROS may be 
important signaling molecules regulating the functions of the interacting molecules. ROS have 
been implicated in atherosclerosis, hypertension, responses to vascular injuries, and other 
vascular diseases. The physiological generation of ROS can be either the byproduct of some 
biological reactions in mitochondria, peroxisomes, and cytochrome P-450, or the specific 
product of uncoupled NOS, xanthine oxidase, cyclo-oxygenase, and NADPH oxidase, which is 
also called the NOX enzyme.108 The NADPH oxidase enzyme is a complex of five components: 
p40phox (phox for phagocyte oxidase), p47phox, p67phox, p22phox and NOX, which is the catalytic 
subunit. The catalytic subunit of the phagocyte NADPH oxidase, commonly referred to as 
gp91phox, is called NOX2. Six homologs of NOX2 have been discovered: NOX1, NOX3, NOX4, 
NOX5, DUOX1, and DUOX2. They catalyze the production of superoxide by the one-electron 
reduction of oxygen molecules using NADPH as the electron donor. Three of these five 
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components, p40phox, p47phox and p67phox, form a complex in the cytosol in resting cells. The 
other two components are located in the membranes. When the resting cell is stimulated, p47phox 
is phosphorylated and the cytosolic complex is transferred to the membrane, where it associates 
with the other two to form the active oxidase. Superoxide can be dismutated by superoxide 
dismutase (SOD) to hydrogen peroxide, which is then decomposed to water and oxygen by the 
enzyme catalase. 
NADPH oxidases are the major source of superoxide. NOX enzymes are expressed in the 
vascular wall. NOX4 is the predominant isoform in ECs, NOX1 and NOX4 in SMCs, NOX4 in 
adventitial fibroblasts, and NOX2 in macrophages. ECs also express NOX2 and NOX5. NOX2 is 
expressed in SMCs as well. 
Mechanical forces activate NADPH oxidase. Cyclic stretch of mouse aortic SMCs caused 
rapid p47phox membrane translocation and an increase in NOX-1 mRNA.93 However, the effects 
of cyclic stretch on superoxide production in human aortic ECs are controversial. Human aortic 
ECs produced more66 or less109 superoxide under cyclic stretch. Further, this response to cyclic 
stretch may depend on the type of ECs. HUVECs generated more superoxide under cyclic 
stretch.109 Static stretch of bovine coronary arteries with denuded endothelium also translocated 
p47phox to the plasma membrane.110 High steady pressure increased the phosphorylation of the 
p47phox via PKC, which led to more superoxide production.111 Pulsatile perfusion increased the 
superoxide level compared to the aortas under steady pressure with the same mean value.87 
Oscillatory flow with zero mean shear stress upregulated the mRNA levels of NOX2 and NOX4 
in bovine aortic ECs, accompanied by an increase in the superoxide production rate.45 The 
increase in the diameter of a mouse carotid artery induced by elevated flow depended on p47phox, 
but not on NOX2.27 Cyclic stretch also upregulated the gene expression of p22phox, p47phox, 
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p67phox, NOX1 and NOX4 in mouse embryonic stem cells, and promoted the differentiation of 
embryonic stem cells towards cardiovascular cells.112  
2.3 GAP JUNCTIONS AND CONNEXINS 
2.3.1 Introduction 
Intercellular gap junctions provide direct communication between neighboring cells.8 
Mammalian cells use gap junctions as a fundamental mechanism to behave as a team. Many 
small molecules can pass through gap junction channels by passive diffusion, such as ions, 
metabolites, cyclic adenosine monophosphate (cAMP), and cyclic guanosine monophosphate 
(cGMP). Interestingly, short interfering RNA (siRNA) can also be transported through the Cx43 
gap junctions, which may coordinate gene expressions.113 However, transfer of siRNA was not 
non-selective. siRNA molecules could not pass through the Cx32/26 gap junction channels. The 
current knowledge of gap junctions will be reviewed. 
2.3.2 The life cycle of gap junctions 
Gap junctions are very dynamic structures. The half-life of connexins may be just about 1~5 h 
both in vivo135, 136 and in vitro,114, 115 which is much shorter than those of most cell membrane 
proteins. The life cycle of gap junctions is tightly controlled.116 Therefore, it is necessary to 
review the current knowledge about all stages of the life cycle of gap junctions in order to 
understand and study the regulation of gap junctions by chemical and mechanical factors. 
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2.3.2.1 Connexin genes 
Connexin genes are ubiquitously expressed in mammals. Each animal may have multiple 
types of connexin genes. For example, twenty connexin genes have be identified in mice, while 
there are 21 in the human genome.117 The connexin gene structure was found to be simple 
initially. There are only two or three exons for Cx43,118 Cx40,142, 143 and Cx37.144 The protein 
coding region is in one exon, which also contains 5’-nontranslated-region (NTR) and 3’-NTR. 
Other exons are part of the 5’-NTR upstream to the 5’-NTR contained in the coding exon. 
However, four more exons have been recently found in the 5’-NTR of the mouse Cx43 gene; and 
nine different Cx43 mRNA species are generated by differential promoter usage and alternative 
splicing mechanisms.119 The rat Cx45 gene also has four exons, which are transcribed to four 
transcripts.120The different transcripts are translated at varying efficiencies.119 And this may be 
one way of regulating gap junctions. Although mice, rats and humans have a similar organization 
of the Cx43 gene to, more studies are needed to determine if the human Cx43 gene also has so 
many exons.  
2.3.2.2 Connexin biosynthesis 
 Connexin mRNA is translated into connexin proteins in ribosomes attached to the 
endoplasmic reticulum (ER) membrane, the same as other transmembrane proteins. The 
connexin molecule is a four-transmembrane spanning protein with two extracellular loops and 
one intracellular loop (Figure 2.1). Both N- and C-termini are intracellular. Among different 
types of connexins, the two extracellular loops are structurally conserved; however, high 
variation exists for the cytoplasmic regions (the N-terminus, the intracellular loop, and the C-
terminus), which may contribute to the connexin-specific properties. Connexins can be classified 
into subgroups (α, β or γ) according to their extent of sequence identity and length of the 
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cytoplasmic loop.121 The newly synthesized polypeptides are inserted into the ER membrane 
cotranslationally.122 
2.3.2.3 Connexin assembly into connexons 
One half of a gap junction channel is called a connexon. Unlike most multimeric 
transmembrane complexes oligomerizing in ER, connexins oligomerize in the place related to 
the Golgi apparatus. However, the exact place of connexin molecule oligomerization into 
connexons might be connexin-isoform specific. Cx43 is assembled in the trans-Golgi network 
after exiting from ER,150-152 while Cx32 is assembled in the ER/cis-Golgi network.124 The 
minimal motif to prevent ER oligomerization of Cx43 consists of the complete third 
transmembrane domain and the second extracellular loop.125 
Different types of connexins can assemble into hetero-oligomeric connexons. For 
example, Cx43 hetero-oligomerizes with Cx40,126 or Cx37.127 Furthermore, these gap junction 
channels display many unitary conductances different from homomeric/homotypic Cx43 or Cx40 
channels.126 However, hetero-oligomerization is selective. All reported hetero-oligomeric 
connexons are composed of two members of the same subgroup. For instance, Cx43, an α-type, 
did not oligomerize with Cx32,128 or Cx26,129 a β-type. The specificity of hetero-oligomerization 
may be based on intrinsic signals that are specific to each connexin subtype.130 
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Figure 2-1 Human Cx43 amino acid sequence, topology, and some interacting molecules. 
Cited from Giepmans.123 
 24 
2.3.2.4 Connexon traffic to the plasma membrane 
Connexons with green fluorescent protein (GFP) tags were delivered in vesicular carriers 
traveling along microtubules from the Golgi to the plasma membrane in all directions.131 These 
connexon-containing vesicles moved along curvilinear tracks to follow microtubules which 
extended to the plasma membrane. The vesicles of Cx43 were predominantly in 100- to 150-
nanometer.132 This delivery route follows the general intracellular transport pathway for 
secretory vesicles.133 However, Cx26 connexons might follow an unidentified alternative 
pathway that is independent of microtubules.155, 156 Intact microfilaments were also required for 
both Cx43 and Cx26 connexon traffic.134 Cx43 was transported to the plasma membrane in its 
non-phosphorylated form (Cx43NP).135 The second extracellular region of Cx43 was required to 
localize to the plasma membrane.136 Cx43 proteins with the point mutations F199L, R202E, and 
E205R in the second extracellular region were localized in the cytoplasm only when expressed in 
HeLa cells, which do not have Cx43 normally. 
2.3.2.5 Docking of connexons into double-membrane spanning gap junction channels 
Connexons are predominantly inserted into the nonjunctional plasma membrane instead 
of gap junctional plaques directly.131 Connexons can diffuse laterally in the plasma membrane.134 
Therefore, newly synthesized connexons were found to be accumulated to the outer margins of 
channel clusters using CX43-GFP and fluorescence recovery after photobleaching (FRAP)131 or 
recombinant Cx43 proteins and pulse-chase labeling.132 This process might not be completely 
random, however. The delivery of Cx43 from a lipid raft domain to gap junctional plaques was  
mediated by the tight junction protein zona occludens-1(ZO-1) in osteoblastic cells.137 Docking 
of connexons was affected by calcium-dependent cell adhesion molecules, such as E-cadherin,138 
and N-cadherin.139 Adherens junctions, maintaining the structural integrity of cell-cell contacts, 
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were thought to act as foci for the gap junction formation.140 The formation of the gap junction 
intercellular channels required a 30° rotation between connexons for proper docking.141 
Protrusions on one connexon fitted into the valleys of the apposed connexon under this degree of 
rotation. There are six conserved cysteines in the extracellular loops of each connexin molecule. 
The disulfides formed between apposing connexons are essential for the docking of connexons. 
An engineered Cys-less version of Cx43 prevented the formation of functional channels even 
though connexons had similar permeability to carboxyfluorescein as wild-type Cx43.142 
Different connexons can form heterotypic intercellular channels.143 Functional gap 
junction intercellular channels can be formed by Cx43 with Cx40,174-176 Cx37,127 or Cx45;144 by 
Cx40 with Cx45,128 or Cx37.145 Heterogeneous channels display different gating activities, 
channel conductance and selectivity compared with homogeneous channels.143 Gap junction 
channels aggregate to from plaques. Individual plaques may have multiple subtypes of connexin 
molecules.146 Three different connexins of aortic ECs are organized within the same gap-
junctional plaques. Some gap junctional plaques are relatively immobile,147 while others are 
highly mobile within the plasma membrane, fusing together or segregating into smaller parts.176 
2.3.2.6 Gap junction removal and degradation 
The regulation of gap junction internalization and degradation has not been fully 
understood. Generally, junctional plaques need to be internalized first before they can be 
degraded intracellularly. Plaques are removed into one of the apposing cells as annular gap 
junctions.148-150 Internalization of a gap junctional plaque occurs in the center of the plaque.132 
Clathrin may play a role in this process. Electron microscopy revealed association of clathrin 
coats with gap junctions.151 Inhibition of clathrin-medicated endocytosis blocked EGF-induced 
Cx43 internalization.152 A tyrosine-based sorting signal of Cx43, known to be involved in the 
 26 
intracellular trafficking of many membrane proteins, affected the gap junction turnover.153 The 
Cx43-Y286A mutation extended the Cx43 half-life from 2 to 6 h.  
Gap junctional plaques are degraded in lysosomes. This degradation is proteasome-
dependent in some cell types.154 Studies have shown more convincing evidence of connexin 
degradation in lysosomes.171, 177, 178 Evidence of direct degradation of junctional plaques by 
proteasomes is still absent although inhibition of proteasomes revealed the involvement of 
proteasomes in the degradation process.185, 188, 190, 191 Only Cx43 and Cx32 have been studied for 
the role of proteasomes so far. It is known that ubiquitination regulates membrane protein 
degradation,155 however, the requirement of ubiquitination for Cx43 junctional plaque 
degradation has not been established. Polyubiquitin modification of proteins is required for 
proteasome degradation of proteins.155 Although cell culture studies demonstrated ubiquitination 
of Cx43,180, 186, 187 Cx43 was ubiquitinated in the form of  multiple monoubiquitinations at lysine 
residues, instead of polyubiquitin.156 Monoubiquitination of Cx43 may be related to 
internalization and degradation of gap junctional plaques.156 It is not known whether Cx43 is also 
ubiquitinated in vivo. Although the E3 ubiquitin protein ligase Nedd4 was found to bind to Cx43 
recently, ubiquitination of Cx43 was not studied.157 Colocalization of Cx43 and Nedd4 was 
found in the plasma membrane and cytoplasm. However, attenuation of Nedd4 using siRNA did 
not significantly increase the total protein level of Cx43 detected by Western blot. Therefore, it is 
possible that proteasomes play indirect roles in junctional connexin degradation by affecting the 
level of monoubiquitin ligation, internalization and trafficking of Cx43.189, 190 
Connexins are phosphor-proteins except Cx26. The short half-life of Cx26 suggests that 
phosphorylation of connexins is not absolutely required for rapid gap junction degradation.158 
However, phosphorylation of some connexin subtypes may facilitate the regulation of connexin 
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degradation.159 Phosphorylation of Cx43 was thought to be required for Cx43 ubiquitination.156 
Although the E3 ubiquitin protein ligase Nedd4 has not been shown to ubiquitinate Cx43, the 
binding of the three WW domains of Nedd4 to Cx43 depended on the phosphorylation status of 
Cx43.157 The WW1 and WW2 domains interacted with the non-phosphorylated form of Cx43 
predominantly, while WW3 bound phosphorylated and non-phosphorylated forms of Cx43 
equally. 
2.3.3 Phosphorylation of connexins 
Phosphorylation is a common posttranslational modification of proteins. Phosphorylation has 
been implicated in the life cycle of connexins, including trafficking, assembly, disassembly and 
degradation.160 Many connexins (Cx31,161 Cx32,162 Cx37,163 Cx40,200 Cx43,164 Cx45,165 Cx46,166 
Cx50,167 and Cx56168) have been reported to be phosphorylated except Cx26.169 Phosphorylation 
was studied by a shift in electrophoretic mobility or direct incorporation of 32P. Phosphorylated 
sites were identified by site-directed mutation of target amino acids. The C-terminal region of 
connexins is the primary phosphorylated domain. Phosphorylation of the N-terminus has not 
been reported. Since Cx43 is widely expressed in tissues and cell lines, Cx43 phosphorylation 
has been studied the most (Figure 2.1).  
Cx43 can be phosphorylated on serines and tyrosines. The following residues have been 
found to be phosphorylatable: Y247,170 S255,209, 210 S262,204, 205 Y265,198-200 S279,208 S282,210 
S325,171 S330,171 S364,205-207 S365,172 S368,173-175 S369,172 S372,176 and S373.172 Multiple 
kinases are involved (Figure 2.1). Phosphorylation of S364, S365, S368, S369 and S373 was 
probably cAMP dependent,172, 177 although PKA has not been established as the kinase for these 
sites. Agents elevating intracellular cAMP level enhanced gap junctional intercellular 
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communication (GJIC) and connexin expression,178 as well as the assembly of new gap 
junctions.179 PKA, Epac and Rap1 were in the cAMP enhanced GJIC signaling pathway.180 S364 
is of particular interest. The S364P mutation was associated with visceroatrial heterotaxia.181 The 
S364P mutation also disrupted the pH gating of Cx43,182 and affected left-right patterning.183 
PKC could phosphorylate S368173 and S372.216 PKCγ was identified as the specific isoform to 
phosphorylate S368.184 PKCε also phosphorylated Cx43 although the specific sites were not 
explored.185 Phosphorylation of S368 by PKC induced a conformational change of Cx43 and 
decreased junctional permeability.186 S262 was phosphorylated by PKC187or p34cdc2.188 S255, 
S279 and S282 were phosphorylated by MAPK (ERK1/2, specifically) following EGF 
treatment.208, 226 Therefore, one amino acid of connexins can be phosphorylated by multiple 
protein kinases, and one protein kinase can phosphorylate many residues. Casein kinase 1 
(CK1δ) phosphorylated S325, S328 and S330 in vitro.171 Phosphorylation of these sites might 
facilitate assembly of gap junctions.171 Cx49 was also phosphorylated by CK1 with decreased 
dye transfer in lens cells.189 CK2 phosphorylated S363 of chicken Cx45.6, which reduced the 
stability of Cx45.6, the homologue of human Cx50.190 S255 of Cx43 was also phosphorylated in 
a p34cdc2-dependent manner.209, 234 Phosphorylation of this site might be related to cell cycle 
progression.188 Y247 and Y265 could be phosphorylated by the non-receptor tyrosine kinase Src, 
which resulted in reduced GJIC.203, 206, 207 The reduced GJIC might result from reduced channel 
open probability and possibly altered selectivity.191 Y265 is critical for docking of the SH2 
domain of v-Src to Cx43. The efficient channel closure by v-Src required the phosphorylation of 
Y247.170 Lipopolysaccharide (LPS) stimulated protein tyrosine kinase-dependent 
phosphorylation of cultured rat microvascular ECs.192 However, the phosphorylated sites and 
tyrosine kinases involved were not identified.  
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Dephosphorylation of connexins was less studied. The protein phosphatases that have 
been studied are PP1, PP2A, PP2B, and receptor protein tyrosine phosphatase mu (RPTPμ). PP1 
dephosphorylated Cx43 in rat cells.231, 232 PP2A dephosphorylated Cx43 of rat cells treated by 18 
β-glycyrrhetinic acid,193 mitotic human vascular ECs,194 cultured ventricular myocytes of 
newborn rats,238 and fibroblasts.195 PP2A was also found to colocalize with Cx43 of left 
ventricles in an arrhythmogenic rabbit model of non-ischemic heart failure.235 PP2B 
dephosphorylated Cx43 of hypoxic astrocytes.231 Transgenic mice with cardiac-specific 
expression of an active form of PP2B had less expression and phosphorylation of Cx43.196 Cx43 
was redistributed from intercalated disk regions to the long axis of the plasma membrane. 
Endogenous RPTPμ co-immunoprecipitated with Cx43 through the first catalytic domain of 
RPTPμ.197 Some protein tyrosine phosphatases might counteract the channel-closure effect of 
Src phosphorylation.  
Detection of phosphorylation events by electrophoretic mobility shift may not reveal the 
specific phosphorylated sites.175 More thorough studies are needed to identify the phosphorylated 
sites, the kinases and phosphatases involved, the temporal and spatial characteristics, and the 
physiological importance of phosphorylation of connexins under different conditions. The mass 
spectrometry analysis of protein phosphorylation is emerging as a powerful tool to study all 
cellular processes.198, 199 However, some technical difficulties need to be conquered before its 
routine use. Fortunately, more phosphorylation site-specific antibodies are available, which may 
detect phosphorylation events in situ as well for some antibodies. The antibodies of Cx43 that 
have been used are for S255,200 S262,187 S279/282,236, 237 and S368.175 Antibodies for S255, S262, 
Y265, S279/282, and S368 of Cx43 are commercially available currently.  
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2.3.4 Gating of gap junction channels and hemichannels 
The permeability of gap junction channels may be regulated by Ca2+, pH, transmembrane 
voltage, phosphorylation and other factors.243-246 A rise in intracellular calcium concentration 
correlated with intercellular electrical uncoupling.201 Furthermore, the uncoupling occurred at the 
junction where the local calcium concentration was increased because of the injection of Ca2+ 
into the cells. Carbon dioxide-induced acidification reduced channel permeability.202 Calmodulin 
(CaM) might be the soluble intermediate to mediate Ca2+ and pH gating of gap junction 
channels. Evidence for this CaM effect was accumulated through a CaM inhibitor,203 mutation of 
CaM,204 colocalization of CaM with connexins,257, 258 and binding of connexins to CaM.205 The 
CaM inhibitor, calmidazolium, inhibited electrical uncoupling induced by an increase in acidity 
after exposure to 100% CO2.203 GJIC shows transjunctional voltage-dependent sensitivity.206 The 
charged N-terminal amino acids of both Cx43 (Cx43D12, K13) and Cx40 (Cx40E12, E13) are 
essential to the voltage-dependent gating property.129 Intracellular acidification was accompanied 
by internalization of Cx43 and increased binding of c-Src to Cx43 in astrocytes.261 
One half of a gap junction channel is called a hemichannel. Hemichannels can also be 
opened under low extracellular Ca2+ concentration,207 or metabolic stresses.255 Calcium induced 
a reversible change in the diameter of the extracellular pore of Cx43 hemichannels that were 
inserted into the reconstituted lipid bilayer.208 Opened hemichannels can release ATP,209, 210 
glutamate,211 and NAD+.212 In addition, hemichannels played a role in calcium wave 
propagation,213 cell volume regulation,270 and transduction of cell survival signals.271 
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2.3.5 Connexin-interacting molecules  
It is important to know the connexin-interacting molecules in order to understand the regulation 
of connexins and gap junctions. Some proteins have been found to associate with connexins 
(Figure 2-1).123 The kinases and phosphatases interacting with connexins have been discussed 
before (Section 2.3.3). 
Binding of Cx43 with ZO-1 has been established272-274 and quantified.275 The C-terminus 
of Cx43 (Cx43CT) interacted with the second PDZ domain of ZO-1.214 The PDZ-2 domain of 
ZO-1 affected the last 19 residues of Cx43CT.215 ZO-1 localized mostly to the periphery of Cx43 
gap junctional plaques.216 c-Src regulated the interaction between Cx43 and ZO-1 in both 
astrocytes217 and cardiac myocytes.218 Phosphorylation of Y265 of Cx43 and binding of c-Src to 
Cx43 reduced the binding of ZO-1 to Cx43.218 However, the function of ZO-1 in regulating 
Cx43 is still controversial. Induction of gap junction endocytosis increased association of Cx43 
with ZO-1, which suggested a role of ZO-1 in gap junction turnover.219, 220 However, the wild 
type and mutant Cx43 which could not bind to ZO-1 had similar turnover rates.246 The mutant 
Cx43 was translocated to the plasma membrane and formed functional GJIC. Therefore, 
formation of functional GJIC does not require binding of Cx43 with ZO-1. Regulation of Cx43 
phosphorylation by ZO-1 was also suggested.275 ZO-1 might regulate the assembly of Cx43 into 
gap junctional plaques.167, 264 The transcription factor ZO-1-associated nucleic acid-binding 
protein (ZONAB) interacted with ZO-1, and colocalized at cell-cell junctions, which implicated 
a role of gene expression regulation.247 This function was further solidified by the dependence of 
association of Cx43 with ZO-1 on cell cycle stages.280 Cx43 bound to PDZ2 domain of ZO-2 in 
normal rat kidney epithelial cells or mouse heart tissues, and was cell cycle stage independent, 
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however.248 Other connexins that interact with ZO-1 are Cx30,221 Cx31.9,222 Cx36,223 Cx40,258 
Cx45,275,224, 225 Cx46,226 Cx47,221 and Cx50.226  
Gap junctions and adherens junctions (formed by cadherin-mediated Ca2+-dependent 
homophilic cell-cell adhesion) are closely related. Proteins found in adherens junctions may also 
interact with connexins. N-cadherin colocalized with Cx43 in NIH3T3 cells.227 E-cadherin 
colocalized with Cx26 in hepatocytes.228 The p120ctn catenin colocalized with Cx43 in neural 
crest cells.229 Adherens junctions were required for the cell surface expression of Cx43 and gap 
junction formation studied by a siRNA gene knockdown method.227 Treatment with antibody Fab 
fragments against N-CAM interfered with cell-cell communications.139, 230 Gap junctions were 
perturbed in cultured cardiac myocytes isolated from N-cadherin-null mice.231 Cardiac specific 
deletion of N-cadherin in adult mice significantly decreased Cx43 and Cx40.232 Transient 
expression of -catenin targeted both Cx43 and Cx32 to the cell surface and induced gap junction 
assembly.233 Mutations in junctional protein plakoglobin and desmoplakin destabilized gap 
junctions.234 N-cadherin cell surface expression and adherens junction formation also required 
Cx43 in cultured Novikoff hepatoma cells or NIH3T3 cells.167, 266 However, Cx43 was not 
required for the organization of adhesion junctions at the intercalated disc in adult cardiac 
myocytes using a Cx43-knockout mouse model.235 This discrepancy might be caused by the in 
vitro or in vivo methods or the different cell types used. It also seems reasonable that formation 
of mechanical connections (adherens junctions) does not require electrical connections (gap 
junctions). The adherens junction protein, β-catenin, is in the Wnt signaling pathway as a 
coactivator to stimulate the transcription of Wnt target genes. Wnt-1 regulated Cx43 gene 
expression in cultured neonatal rat cardiomyocytes.268 However, the role of Wnt and β-catenin in 
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physiological gene expression of Cx43 is not clear. Signaling of Wnt pathway could also be β-
catenin independent.236  
Connexins may bind to cytoskeletal proteins. The Cx43 tail bound directly to the 
microtubule protein tubulin identified by pull-down experiments.237 Spectrin might play a role in 
connecting connexins to actin microfilaments.238 Another actin-binding protein drebrin interacted 
with Cx43 to stabilize Cx43 at junctional regions.239 Annular gap junctions are the double-
membrane, intracellular structure that is formed by connexin proteins.151 Cytoskeletal elements 
were also involved in annular gap junction turnover.240  
Cx43 colocalized and coimmunoprecipitated with caveolin-1, the marker protein of 
specialized lipid raft domains, caveolae, in NIH 3T3 cells.241 Some other transfected connexins, 
Cx32, Cx36, and Cx46, were also targeted to lipid rafts. However, Cx26 and Cx50 were 
excluded from these membrane microdomains.241 The functional roles of the association of 
connexins with caveolins have not been studied. Whether there is in vivo interaction of caveolin-
1 with cardiovascular connexins is not known. Because lipid rafts provide structural 
microdomains for many signaling molecules,242 this association may serve signaling roles. 
Interestingly, caveolin-1 regulated inter-endothelial cell permeability in lungs in vivo.243 
CaM colocalized with Cx32 in Xenopus oocytes,244 and bound neuronal gap junction 
proteins Cx35,Cx36 and Cx34.7.245 One role of CaM is to control gap junctional gating in 
responding to alterations of pH. 
Connective tissue growth factor CCN3 (NOV) bound Cx43 and inhibited the growth of 
C6 glioma cells.296, 297 The C-terminus of Cx43 was required for this interaction, which was 
specific because Cx40 and Cx32 did not associate with NOV. Further studies are needed to 
investigate the in vivo interaction of Cx43 and NOV. 
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CIP85 (Cx43-interacting protein of 85-kDa) is a new member of the Cx43 binding 
proteins involved in the degradation of Cx43 through the lysosomal pathway.246 CIP85 was 
ubiquitously expressed in mouse and human tissues, although the expression in vascular tissues 
has not been studied. CIP150 is another novel Cx43 interacting protein which regulates the Cx43 
plasma membrane localization in rat cells.247 
FAK coimmunoprecipitated with Cx26 in prostate cancer cells.248 Inhibitors of gap 
junctions reduced invasion and migration. In view of the broad functions of FAK in regulating 
cell adhesion and other related processes,249 and the connexin expression regulation by 
extracellular matrix components,250 interactions between connexin proteins with FAK deserves 
to be studied further. 
2.3.6 Roles of connexins independent of intercellular junctions  
Connexins have been reported to inhibit the growth of cells independent of gap junctional 
activities.136, 251-255 However, the mechanisms are poorly understood. Several lines of evidence 
suggested a role of connexins in gene regulation. Expression of Cx26 upregulated an anti-
angiogenic protein thrombospondin-1, and downregulated another angiogenesis-related gene 
connective tissue growth factor.256 Cx43 transfection reduced the expression of monocyte 
chemotactic protein-1 (MCP-1).257 FAK is another candidate as mentioned before.248 Enhanced 
Cx43 expression increased the protein level of the cyclin-dependent kinase (CDK) inhibitor 
p27,258 through inhibiting the expression of Skp2.259 Cx43CT was localized in nuclei of 
cardiomyocytes and HeLa cells, which might suggest a gene regulation role.255 However, there is 
no report on nuclear localization of whole Cx43 molecules yet.  
 35 
Cx43 has been found to be localized in mitochondria of HUVECs treated with 
homocysteine260 and of rat, mouse, pig, and human hearts.313, 314 However, the exact localization 
was reported to be either at the outer261 or inner mitochondrial membrane.262 Cx43 was 
transported into mitochondria through the regular mitochondrial protein import machinery.262 
Cx43 in mitochondria played roles in protecting hearts with ischemic preconditioning.263 
2.3.7 Gap junction studies using transgenic animal models 
Some connexin related transgenic animal models have been generated to study the possible 
functions of connexin in vivo. 
Cx43-null mice died at birth with a failure in pulmonary gas exchange caused by a swelling 
and blockage of the right ventricular outflow tract,264 with dysregulated coronary 
vasculogenesis.317, 318 Altered innervation also might contribute to cardiac abnormalities in Cx43 
null animals.265, 266 The EC-specific loss of Cx43 allows studying Cx43 functions in ECs of live 
animals. The homozygous vascular EC Cx43 knockout mice survived to maturity. However, they 
were hypotensive and bradycardiac with a increased NO production (determined by measuring 
plasma nitrite and nitrate concentration), and elevated angiotensin I and II levels.267 In contrast, 
no blood pressure alteration was observed using a similar technique.268 Roles of Cx43 in 
regulating blood pressure were investigated by replacing Cx43 with Cx32 in the mouse line 
Cx43KI32 (KI32).269 The renin expression in the kidneys of the homozygous mice was reduced 
compared with wide type and heterozygous littermates. Hypertension can be induced by clipping 
only one renal artery (the 2-kidney, 1-clip (2K1C) model). Interestingly, the 2K1C homozygous 
littermates remained normotensive and showed unchanged plasma renin activities.269 The role of 
Cx43 in atherosclerosis and response to injuries was studied as well. The atherosclerotic lesions 
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of low-density lipoprotein (LDL) receptor-deficient mice were reduced in aortas of Cx43+/- mice 
compared with the Cx43+/+ controls.10 Furthermore, the Cx43+/- mice had less neointima 
formation fallowing balloon distension injury.270 However, mice with SMC-specific knockdown 
of Cx43 had more neointima formation responding to injuries induced by a wire.271  The 
discrepancy may be because of the use of different models. There is only one half of the Cx43 
gene left in all cells, including ECs, in Cx43+/- mice.270 These LDL receptor-deficient mice were 
fed with high-fat diet as well. However, Cx43 gene was deleted from all SMCs.271 The C57BL/6 
mice with SMC-specific knockdown of Cx43 were fed with normal diet. 
In contrast to Cx43, mice with the deletion of Cx40 or Cx37 can survive. However, Cx40-
deficient mice showed impaired endothelium-dependent conduction of vasodilation along 
arterioles,272 and were hypertensive.273 Female mice lacking Cx37 were infertile.274 However, 
mice with simultaneous deletion of Cx37 and Cx40 had severe vascular abnormalities and died 
perinatally, which demonstrated that Cx40 and Cx37 overlapped functionally.275 The alteration 
of other types of connexin after ablation of one connexin is controversial. Mice deficient in Cx37 
or Cx40 showed downregulation of non-ablated connexins in aortic endothelium, whereas, both 
Cx37 and Cx43 were increased in media in Cx40-/- aortas.276 Interestingly, Cx40-deficient mice 
had renin-producing cells in the extraglomerular mesangium rather than in afferent arterioles.277 
This observation indicated that gap junctions are necessary for the correct juxtaglomerular 
positioning and recruitment of renin-producing cells. Furthermore, Cx40-dependent gap 
junctions are essential for the calcium-dependent negative control of renin secretion and 
synthesis induced by AngII and intrarenal pressure,278 which may explain why the Cx40-
deficient mice were hypertensive.273 
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Cx37 protected against atherosclerosis by regulating adhesion of monocytes to ECs in 
apolipoprotein E–deficient mice, which is one of the initial steps toward atherosclerosis.279 
Monocytes and macrophages express Cx37. Monocytes release ATP through Cx37 hemichannels 
to inhibit their adhesion to ECs. Therefore, more monocytes were adhered to ECs in the Cx37-
deficient mice.  
Embryos of Cx45-deficient mice had striking abnormalities in vascular development and 
died between embryonic day 9.5 and 10.5.280 Vasculogenesis in these mice was normal, but 
transformation into mature vessels was blocked. TGF-β signaling was also defective.  
2.3.8 Gap junction regulation by exogenous chemicals 
Some chemicals that have cardiovascular implications have been applied to in vitro culture or 
animals to study the gap junction regulation. 
TGF-β1. TGF-β1 treatment of cultured bovine aortic ECs upregulated Cx43 mRNA and 
protein with a intense vesicular staining, which colocalized with lysosomes.281 TGF-β1 treatment 
reduced the Cx43 degradation through lysosomes. Neonatal rat ventricular myocytes also had 
more Cx43 protein upon TGF-β1 incubation.282 Upregulation of Cx37 expression in confluent 
cells was suppressed by TGF-β1.341, 343 However, the underlying mechanisms are unknown. One 
the other hand, Cx43 also mediated the functions of TGF-β1 through competing with Smad2/3 
for binding to microtubules.283 Of note, Smad2/3 are in the TGF-β1 signaling pathway. The 
binding of Cx43 to microtubules may induce the release of Smad2/3 from microtubules and lead 
to activations of the transcription of target genes induced by TGF-β stimulation. 
TNF-α. TNF-α regulated Cx37, Cx40 and Cx43 in HUVECs differently.284 Cx37 and 
Cx40 proteins were undetectable and the mRNA levels were reduced, whereas the Cx43 protein 
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level seemed to be unaltered otherwise with more perinuclear staining. The level of Cx43 mRNA 
remained unaltered although it was reported that Cx43 promoter activity was decreased by TNF-
α in a rat myoblast cell line.285 On the contrary, TNF-α increased the Cx43, but not Cx40 or 
Cx45, expression in neonatal rat cardiomyocytes. 
NO. NO enhanced de novo formation of gap junctions between acutely coincubated 
HUVECs by increasing the incorporation of Cx40 into the plasma membrane, which was due to 
PKA activation.286 The NO donor S-nitroso-N-acetylpenicillamine (SNAP) enhanced GJIC and  
the protein expression of Cx43 in mesangial cells by activating PKA as well.287 Inhibition of 
NOS decreased the Cx43 mRNA and protein levels in rat aortas.288 However, NO reduced the 
expression of Cx43 mRNA and protein in cultured human uterine myocytes.289 SNAP also 
reduced transfer of carboxyfluorescein to adjacent confluent HUVECs.342 The direct effect of 
NO on Cx43 in VSMCs has not been studied. 
ET-1. The regulation of connexins by ET-1 is controversial. Short term ET-1 treatment 
led to a 50-75% inhibition in GJIC in human ovarian carcinoma cells through ETA receptors. The 
inhibition was also regulated through Cx43 tyrosine phosphorylation by c-Src.290 Treatment of 
cultured cortical astrocytes by ET-1 for 24 h inhibited Cx43 expression through ETB receptors. 
However, ET-1 upregulated the Cx43 protein and mRNA expression and enhanced GJIC for 
long-term effects in rat hepatic stellate cells through ETA and ETB receptors.291 ET-1 treatment of 
cultured neonatal rat ventricular myocytes for 24 h also increased Cx43 protein and 
communication through ETA receptors and ERK1/2.346 The effects of ET-1 on connexin 
expression of vascular cells have not been studied although ET-1 is important in the 
cardiovascular system. 
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AngII. Similar to ET-1, AngII increased the Cx43 protein level in cultured neonatal rat 
ventricular myocytes.292, 293 AngII also increased both mRNA and protein of Cx43 in SMCs of 
human saphenous veins and internal mammary arteries.294 These effects were through AT1 
receptors, ERK and p38 pathway. 292-294 AT1 receptors also regulated cyclic stretch induced 
increase in Cx43 mRNA and protein in neonatal rat cardiomyocytes.295 AngII level can be 
elevated by overexpressing angiotensin converting enzyme (ACE). However, both mRNA and 
protein of Cx43 were reduced in the hearts of cardiac-restricted ACE overexpression mice.296 
The AT1 receptor antagonist candesartan also corrected increased Cx43, and decreased Cx40 and 
Cx37 protein levels in ECs of mesentery arteries in spontaneous hypertensive rats (SHR).297 
Inhibition of ACE in SHR restored the endothelial connexin expression in both aortas and caudal 
arteries, while ACE inhibition had no effects on medial connexin expression.298 Therefore, the 
effects of AngII on connexin expression depend on cell types and specific experimental 
conditions. 
VEGF. VEGF is an important signaling protein for both vasculogenesis (the de novo 
formation of the embryonic vascular system) and angiogenesis (the growth of blood vessels from 
pre-existing vasculature). VEGF is also a vasodilator and increases microvascular permeability. 
VEGF transiently disrupted communication among EA.hy926 ECs (a hybridoma of human aortic 
endothelium and adenocarcinoma) through the VEGFR-2, Src and ERK pathway.299 The 
disruption involved ATP release, and the PI3K/Akt pathway as well in capillary ECs.300 
Upregulation of Cx43 by cyclic stretch in neonatal rat ventricular myocytes was mediated by 
VEGF,282 in addition to AngII.295 However, the relationship of VEGF and AngII in this process 
has not been studied. 
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FGF-2. FGF-2 is a member of the fibroblast growth factor family. It is also called basic 
fibroblast growth factor. FGF-2 decreased dye transfer between cardiomyocytes within 30 
minutes of administration.301 FGF-2 did not affect the Cx43 mRNA or protein level after 24 h. 
However, FGF-2 increased Cx43 phosphorylation. FGF-2 was further found to upregulate 
phosphorylation of the PKC target serines 262 and 368 of Cx43 in adult rat hearts.302 In contrast, 
FGF-2 increased intercellular communication in cardiac fibroblasts at 6 h but not 30 minutes 
after bFGF treatment.303 FGF-2 also increased Cx43 mRNA and protein at 6 h after addition. 
Similarly, FGF-2 increased dye transfer in a time-dependent manner in microvascular ECs.304 
Cx43 mRNA and protein were increased as well. FGF-2 also transiently increased gap junctional 
intercellular communication in VSMCs isolated from human umbilical cord arteries.305 
Intriguingly, FGF-2 inhibited gap junctions, while it stimulated ATP release via hemichannels in 
C6 glioma cells.306 
Cholesterol. Cx37 and Cx40 were downregulated in aortas of mice fed with cholesterol-
enriched diet. Cx40 remained depressed, but Cx37 recovered to 94% of the level found in non-
cholesterol-fed mice after simvastatin treatment.307 Hypercholesterolemia reduced Cx43 protein 
in medial SMCs at the rabbit aortoiliac bifurcation as compared with normal counterparts in 
control animals.308 
Glucose. High glucose (22.2 mM) inhibited activities of gap junctions in bovine aortic 
ECs and SMCs compared to the normal glucose level (5.5 mM) through PKC.367, 368 High 
glucose also elevated phosphorylated Cx43 rapidly in SMCs.309 Regulation of gap junctions by 
glucose in microvascular ECs were also studied. High glucose (30 mM) reduced Cx43 mRNA 
and protein in rat microvascular ECs without affecting the Cx37 and Cx40 expression.310 
Furthermore, high glucose enhanced proteasome-dependent degradation of Cx43 in bovine 
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retinal ECs.311 However, chronic effects of glucose on mRNA and protein of connexins in 
arterial vascular cells have not been studied. 
Nicotine. Cx43 protein and communication function were reduced by nicotine, while 
Cx43 mRNA was upregulated in HUVECs. Statins reduced the effects of nicotine on 
connexins.312 
Homocysteine (Hcy). Hcy is a homologue of the amino acid cysteine, differing in that its 
side chain contains an additional methylene group. A high level of blood serum homocysteine is 
a risk factor for cardiovascular diseases. Cx43 mRNA and protein were increased in Hcy-treated 
HUVECs. However, GJIC was not enhanced. Cx43 was also found to colocalize with 
mitochondria in Hcy-treated HUVECs260 or in cardiomyocytes.261-263 
Lipopolysaccharide (LPS). LPS is a major component of the outer membrane of Gram-
negative bacteria, contributing largely to the structural integrity of the bacteria. LPS also protects 
the membrane from chemical attack. LPS is an endotoxin, inducing a strong immune response in 
animals. The LPS treatment of mice resulted in a reduction in endothelial Cx40 protein, while 
Cx37 was only changed slightly. The endothelial dye dye transfer was decreased by 49%.313 LPS 
changed the Cx43 mRNA level dramatically and rapidly in rat hearts.285  
Oxygen. Hypoxia/Reoxygenation regulated GJIC in HUVECs,314 rat microvascular 
ECs,374 rat thoracic aorta SMCs,315 rat hearts,316 cultured cardiomyocytes,317 and rat astrocytes.231 
VSMCs cultured under a reduced oxygen partial pressure (15 mmHg) for 24 h showed increases 
in Cx43 mRNA, protein, and GJIC mediated through ROS.315 However, hypoxia transiently 
disrupted GJIC and increased Cx43 dephosphorylation by PP2B,231 or reduced the total Cx43 
protein without affecting the unphosphorylated form of Cx43.351 Hypoxia of rat hearts under 
Langendorff preparation dephosphorylated Cx43 and changed its localization to the entire 
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plasma membrane although ZO-1 localized at the intercalated disc normally.316 Reoxygenation 
after hypoxia first disrupted GJIC followed by a return to normal.314 Tyrosine and MAP kinases 
regulated the reduced GJIC in ECs.318 Reversible dephosphorylation and rephosphorylation of 
Cx43 during hypoxia and reoxygenation were sensitive to the cellular ATP level.319  
2.3.9 Gap junction regulation by mechanical factors 
Studies have shown that gap junctions can be regulated by mechanical factors, such as flow or 
shear stress, pressure and stretch. 
Flow (shear stress). In situ immunostaining revealed that endothelial Cx43 was mainly 
expressed at locations with disturbed flow, such as the downstream edge of the ostia of 
branching vessels and flow dividers, where exists spatial gradients in wall shear stress.320 
Consistent with this observation, shear stress spatial gradients in regions of disturbed flow 
created by a step in the flow chamber upregulated the expression of Cx43 in cultured bovine 
aortic ECs.13 Connexin expression was further studied using two flow waveforms.321 One was 
called athero-protective, which represented the flow in straight arteries. The other was called 
athero-prone, which exists in the regions of bifurcation and curvature. Again, Cx43 expression 
was upregulated by the athero-prone flow waveform after culturing for 24 h. However, the Cx43 
mRNA level of ECs isolated from the region with disturbed flow in aortas of healthy adult pigs 
was downregulated in a microarray study, which was verified by quantitative real-time PCR.322 
Unfortunately, protein levels of Cx43 in these two regions were not detected. Because a higher 
mRNA level may not necessarily lead to a higher protein level, it is possible that there are more 
Cx43 proteins in the disturbed flow region of aortas of healthy adult pigs. Similarly, the mRNA 
levels of Cx43 were not measured in locations with disturbed flow.320 Conducting these 
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“missing” experiments may give us a better understanding of the regulation of Cx43 by flow in 
vivo. A temporal gradient in shear stress upregulated Cx43 mRNA and protein in HUVECs as 
well.323  
Cx40 and Cx37 are distributed more uniformly along the systemic arteries.320 The Cx37 
and Cx40 levels were elevated by the athero-protective flow waveform in HUVECs after 
culturing for 24 h.321 However, athero-protective steady laminar flow downregulated Cx40 
mRNA in cultured human aortic ECs.324 
The regulation of the gap junctional dye transfer function of ECs by flow in vitro is still 
controversial. Dye spread was at a very low level in statically cultured human aortic ECs 
although there was a strong peripheral Cx43 and Cx40 staining.325 Laminar flow for 24 h 
increased dye coupling 7.5-fold, which was attributed mainly to Cx40. Using the same cell type, 
laminar flow, however, reduced dye transfer between cells.326 
Pressure (wall stress/strain). Vascular connexin expression correlated with in vivo 
blood pressure in different ways. Rats which were made hypertensive by clipping one renal 
artery (2K1C) or feeding deoxycorticosterone and salt (DOCA-salt model) had more Cx43 
mRNA and protein in aortas (with ECs and SMCs).358, 359 However, hypertensive rats induced by 
inhibiting NOS with NG-nitro-L-arginine methyl ester (L-NAME model) had less Cx43 mRNA 
and protein in aortas although similar systemic blood pressure was obtained in these three 
models.327 Cx43 protein in the media of aortas was also reduced in SHR.298 In contrast, 
endothelial Cx43 in mesentery arteries was elevated in SHR. On the other hand, the 
antihypertensive drug carvedilol rectified the reduced expression of Cx43 and 37 in L-NAME 
model while only partially by atenolol although both drugs decreased blood pressure 
efficiently.328 Similarly, the AT1 receptor antagonist candesartan decreased endothelial Cx43 in 
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SHR while the combination of hydralazine and hydrochlorothiazide did not show the same effect 
although blood pressure was both decreased to normal.297 The antihypertensive treatment by the 
inhibition of ACE also could not increase the reduced level of Cx43 in aortic SMCs.298 Therefore, 
pressure does not regulate connexin expression independently in vivo. Other factors play roles as 
well, although these factors have yet to be identified. 
A higher hydrostatic pressure (150 mmHg) did not increase Cx43 protein in bEnd.3 cells 
compared with the normal pressure (100 mmHg) at shear stress 0.3±0.1 or 6±3 dyne/cm2.12 
Although pressure was pulsatile (pulse pressure 40 mmHg), there was no stretch in these 
experiments. 
Stretch regulates gap junctions in vitro. Twenty percent static stretch of cultured VSMCs 
increased the Cx43 mRNA level by 2 h. The Cx43 protein level was increased by 4 h and 
remained elevated for 16 h.14 Cyclic stretch (4%) for 4 h increased Cx43 protein in bEnd.3 cells 
with shear stress 6±3 dyne/cm2.12 Cyclic stretch also increased both mRNA and protein of Cx43 
in cultured neonatal rat cardiomyocytes through AngII,295 TGF-β1,282 VEGF,282 and was 
associated with the activation of Na-H exchangers.329 The effects of stretch on Cx43 varied with 
extracellular matrix proteins.330 Cyclic stretch increased the Cx43 protein level in cells grown on 
native collagen through β1 integrin; but there was no increase in cells grown on fibronectin or 
denatured collagen. Cyclic stretch may regulate Cx43 phosphorylation. For example, osteoblasts 
had more phosphorylated Cx43 under cyclic stretch although the steady state mRNA level did 
not change.331  
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2.4 OVERALL SUMMARY OF BACKGROUND 
Previous studies have clearly demonstrated that mechanical factors regulate vascular structure 
and functions. Vascular cells have the capability of sensing and transducing mechanical factors 
through complex mechanisms. However, controversies still exist regarding to the effects of 
mechanical factors on vascular cells, and the underlying mechanisms. Part of the reason is 
because of the different methodologies utilized in different studies. 
Vascular gap junctions are important for the homeostasis of the vasculature. There is 
association between vascular gap junctions and vascular diseases (e.g., hypertension). Previous 
studies have shown that vascular gap junctions are regulated by mechanical factors in addition to 
chemicals. However, it is still not clear how mechanical factors regulate vascular gap junctions, 
and the mechanisms are largely unknown. Using ex vivo culture of arteries, we investigated the 
regulation of Cx43 by the mean pressure level and pulsatility in intact arteries. Our results 
demonstrate that both the mean pressure level and pulsatility regulate Cx43. 
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3.0  MATERIALS AND METHODS 
3.1 ISOLATION OF RABBIT DESCENDING THORACIC AORTAS 
 All procedures involving animals were approved by the Institutional Animal Care and Use 
Committee of the University of Pittsburgh, and conform with the guidelines of the National 
Institute of Health for the care and use of laboratory animals (NIH Publication No. 85-23, 
revised 1996).  
The descending thoracic aortas of male New Zealand white rabbits weighing 2 to 3 kg 
were harvested using a procedure adopted from Bardy et al.332 The diameter of the aorta is 
around 5 mm. The length of the DTA is about 9 cm. Therefore, the rabbit aorta is appropriate for 
ex vivo culture. Rabbits were first anesthetized by a mixture of ketamine (45 mg/kg, Kataject®, 
Phoenix Pharmaceutics) and xylazine (5 mg/kg, Xyla-Ject®, Phoenix Pharmaceutics) injected 
intramuscularly for preparing the skin and ear veins. A heating pad was applied underneath the 
rabbit to maintain the temperature of the rabbit. Intra-venous catheters (22 GA, BD InsyteTM, BD 
Biosciences) were used to infuse ketamine and saline. Ketamine (80 mg/kg·h) was then 
continuously infused during the procedure using a syringe infusion pump (model 22, Harvard 
Apparatus). Saline (0.9% sodium chloride, Hospira) was continuously infused via another ear 
vein. Rabbits were mechanically ventilated through the trachea using a Harvard rodent ventilator 
(model 683, Harvard Apparatus). Betadine® solution (containing 5% povidone-iodine, Perdue 
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Products L.P.) was applied to disinfect the skin. Abdominal and pleural cavities were opened to 
expose the DTA. The chest was expanded by a rib spreader. Blunt dissection techniques were 
used to isolate branches. Intercostal arteries were ligated with 6-0 silk sutures (18020-60, Fine 
science Tools). The warm (37 °C) Tyrode’s salts solution with heparin (1 USP units/ml, Baxter 
Healthcare), papaverine (100 mg/liter, Sigma) and antibiotics (100 U/ml of penicillin, 100 µg/ml 
of streptomycin (Gibco), and 5 µg/ml of amphotericin B (Sigma)) was applied frequently to the 
outside of the aorta in order to prevent drying and spasm. Heparin (1000 U) was injected through 
an ear vein before cannulation. Then both ends of the DTA were cannulated using vessel 
cannulae (DLP®30003, Medtronic). The cannula closer to the heart was capped. A bag of 
Tyrode’s salts solution with heparin (1U/ml), papaverine (100 mg/liter) and antibiotics (100 
U/ml of penicillin, 100 µg/ml of streptomycin, and 5 µg/ml of amphotericin B) was connected to 
the distal cannula in order to prevent collapse of the DTA. Two custom-designed vascular 
stabilizers (Appendix C) held the DTA at in vivo length. Then the DTA was cut into two 
segments and put into a tray with Tyrode’s salts solution. Each aortic segment was held at in vivo 
length by one stabilizer. The other end of the DTA was cannulated and connected to an ex vivo 
culture system.  
3.2 PERFUSION ORGAN CULTURE OF AORTAS AND EXPERIMENTAL 
PROTOCOL 
Perfusion organ culture of aortas. The ex vivo culture system is shown in Figure 3-1. The 
mean and pulsatile components of a pulsatile pressure could be adjusted individually. A 
computer-compatible/programmable drive (VX-07550-30, Cole-Parmer) and a six-roller 
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cartridge pump head (EW-07519-10, Cole-Parmer) with multi-channel cartridges (EW-07519-
75, Cole-Parmer) (1, Figure 3-1) generated desired mean flow under different pressures. A 
compliance chamber (SA-07596-20, Cole-Parmer) (2, Figure 3-1A) reduced the pulsation of 
pressure and flow. A manual valve (C-98002-00, Cole-Parmer) (2, Figure 3-1B) was used 
instead to adjust the pulse pressure for pulsatile perfusion. An ultrasonic flow rate sensor and 
flow meter (Transonic Systems) (3) measured flow rates. A pressure transducer (DTXTM Plus, 
BD Biosciences) and amplifier (LDS Test and Measurement) (4) measured pressure. The DTA 
was cultured in a custom-made polycarbonate chamber (5) in its in vivo length and flow 
direction. The culture medium was Dulbecco’s Modified Eagle Medium (DMEM, Cambrex) 
supplemented with 10% FBS (Mediatech), 25 mM HEPES (Sigma), 100 U/ml of penicillin, 100 
µg/ml of streptomycin (Gibco), and 2.5 µg/ml of amphotericin B (Sigma). The level of the mean 
pressure was adjusted by a manual valve (C-98450-37, Cole-Parmer) (6) downstream of the 
DTA. The Precision PharMed ® tubing was used for the pump. The rest was Nalgene® 180 Clear 
PVC tubing (Cole-Parmer). The entire loop was put into a standard water-jacketed CO2 incubator 
(3250, Forma Scientific) with 7.5% CO2 to maintain the physiological pH and temperature. The 
partial pressures of CO2 and O2 (pCO2, pO2), and pH were measured by a blood gas analyzer 
(ABL5, Radiometer America). All components that contacted the culture medium were sterilized 
through autoclave or ethylene oxide. One LabVIEW program (National Instruments) was 
running to collect the flow and pressure data.  
 49 
 Figure 3-1 Schematic of the perfusion organ culture system. 
The system shown in A generates steady pressure and flow. The system in B generates pulsatile pressure and 
flow. 1: MasterFlex pump, 2: compliance chamber in (A), or manual pinch valve in (B), 3: flow probe, 4: 
pressure probe, 5: culture chamber, 6: manual valve. 
 
TUNEL apoptosis assay. Arterial sections were detected for apoptosis using the TUNEL 
(Transferase-mediated dUTP Nick End Labeling) assay (ApopDETEK Red Cell Death Assay, 
Enzo Life Sciences, NY) in order to test the ex vivo culture system. Broken DNA molecules are 
stained red in this assay. Nuclei are stained blue by DAPI (4'-6-Diamidino-2-phenylindole). The 
colocalization of red and blue represents apoptotic cells, which are magenta in merged images. 
Arteries were fixed in 4% paraformaldehyde for 3 h at room temperature, followed by 
preservation in 30% sucrose at 4 °C. Both fresh (Figure 3-2A, 10 μm section radially) and 
cultured DTAs (steady pressure 140 mmHg, 40 ml/min, 22 h, 5 μm-section longitudinally, 
Figure 3-2B) had very few positive apoptotic staining. The DNase I treated positive control 
section stained most nuclei positive (Figure 3-2C), while the section without the terminal 
deoxynucleotidyl transferase did not show specific apoptotic staining (Figure 3-2D).  
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 Figure 3-2 TUNEL apoptosis detection of aortic sections. 
Colocalization (pink) of fragmented DNA (red) and nuclei (blue) signify apoptotic cells. The DTA cultured 
at 140 mmHg, 40 ml/min for 22 hours showed very few apoptotically positive staining (B) as the freshly 
isolated control sample (A). The DNase I treated section had strong staining (C). The section without the 
terminal deoxynucleotidyl transferase in the reaction solution had no specific apoptotic staining (D).  
 
Vasocontraction test of cultured DTA. One DTA was cultured under steady pressure 
210 mmHg and steady flow 200 ml/min for 24 h. Epinephrine-induced vasoconstriction was used 
to assess the contractility of the DTA after culturing for 24 h. This test was conducted at a 
distending pressure of 100 mmHg and epinephrine (Sigma) concentration of 1 mg/liter. The 
outer diameter of the DTA was measured using a Nikon SMZ645 stereomicroscope. Figure 3-3 
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shows the relative outer diameter after epinephrine was added. The DTA contracted rapidly and 
vigorously following addition of epinephrine, which demonstrated the viability and functionality 
of the cultured DTA. 
 
Figure 3-3 Vasocontraction test of cultured DTA. 
The diameter change of DTA after culturing at 210 mmHg for 24 h was measured following addition of 
epinephrine to the culture medium at 1mg/liter at the end of culture (time zero in the figure). The DTA 
contracted quickly following epinephrine addition.  
 
Experimental Protocols. Experiments were conducted in a pair-wise fashion. Each aorta 
was cut into two segments that were arbitrarily cultured under either an experimental or control 
condition. Some experiments were designed to study the effects of the mean pressure level. 
Therefore, aortas were cultured under either high steady pressure (150 mmHg, without 
pulsatility), or normal (low) steady pressure (80 mmHg) as the control for 6 h or 24 h. The 
duration of 6 h culture was thought to be a short-term, while the relatively long effect was 
studied by 24 h culture (long-term). The diameter of DTA under 80 mmHg was similar to the in 
vivo value.87 The flow was 20 ml/min, which was lower than the physiological one (~200 
ml/min).87 Both segments were cultured under pulsatile conditions but with different mean 
pressure (80 versus. 150 mmHg, pulse pressure 30 mmHg for both, mean flow 25 ml/min, 192 
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cycles/min) in one set of experiments for 24 h. The diameter change under this pulsatile 
condition was not measured in this study. However, the pulsatile pressure 70~90 mmHg induced 
10% cyclic stretch of the DTA.87 To detect the effects of cylcic stretch compared with steady 
stretch, one vessel was cultured under pulsatile perfusion (mean pressure 80 mmHg, pulse 
pressure 30 mmHg, mean flow 25 ml/min); the other one was under steady pressure (80 mmHg) 
with the same flow. Because of the nonlinearity of the mechanical properties of aortas, the cyclic 
stretch is larger under the same pulse pressure (30 mmHg) if the mean pressure is 80 mmHg 
compared with 150 mmHg.15 Therefore, one set of experiments was performed to clarify the 
effect of cyclic stretch versus cyclic stress by culturing one segment with pulsatile perfusion 
(mean pressure 150 mmHg, pulse 30 mmHg), the other one with steady high pressure (150 
mmHg) for 24 h. The Src specific inhibitor PP1 (10 μM, BIOMOL, PA) was added to the media 
of steady high or low pressure at the onset of experiments to investigate the role of Src. PP1 is a 
a highly specific inhibitor of Src family kinases.333 The concentration of PP1 (10 μM) has been 
used by most, if not all, studies using PP1.31, 334, 335 Arteries cultured pulsatile had more 
superoxide,87 which mainly come from NADPH oxidase.336 The inhibitor of NADPH oxidase 
apocynin (0.4 mM, Sigma) was added to the media of pulsatile perfusion for 24 h to explore the 
role of ROS on mediating the Cx43 regulation by cyclic stretch. Apocynin (0.4 mM) was also 
added to the media of relaxed aortas (in a Petri dish) for 6 h. Apocynin is a methoxy-substituted 
catechol. It impedes the assembly of the p47phox with the membrane-bound NADPH oxidase 
complex.337 Apocynin was used  at 1 mM for mouse aortas,338 0.3 mM for rat femoral  
arteries.111 
Superoxide measurement. Apocynin is a methoxy-substituted catechol, which exists in 
some plants. Apocynin impedes the assembly of the p47phox and p67phox subunits with the 
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membrane NADPH oxidase complex,339 thus inhibits the full activation of NADPH oxidase. 
However, apocynin increased superoxide in aortic fibroblasts.340 In order to test if apocynin 
actually inhibited NADPH oxidase, levels of superoxide were measured using the 
chemiluminescence dye L-012.341 In three separate experiments, AngII (1.3 μM, Fisher 
Scientific), superoxide dismutase (SOD, 100 U/ml, Sigma), and apocynin (0.4 mM) was added to 
a vial with an aortic ring in a Krebs-HEPES buffer (pH 7.4; in mM: NaCl 99, KCl 4.69, CaCl2 
1.87, MgSO4 1.2, NaHEPES 20, K2HPO4 1.03, NaHCO3 25, and D(+)Glucose 11.1),341 
respectively. The concentration of L-012 (Wako Pure Chemical Industries) was 100 μM. Photons 
were counted for two seconds in every minute using the Femtomaster FB14 luminometer (Zylux). 
3.3 PROTEIN EXTRACTION, ELECTROPHORESIS AND WESTERN BLOT 
Protein extraction. After culture, aortas were snap-frozen in liquid nitrogen. Frozen tissues 
were stored at -80 °C until use. Tissues of the same rabbit were processed together. Samples 
were maintained cold by putting on ice or in a cold room during protein extraction. Tissues in a 
lysis buffer were cut into small pieces, and homogenized. The lysis buffer contained: NaCl 150 
mM, Tris 20 mM pH7.5, ethylenediamine-tetraacetic acid (EDTA, 1 mM), aprotinin 10 μg/ml, 
pepstatin A 11.4 μg/ml, leupeptin 15 μg/ml, phenylmethanesulfonyl fluoride (PMSF, 2 mM), 
activated sodium orthovanadate 2mM, sodium fluoride 50mM, and sodium dodecyl sulfate 
(SDS, 1%). After sonicating 3×10 seconds, samples were incubated for 45 minutes.  Then, 
samples were centrifuged for 15 minutes at 13,000 rpm. Supernatants were aspirated and stored 
at -80 °C. Protein concentrations were measured by the BCA method (23227, Pierce), which was 
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more compatible with detergents (SDS here). The protein concentrations were around 2 μg/μl for 
most samples.  
SDS-PAGE (polyacrylamide gel electrophoresis) and Western blot. Proteins can be 
separated according to their molecular weight using SDS-PAGE. Proteins are charged negatively 
by SDS. An electric current is used to drive protein molecules to the positive end across a 
polyacrylamide gel during electrophoresis. The polyacrylamide gel is a cross-linked matrix 
functioning as a sieve. Smaller proteins navigate faster. Protein samples from the same rabbit 
were analyzed in the same gel. Proteins in the sample buffer (1×, 3% SDS, 5% glycerol, 5% 2-
mercaptoethanol, and bromophenol blue) were boiled for 5 minutes before loading. Protein 
concentrations were adjusted to the same by adding the lysis buffer. After centrifuging for 30 sec 
at a relative centrifugal force 10,000g, equal amounts of total proteins  (15~40 µg) were carefully 
loaded into wells on 10% polyacrylamide gels. The BenchMark prestained protein ladder 
(Invitrogen) was also loaded to each gel to help determine the molecular weight. Proteins were 
then electrophoresed at 200 volts using a Bio-Rad Mini-Protean III apparatus.  
Separated proteins were electrophoretically transferred to polyvinylidene difluoride 
membranes (PVDF, Millipore) at 320 mA for 80 minutes in a cold room. The transfer buffer had 
25 mM Tris, 192 mM glycine, 0.3 g/liter SDS, and 20% methanol. Proteins were transferred out 
of the gel except at the top under this transfer condition (Figure 3-4). Membranes were blocked 
for 1 h at room temperature in order to reduce non-specific bindings. The blocking solution was 
5% non-fat dried milk for most antibodies or 5% bovine serum albumin (BSA) for total Src and 
total Akt antibodies in 20 mM Tris buffered saline (TBS, pH 7.5) with 0.1% tween-20 (TBST). 
Membranes were then incubated with primary antibodies.  The dilution and incubation were: 
rabbit polyclonal anti-Cx43 (immunogen is a synthetic peptide derived from the cytoplasmic 
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loop of rat Cx43, affinity purified, 71-0700, Zymed Laboratories), 1:250 (1 μg/ml), overnight (in 
the cold room otherwise specified); rabbit polyclonal anti-non-phospho-Src (Tyr-527, active Src, 
immunogen is a synthetic peptide (KLH-coupled) corresponding to residues surrounding Tyr527 
of human Src, purified by protein A and peptide affinity chromatography, 2107,  Cell Signaling 
Technology), 1:500, overnight; rabbit polyclonal anti-Src (total Src, immunogen is at the C-
terminus of Fyn of human origin, affinity purified, sc-18, Santa Cruz Biotechnology), 1:2000 
(0.1 μg/ml), overnight; mouse monoclonal anti-phospho-Akt (Ser473, active Akt, immunogen is 
a synthetic phospho-peptide (KLH-coupled) corresponding to residues around Ser473 of mouse 
Akt, 4051S, Cell Signaling Technology), 1:500, overnight; rabbit anti-Akt (total Akt, 
immunogen is a synthetic peptide (KLH-coupled) derived from the carboxy-terminal sequence of 
mouse Akt, purified by protein A and peptide affinity chromatography, 9272, Cell Signaling 
Technology), 1:1000, overnight; mouse monoclonal anti-p27kip (referred to as p27 hereafter) 
(immunogen is against mouse p27, IgG1, purified from tissue culture supernatant or ascites by 
affinity chromatography, 610241, BD Biosciences), 1:4000 (0.0625 μg/ml), overnight; mouse 
monoclonal anti-β-catenin (immunogen is amino acids 680-781 mapping at the C-terminus of β-
catenin of human origin, IgG1, sc-7963, Santa Cruz Biotechnology), 1:1000 (0.2 μg/ml), 
overnight; and mouse monoclonal anti-β-actin (immunogen is slightly modified β-actin N-
terminal peptide, Ac-Asp-Asp-Asp-Ile-Ala-Ala-Leu-Val-Ile-Asp-Asn-Gly-Ser-Gly-Lys, 
conjugated to KLH, IgG1, purified, A1978, Sigma) antibody, 1:1000, 45 minutes, room 
temperature. After washing 3×10 minutes in TBST, membranes were incubated with secondary 
antibodies for 1 h at room temperature. The new mouse monoclonal anti-rabbit IgG, light chain-
specific antibody (211-032-171, Jackson ImmunoResearch Laboratories) was used to detect 
primary antibodies generated in rabbits at dilution 1:50,000. The goat anti-mouse antibody with 
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horseradish peroxidase (HRP) (554002, BD Pharmingen) was used to detect primary antibodies 
produced in mice. After washing 3×10 minutes in TBST, protein bands were detected by 
enhanced ECL reagents (ECL plus, GE Healthcare) for most proteins or regular ECL reagents 
(32106, Pierce) for β-actin. The Kodak Image Station 2000R (Eastman Kodak Company) was 
used to take images and do densitometric analysis of bands. Intensities of target protein bands 
were normalized to the corresponding  bands of β-actin, which has been widely used as the 
control protein. Our results also demonstrated that protein levels of β-actin were not significantly 
changed in these culture conditions. 
 
 
Figure 3-4 Coomassie blue staining of a transferred gel to test protein transfer efficiency. 
Except at the top of the gel, proteins have been transferred out of the gel. The proteins at the top of the gel 
have very large molecular weights, which are out of the range of our interested proteins. Therefore, the 
transfer was efficient.  
 
The specificity of the Cx43 bands was tested by omitting the primary antibody 
(secondary antibody only in Figure 3-5A) or incubating the immunogen peptide with the primary 
antibody. Proteins from a mouse heart (mH in Figure 3-5A) and a rabbit heart (rH) were loaded 
as the positive controls. There were no bands after omitting the primary antibody or with the 
immunogen peptide blocking (Figure 3-5A). Samples from the mouse and rabbit hearts, and 
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DTA had bands with a molecular weight around 43 kDa (Figure 3-5A). The corresponding 
positions of these membranes are shown in Figure 3-5B. 
 
 
 
Figure 3-5 The Cx43 bands are specific to the Cx43 antibody. 
The specificity of the Cx43 bands was tested by omitting the primary antibody (secondary antibody only in 
A) or incubating the immunogen peptide with the primary antibody. There were no bands after omitting the 
primary antibody or with the immunogen peptide blocking (A). Samples from the mouse and rabbit hearts, 
and DTA had bands with a molecular weight around 43 kDa (A). The corresponding positions of these 
membranes are shown in B and drawn in A. 
 
Bands may reach saturation when too much protein is loaded. Possibility of Cx43 band 
saturation was tested by loading different amounts of total proteins (Figure 3-6). Bands of Cx43 
and β-actin with 40 μg total proteins had an intensity which was approximately twice of that with 
20 μg total proteins, respectively. Similarly, bands of Cx43 and β-actin with 20 μg total proteins 
had an intensity which was approximately twice of that with 10 μg total proteins, respectively 
Therefore, bands were not saturated for both Cx43 and β-actin when loading 40 μg total proteins. 
 58 
Although we did not test the full range of linearality of Cx43 and β-actin, it was linear for the 
amount of total proteins loaded in this dissertation (15~40 μg). 
 
 
Figure 3-6 Saturation test of Cx43 bands. 
Different amounts of total proteins from aortas cultured under high pressure (H, 150 mmHg) or low pressure 
(L, 80 mmHg) were loaded to test the linearality of Western blot for Cx43 and β-actin. It is approximately 
linear in the range of 10 to 40 μg total proteins, the amount that had been loaded in this study.  
3.4 QUANTITATIVE MESSENGER RNA ANALYSIS 
Real-time polymerase chain reaction (PCR) can be used to detect gene expression levels 
quantitatively. It is more sensitive and accurate than end-point PCR in which PCR products are 
detected after amplification by running gels. The TaqMan® PCR assay uses special probes and a 
fluorescent reporter dye to detect the cycle-by-cycle increase in the amount of PCR products in 
real time. Gene-specific primers and probes improve specificity of PCR results. 
 
Total RNA extraction. After culture, aortas were snap-frozen in liquid nitrogen. Frozen 
tissues were stored at -80 °C until use. The RNeasy kit for fibrous tissues (Qiagen) was used to 
extract total RNA from aortas per manufacturer’s protocol with modifications in order to 
increase the yield. Proteinase K was used to digest fibers. Genomic DNA molecules were 
degraded by the RNase-free DNase I treatment. RNA samples were diluted in 10 mM Tris pH7.0 
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buffer when measuring concentrations at A260 using a Spectronic Biomate spectrometer (Thermo 
Electron Corporation). The ratio of A260/A280 is an estimate of the purity of RNA samples. A 
ratio of 1.9~2.0 indicates highly purified RNA. The integrity of RNA was checked using 1% 
agarose gel electrophoresis and ethidium bromide (EtBr) staining. The BioRad mini-sub cell GT 
system was used to cast gels and run electrophoresis. One example of EtBr staining was shown 
in Figure 3-7. The integrity of RNA sample was shown by the ratio of 28S to 18S ribosomal 
RNA, the most abundant RNA in mammalian cells. Undegraded total RNA samples have a ratio 
of 2, which was the case in Figure 3-6. RNA samples were stored at -80 °C until doing reverse 
transcription. 
 
 
Figure 3-7 Integrity test of total RNA extracted from rabbit aortas. 
Total RNA extracted from a rabbit descending thoracic aorta was separated by electrophoresis using an 
agarose gel. Bands were stained with ethidium bromide. The integrity of RNA sample was shown by the ratio 
of 28S (the upper band) to 18S (the lower band) ribosomal RNA. Two clear bands were detected. The 28S 
band was much stronger than the 18S band. Therefore, the RNA sample was not degraded. 
 
Reverse transcription. mRNA molecules in total RNA samples were reverse transcribed 
to complimentary single-stranded DNA (cDNA), which was used in the subsequent PCR step. 
The High Capacity cDNA Archive Kit from Applied Biosystems was used. Random primers 
were used in this kit. The amount of total RNA that can be loaded in one reaction with volume 
100 μl is 0.1~10 μg for this kit. Total RNA at the amount of 0.5 μg of total RNA was loaded into 
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a 0.2 ml thin wall PCR vial. The negative control for reverse transcription did not have the 
reverse transcriptase. Vials were kept at 25 °C for 15 minutes first. The reaction lasted for 2 h at 
37 °C in a thermal cycler (TC-312, Techne) before vials were maintained at 4 °C.  Samples were 
stored at -80 °C until doing PCR.  
Real-time polymerase chain reaction. The TaqMan® gene expression assay was used to 
compare Cx43 mRNA levels using GAPDH as the reference, or Cx40 mRNA levels using VE-
cadherin as the reference. The reason of choosing VE-cadherin as the reference is because both 
Cx40 and VE-cadherin are expressed in ECs only in rabbit descending thoracic aortas. The assay 
uses a single FAMTM dye-labeled TaqMan® probe with a DNA minor groove binder moiety and 
two unlabeled oligonucleotide primers. The TaqMan Universal PCR Master Mix (Applied 
Biosciences) contains necessary components for accurate amplification and detection of PCR 
products. These components are AmpliTaq Gold DNA polymerase, dNTPs with dUTP, passive 
internal reference ROX, optimized buffer components, and AmpErase Uracil N-glycosylase 
(UNG). The passive internal reference minimizes well-to-well variability that can result from a 
variety of causes, such as pipetting errors and sample evaporation. UNG eliminates products 
from previous PCR amplifications by excising uracil residues. Samples were loaded into a 96-
well plate in triplicate. The reaction volume was 25 μl in each well. The plate was covered by an 
optical adhesive cover (Applied Biosciences). PCR was conducted in the TaqMan® core facility 
of the Genomics and Proteomics Core Laboratories of the University of Pittsburgh. Samples 
were kept at 50 °C for 2 minutes first. Temperature was increased to 95 °C and kept for 12 
minutes before the amplification reaction. Forty cycles were repeated. Each cycle was held at 95 
°C for 15 seconds and at 60 °C for 1 minute. The primers and probes for rabbit Cx43 gene (GI # 
39981122, NCBI CoreNucleotide accession # AY382590), GAPDH gene (GI # 406106, NCBI 
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CoreNucleotide accession # L23961), Cx40 gene (GI # 81238392, NCBI CoreNucleotide 
accession # DQ242483), and VE-cadherin (Ensembl gene ID ENSOCUG00000016941) are as 
follows: 
Cx43 forward primer 5’-AGTGCAGAACAAAACCGAATGG-3’ 
Cx43 reverse primer 5’-GCTGTGCATGGGAGTTGGA-3’  
Cx43 probe 5’-CAGGCAGGAAGTACCATC-3’ 
GAPDH forward primer 5’-CGGATTTGGCCGCATTGG-3’ 
GAPDH reverse primer 5’-GGCGACAACATCCACTTTGC-3’  
GAPDH probe 5’-CCAGGGCTGCTTTTAA-3’ 
Cx40 forward primer 5’-GGTGCTGCAGATCATCTTCGT-3’ 
Cx40 reverse primer 5’-TCTTGCGCTTCTCCTGCAT-3’  
Cx40 probe 5’-CCTGGTGTACATGGGCCAC-3’ 
VE cadherin -forward primer 5’-TCCGTGCCCGAGATGTC-3’ 
VE cadherin -reverse primer 5’-CGCATCCACTGCTGTCACA-3’  
VE cadherin -probe 5’-ACCGAGGTCCCCACAGAT-3’ 
Levels of mRNA were relatively quantified using the comparative Ct (ΔΔCt) method. 
The threshold cycle (Ct) is the PCR cycle at which there is a significant increase in reporter 
fluorescence signal above a baseline in a given well. ΔCt is the difference between the threshold 
cycle of a target gene and the threshold cycle of the corresponding reference gene in the same 
well. Therefore, ΔCt = Ct (target) – Ct (endogenous reference). ΔΔCt is the difference between 
the average ΔCt value of an experimental sample and the average ΔCt for the corresponding 
control sample. Thus, ΔΔCt = ΔCt (experimental sample) – ΔCt (control sample). The fold 
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change in mRNA is calculated by the equation: Expression fold value = 2-ΔΔCt. Ct values were 
obtained using the software SDS2.2 (Applied Biosciences). 
A series of cDNA samples in triplicate was loaded in order to compare the amplification 
efficiency under different substrate concentrations using cDNA generated by reverse 
transcription from 100 ng, 25 ng, 5 ng, 1 ng, and 0.2 ng of total RNA. Figure 3-8 shows 
fluorescent signal changes over amplification cycles for Cx43 (right curves) and GAPDH (left 
curves) at 10 ng total RNA in triplicate. Cycles from 3 to 15 were used to calculate the baseline 
signal. The threshold value was 0.17. The Cx43 no-template negative control well had no 
amplification. The Cx43 no-reverse-transcription control well showed amplification. But the Ct 
value was 37.7, which was much larger than the Ct values of reverse transcribed samples (~21). 
The GAPDH no-template or no-reverse-transcription negative control well had amplification 
with Ct 35.89, 32.22 respectively, which were much larger than the Ct values of reverse 
transcribed samples (~17). Based on the Ct values under different concentrations of cDNA (or 
total RNA), the amplification efficiency of Cx43 and GAPDH was 94.6% and 96.9%, 
respectively (Efficiency = (10-1/slope-1)×100%; For Cx43, Ct=-3.46log[RNA]+28.11. For 
GAPDH, Ct=-3.4log[RNA]+24.93. The slope was -3.46, -3.4, respectively). Therefore, both 
cDNA samples were amplified efficiently and had similar efficiency which was close to 100%. 
The ΔCt values (CtCx43 – CtGAPDH) at different cDNA concentrations were similar as well (ΔCt=-
0.06log[RNA]+3.18. The very small slope (0.06) represents independence of ΔCt on RNA 
concentration). These analyses verified that 2-ΔΔCt method could be used to compare gene 
expression levels of rabbit Cx43 in arterial tissues.   
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 Figure 3-8 One example of the PCR amplification plot of Cx43 (right) and GAPDH (left) genes. 
3.5 IMMUNOHISTOCHEMISTRY AND CONFOCAL MICROSCOPY 
Expression of connexin proteins in rabbit DTAs has not been reported. Freshly harvested rabbit 
DTAs were stained either en face or after sectioning (8 µm) for Cx43, Cx40 and Cx37, the most 
common connexin proteins in large arteries. En face staining of the endothelium used whole 
mounts of aortic rings (5 mm long). To prepare DTAs for section, DTAs were frozen in 
isopentane (Fisher Scientific) at -160 °C which was achieved using liquid nitrogen. DTAs were 
then embedded in Tissue-Tek® O.C.T. Compound (Fisher Scientific) which was frozen on dry 
ice. Cardiac ventricles have abundant Cx43 expression in intercalated discs. Therefore, rabbit left 
ventricles were processed similarly to DTAs to act as the positive control of Cx43 staining. 
Aortic rings and sections were fixed in -20 °C acetone (Sigma) for 10 minutes. After brief 
washing, samples were blocked in phosphate buffered saline (PBS, Sigma) with 10% normal 
goat serum (Sigma) and 1% BSA (Calbiochem) for 1 h at room temperature. Samples were then 
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incubated at 4 °C overnight with the rabbit polyclonal anti-Cx43  (71-0700, Zymed), 1:50 
dilution (5 μg/ml); anti-Cx40  (immunogen is a peptide with 19 amino acids of mouse Cx40, 
affinity purified, IgG1, Cx40-A, Alpha Diagnostic Intl.), 1:100 (10 μg/ml); or anti-Cx37 
(immunogen is a peptide with 16 amino acids of mouse Cx37, affinity purified, IgG1, Cx37A11-
A, Alpha Diagnostic Intl.), 1:200 (5 μg/ml), primary antibody, respectively. Antibodies were 
diluted in PBS. After washing in PBS for 3×15 minutes, samples were incubated with the goat 
anti-rabbit IgG-Alexa Fluor 488 secondary antibody (Molecular Probes), 1:500 with PBS for 1 h 
at room temperature. After washing in PBS for 3×15 minutes, nuclei were stained with 
propidium iodide in the Vectashield mounting medium (Vector Laboratories). Secure-seal 
adhesive spacers (Molecular Probes) were used to mount the axially opened aortic tissues. 
Peripheries of coverslips were sealed using nail polish. Images were taken sequentially using the 
upright Leica TCS-SL laser scanning confocal microscope (Leica Microsystems GmbH, 
Germany). As a negative control, the slide with secondary antibody only was included such that 
no staining was visible for this slide under the same imaging settings. Images were projected and 
adjusted contrasts using NIH ImageJ. 
3.6 STATISTICAL ANALYSIS 
Data were expressed as means ± standard errors (SE). Differences between the experimental 
groups and the controls were compared using paired t-test in SigmaPlot (Systat Software). In 
case of non-normal distribution, non-parametric tests were performed. In most cases, three to 
five independent experiments were performed in each group. Differences were considered 
significant when P < 0.05. 
 65 
4.0  RESULTS 
4.1 CONNEXIN EXPRESSION IN RABBIT DESCENDING THORACIC AORTAS 
Rabbit descending thoracic aortas were used to study regulation of gap junctions by mechanical 
factors. Therefore, it was necessary to know the connexin expression pattern in these aortas. 
Freshly isolated aortas were stained en face for ECs or sectioned for both ECs and SMCs. 
Connexin proteins were stained green. Nuclei were stained red by propidium iodide in the 
mounting medium.  Images were taken using a scanning confocal microscope. Endothelial cells 
expressed Cx43 with a typical punctate staining pattern (Figure 4-1). Cx40 (Figure 4-2) and 
Cx37 (Figure 4-3) were also expressed in ECs with strong staining at cell peripheries. Cx43 was 
strongly expressed in SMCs as well (Figure 4-4). However, Cx40 was not expressed in SMCs 
(Figure 4-5). Similarly, Cx37 was not expressed in SMCs (Figure 4-6). The very few green 
staining in the media was most likely caused by incomplete washing and/or macrophages, which 
express Cx37. Cx43 was detected using a widely used antibody (71-0700, Zymed). It was known 
that cardiac ventricles express Cx43. As a positive control of this antibody, sections of rabbit left 
ventricles were stained with this rabbit polyclonal antibody (Figure 4-7A). Another mouse 
monoclonal antibody (MAB3067, Chemicon) gave a similar staining pattern of rabbit ventricles 
(Figure 4-7B, note the different scale from A). 
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 Figure 4-1 Cx43 is expressed in endothelial cells of rabbit descending thoracic aortas. 
A fresh DTA was En face stained for Cx43 in ECs. The typical punctate staining pattern of connexin was 
visible (A). Nuclei were stained red (B). Most staining of Cx43 was peripheral (C, merge of A and B). The 
scale bar equals 10 μm. 
 
 
Figure 4-2 Cx40 is expressed in endothelial cells of rabbit descending thoracic aortas. 
A fresh DTA was En face stained for Cx40 in ECs. The typical punctate staining pattern of connexin was 
visible (A). Nuclei were stained red (B). Most staining of Cx40 was peripheral (C, merge of A and B). The 
scale bar equals 10 μm. 
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 Figure 4-3 Cx37 is expressed in endothelial cells of rabbit descending thoracic aortas. 
A fresh DTA was En face stained for Cx37 in ECs. The typical punctate staining pattern of connexin was 
visible (A). Nuclei were stained red (B). Most staining of Cx37 was peripheral (C, merge of A and B). The 
scale bar equals 10 μm. 
 
 
Figure 4-4 Cx43 is expressed in smooth muscle cells of rabbit descending thoracic aortas. 
A fresh DTA was frozen and sectioned at 8 μm thickness. Cx43 was stained as green, while nuclei were 
stained as red. The scale bar equals 10 μm. 
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 Figure 4-5 Cx40 is not expressed in smooth muscle cells of rabbit descending thoracic aortas. 
A fresh DTA was frozen and sectioned at 8 μm thickness. Cx40 was stained as green, while nuclei were 
stained as red. The scale bar equals 10 μm. 
 
 
Figure 4-6 Cx37 is not expressed in smooth muscle cells of rabbit descending thoracic aortas. 
A fresh DTA was frozen and sectioned at 8 μm thickness. Cx37 was stained as green, while nuclei were 
stained as red. The scale bar equals 10 μm. 
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 Figure 4-7 Rabbit left ventricle staining of Cx43. 
The heart tissue was snap-frozen in liquid nitrogen, and cryosectioned at 6 μm thickness. Cx43 was stained 
as green using the antibody 71-0700, Zymed (A) or MAB3067, Chemicon (B), while nuclei were stained as 
red. 
 
In summary, ECs in rabbit descending thoracic aortas express Cx43, Cx40 and Cx37, 
while VSMCs express Cx43 only. This expression pattern is consistent with that observed in 
large arteries. 
4.2 REGULATION OF GAP JUNCTIONS BY THE MEAN PRESSURE LEVEL 
4.2.1 Regulation of gap junction expression by the steady pressure level 
Rabbit descending thoracic aortas were harvested, and cultured under steady high pressure (150 
mmHg, HPr) or normal (low) pressure (80 mmHg, LPr) for short- (6 h) or long-term (24 h). The 
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flow was the same (20 ml/min). Proteins and RNA molecules were extracted and analyzed. 
Western blot was used to quantitatively detect the protein levels. The rabbit polyclonal anti-Cx43 
antibody could detect a few bands of Cx43 because of the different phosphorylation states 
(Figure 4-8). The results were expressed as the ratio of HPr to LPr. To compare mRNA levels, 
the mRNA of GAPDH was used as the reference (control) gene. Short-term high pressure 
increased the Cx43 mRNA level significantly (1.93±0.18-fold, P<0.01, Figure 4-9). 
Furthermore, the Cx43 protein level was also increased by short-term high pressure (2.26±0.29-
fold, P<0.05, Figure 4-9). 
 
 
Figure 4-8 The Cx43 antibody (71-0700) can detect a few bands of the Cx43 protein because of 
phosphorylation. 
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 Figure 4-9 Short-term (6 h) regulation of Cx43 expression by steady pressure. 
The rabbit descending thoracic aorta was cut into two segments. One segment was cultured under high steady 
pressure (HPr, 150 mmHg), while the other segment was under low steady pressure (LPr, 80 mmHg) for 
short-term (6 h). Flow was the same (20 ml/min). GAPDH was the reference gene for comparing the Cx43 
mRNA levels. The Cx43 protein levels were normalized by the corresponding -actin protein levels. Results 
were expressed as ratios of high to low steady pressure values. High steady pressure increased the Cx43 
mRNA and total protein levels after 6 h. Error bars indicate SE of 5 independent experiments.  
 
Cx43 can also be regulated in terms of different phosphorylation states. To quantify the 
different phosphorylation states, ratios of phosphorylated (the band P1, P2 and P3 in figure 4-8) 
to non-phosphorylated (the band P0 in figure 4-8) Cx43 were calculated. In cases where there 
were only three bands, the lowest one (i.e., the smallest molecular weight) was treated as P0. 
Short-term high steady pressure reduced the ratio of phosphorylated to non-phosphorylated Cx43 
as compared with the low pressure controls (0.69±0.07-fold, P<0.05, Figure 4-10). 
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 Figure 4-10 Short-term (6 h) regulation of Cx43 phosphorylation by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg), while the other 
segment was under low steady pressure (LPr, 80 mmHg) for short-term (6 h). Flow was the same (20 
ml/min). High steady pressure decreased the level of phosphorylated to non-phosphorylated Cx43 protein 
after 6 h. The error bar indicates SE of 5 independent experiments. 
 
In addition, the mRNA levels of Cx40 in aortas were detected. Of note, Cx40 is only 
expressed in ECs. However, the analyzed RNA samples came from VSMCs as well. Therefore, 
the reference gene is critical for the accurate comparison of Cx40 gene expression. Two genes 
were tried. One was again GAPDH, which is expressed in both ECs and SMCs. The Cx40 
mRNA levels were similar between aortas cultured under short-term high and low steady 
pressure (1.21±0.26-flod, Figure 4-11). The other one was VE-cadherin, which is an EC-specific 
protein at adherens junctions. The Cx40 mRNA levels were also not significantly different 
(1.71±0.60-flod). The VE-cadherin mRNA levels were similar if using GAPDH as the reference 
gene (0.81±0.15-flod). 
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 Figure 4-11 Short-term (6 h) regulation of Cx40 mRNA expression by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg), while the other 
segment was under low steady pressure (LPr, 80 mmHg) for short-term (6 h). Flow was the same (20 
ml/min). GAPDH or VE-cadherin was the reference gene for comparing the Cx40 mRNA levels. GAPDH 
was the reference gene for comparing the VE-cadherin mRNA levels. High steady pressure did not 
significantly alter the Cx40 mRNA level using either GAPDH or VE-cadherin as the reference gene. High 
steady pressure also did not significantly alter the VE-cadherin mRNA level. Error bars indicate SE of 5 
independent experiments.  
 
Aortas were also cultured for 24 h to investigate the long-term effects of steady pressure 
on gap junctions. The Cx43 mRNA level was increased by high pressure after 24 h (3.13±0.38-
fold, P<0.01, Figure 4-12). However, the protein levels were similar (1.18±0.10-fold). 
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 Figure 4-12 Long-term (24 h) regulation of Cx43 expression by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg), while the other 
segment was under low steady pressure (LPr, 80 mmHg) for long-term (24 h). Flow was the same (20 
ml/min). High steady pressure increased the Cx43 mRNA levels. However, the Cx43 total protein levels 
were similar after 24 h. Error bars indicate SE of 5 independent experiments.  
 
The ratios of phosphorylated to non-phosphorylated Cx43 were similar between aortas 
under high and low steady pressure for long-term (24 h) cultures (0.79±0.09-fold, Figure 4-13). 
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 Figure 4-13 Long-term (24 h) regulation of Cx43 phosphorylation by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg), while the other 
segment was under low steady pressure (LPr, 80 mmHg) for long-term (24 h). Flow was the same (20 
ml/min). The ratios of phosphorylated to non-phosphorylated Cx43 were similar between aortas under high 
and low steady pressure. The error bar indicates SE of 5 independent experiments.  
 
The Cx40 mRNA levels were not different after culturing for long-term under high or 
low steady pressure using either GAPDH (1.03±0.37-flod, Figure 4-14) or VE-cadherin 
(0.90±0.33-flod) as the control. The VE-cadherin mRNA levels were also similar if using 
GAPDH as the control (1.69±0.97-flod). 
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 Figure 4-14 Long-term (24h) regulation of Cx40 mRNA expression by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg), while the other 
segment was under low steady pressure (LPr, 80 mmHg) for long-term (24 h). Flow was the same (20 
ml/min). GAPDH or VE-cadherin was the reference gene for comparing the Cx40 mRNA levels. GAPDH 
was the reference gene for comparing the VE-cadherin mRNA levels. High steady pressure did not 
significantly alter the Cx40 mRNA level using either GAPDH or VE-cadherin as the reference gene after 24 
h. High steady pressure also did not significantly alter the VE-cadherin mRNA level. Error bars indicate SE 
of 5 independent experiments.  
 
To examine whether intraluminal perfusion rate affected the steady pressure-induced 
regulation of the Cx43 protein level, aortas were cultured under a higher flow (300 ml/min) for 
24 h in one experiment. Again, the protein level of Cx43 was not increased by high steady 
pressure (Figure 4-15). 
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 Figure 4-15 Long-term (24 h) regulation of the Cx43 protein level by steady pressure at high 
flow (300 ml/min). 
In one experiment, one segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg), 
while the other segment was under low steady pressure (LPr, 80 mmHg) for long-term (24 h). Flow was the 
same for these two segments (300 ml/min). The Cx43 total protein levels were similar.  
 
To study the effects of culture duration on Cx43 protein levels, samples for 6 h and 24 h 
cultures under the same steady pressure level (low or high) were loaded onto the same gel. The 
Cx43 protein level was increased from 6 to 24 h in culture under low (Figure 4-16) or high 
(Figure 4-17) steady pressure. 
 
 
Figure 4-16 The Cx43 protein level is increased from 6 to 24 h under low steady pressure. 
Protein samples from aortas cultured under low steady pressure (80 mmHg) for 6 or 24 h were detected the 
Cx43 protein levels using Western blot to study the culture duration effects. The bands shown are 
representative of 4 independent experiments. 
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 Figure 4-17 The Cx43 protein level is increased from 6 to 24 h under high steady pressure. 
Protein samples from aortas cultured under high steady pressure (150 mmHg) for 6 or 24 h were detected the 
Cx43 protein levels using Western blot to study the culture duration effects. The bands shown are 
representative of 4 independent experiments. 
 
4.2.2 Effects of pressure pulsatility on the mean pressure level-induced regulation of gap 
junction expression 
High steady pressure did not upregulate the Cx43 protein level at 24 h. However, in vivo blood 
pressure has both mean and pulsatile components. It is possible that the presence of pressure 
pulsatility may alter the mean pressure-induced regulation of Cx43 expression. To examine this 
issue, experiments were repeated with the addition of the same pulse pressure (30 mmHg peak-
to-peak amplitude, 192 cycles/min) to both high (150 mmHg) and low (80 mmHg) mean 
pressures. Data were collected after 24 h with intraluminal flow of 25 ml/min. High pressure 
increased Cx43 mRNA (3.09±1.03-fold, n=3, Figure 4-18) although it was not statistically 
significant. However, the Cx43 protein levels were again similar (0.86±0.25-fold). Thus, the 
presence of pressure pulsatility does not alter the mean pressure-induced regulation of Cx43 
expression. 
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 Figure 4-18 Long-term (24 h) regulation of Cx43 expression by mean pressure in the presence 
of pressure pulsatility. 
One segment of the DTA was cultured under high pulsatile pressure (HPr, mean pressure 150 mmHg, pulse 
pressure 30 mmHg, 192 cycles/min), while the other segment was under low pulsatile pressure (LPr, mean 
pressure 80 mmHg, pulse pressure 30 mmHg, 192 cycles/min) for long-term (24 h). Mean flow was the same 
(25 ml/min). High pressure increased Cx43 mRNA although it was not statistically significant. The Cx43 
protein levels were similar. Error bars indicate SE of 3 independent experiments.  
 
Long-term high mean pressure in the presence of pressure pulsatility did not alter the 
ratio of phosphorylated to non-phosphorylated Cx43 (1.34±0.31-fold, Figure 4-19). Therefore, 
long-term (24 h) high pressure, either steady or pulsatile, does not alter the ratio of 
phosphorylated to non-phosphorylated Cx43. 
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 Figure 4-19 Long-term (24 h) regulation of Cx43 phosphorylation by mean pressure in the 
presence of pressure pulsatility. 
One segment of the DTA was cultured under high pulsatile pressure (HPr, mean pressure 150 mmHg, pulse 
pressure 30 mmHg, 192 cycles/min), while the other segment was under low pulsatile pressure (LPr, mean 
pressure 80 mmHg, pulse pressure 30 mmHg, 192 cycles/min) for long-term (24 h). Mean flow was the same 
(25 ml/min). The ratios of phosphorylated to non-phosphorylated Cx43 were similar between aortas under 
high and low mean pressure. The error bar indicates SE of 3 independent experiments.  
4.2.3 Potential mechanisms underlying regulation of Cx43 by the steady pressure level 
Src regulation. Src is known to be involved in transducing shear stress31 and pressure.83 
Therefore, levels of active (nonphospho-Y527) and total Src were quantified to study whether 
Src was involved in the steady pressure-induced regulation of Cx43 expression. For short-term (6 
h) cultures, the active and total Src levels and the ratio of the two (active/total) were not different 
between the low and high pressure groups (Figure 4-20). In contrast, active Src was more for 
high steady pressure in long-term (24 h) cultures (1.95±0.23-fold, P<0.05, Figure 4-21). Total 
Src was also increased (1.56±0.24-fold), although it did not reach the statistically significant 
level (P=0.067). The ratios of active to total Src were again similar (1.17±0.10-fold). 
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 Figure 4-20 Short-term (6 h) regulation of Src by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg), while the other 
segment was under low steady pressure (LPr, 80 mmHg) for short-term (6 h). Flow was the same (20 
ml/min). The levels of active and total Src, and the ratio of these two were similar between the low and high 
pressure groups. Error bars indicate SE of 5 independent experiments. 
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 Figure 4-21 Long-term (24 h) regulation of Src by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg), while the other 
segment was under low steady pressure (LPr, 80 mmHg) for long-term (24 h). Flow was the same (20 
ml/min). The levels of active Src were significantly increased by high pressure. The levels of total Src were 
also increased by high pressure, although it was not statistically significant. The ratios of these two were 
similar between the low and high pressure groups. Error bars indicate SE of 5 independent experiments. 
 
We investigated whether the presence of pressure pulsatility affected different mean 
pressure levels-induced changes in Src regulation. Because we observed differential Src 
regulation by long-term (24 h) cultures only (vide supra), experiments in the presence of 
pressure pulsatility were conducted for this culture duration only. Active Src was still more for 
high mean pressure (1.43±0.10-fold, P<0.05, Figure 4-22). Total Src was not significantly 
different (1.38±0.15-fold, P=0.13). The ratios of active to total Src were again similar. Thus, the 
presence of pressure pulsatility does not alter the pattern of Src regulation by the mean pressure 
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level. Specifically, an increase in the mean pressure level elevates levels of total and active Src in 
long-term (24 h) cultures, without changing the percentage of active Src in total Src. 
 
 
Figure 4-22 Long-term (24 h) regulation of Src by mean pressure in the presence of pressure 
pulsatility. 
One segment of the DTA was cultured under high pulsatile pressure (HPr, mean pressure 150 mmHg, pulse 
pressure 30 mmHg, 192 cycles/min), while the other segment was under low pulsatile pressure (LPr, mean 
pressure 80 mmHg, pulse pressure 30 mmHg, 192 cycles/min) for long-term (24 h). Mean flow was the same 
(25 ml/min). The levels of active Src were significantly increased by high pressure. The levels of total Src 
were also increased by high pressure, although it was not statistically significant. Error bars indicate SE of 3 
independent experiments.  
 
Experiments with Src inhibition. The Src inhibitor PP1 is commonly used to explore 
the role of Src. Because we observed differential regulation of Cx43 mRNA and protein by high 
pressure for short-term (6 h) cultures only, PP1 (10 μM) was added to the media of high steady 
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pressure cultures for 6 h at the onset of culturing in one set of experiments. Both the mRNA and 
protein levels of Cx43 were similar after Src inhibition (Figure 4-23). Therefore, Src inhibition 
blocked the increase of both mRNA and protein of Cx43 by high steady pressure (Figure 4-9). 
Src may mediate upregulation of both mRNA and protein levels of Cx43 by short-term high 
pressure. The levels of active and total Src were similar between the two culture conditions. 
Consequently, the ratio of active to total Src was not different. Therefore, PP1 does not alter 
expression of Src for short-term cultures. It inhibits the activity of Src. 
 
 
Figure 4-23 Src may mediate short-term (6 h) regulation of Cx43 expression by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg) with the Src inhibitor 
PP1 (10 μM), while the other segment was under low steady pressure (LPr, 80 mmHg) for short-term (6 h). 
Flow was the same (20 ml/min). The mRNA and protein levels of Cx43 were similar between the low and 
high pressure groups after Src inhibition, respectively. The levels of active and total Src, and the ratio of 
these two were also similar between the low and high pressure groups after Src inhibition. Error bars indicate 
SE of 4 independent experiments.  
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We observed that short-term high steady pressure reduced the ratio of phosphorylated to 
non-phosphorylated Cx43 as compared with the low steady pressure controls (Figure 4-10). 
However, the ratios were similar after Src inhibition (0.95±0.17-fold, Figure 4-24). Therefore, 
inhibition of Src eliminated the difference in the ratio of phosphorylated to non-phosphorylated 
Cx43. Src may mediate downregulation of Cx43 phosphorylation by short-term high steady 
pressure. 
 
 
Figure 4-24 Src may mediate short-term (6 h) regulation of Cx43 phosphorylation by steady 
pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg) with the Src inhibitor 
PP1 (10 μM), while the other segment was under low steady pressure (LPr, 80 mmHg) for short-term (6 h). 
Flow was the same (20 ml/min). The ratios of phosphorylated to non-phosphorylated Cx43 were similar 
between the low and high pressure groups after Src inhibition. The error bar indicates SE of 4 independent 
experiments. 
 
Other molecules-p27. The phenotypes of cells, such as proliferation, may alter gap 
junction expression. The protein p27 is a cyclin-dependent kinase inhibitor, and inhibits cell 
proliferation. Its level is reduced when cells are proliferating. In order to see whether cells had 
entered or had the tendency of entering cell cycles under high pressure for 6 h, levels of p27 
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were quantified using Western blot. There was no significant difference between these two 
pressure levels at 6 h (0.80±0.11-fold, Figure 4-25). Therefore, the protein level of p27 is not 
affected by the pressure level in short-term culture. The p27 protein levels were still similar after 
inhibition of Src in aortas cultured under high pressure for 6 h (1.05±0.09-fold, Figure 4-26). 
Thus, Src does not affect the relative protein levels of p27 between these two pressure levels for 
short-term cultures. 
 
 
Figure 4-25 Short-term (6 h) regulation of the p27 protein level by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg), while the other 
segment was under low steady pressure (LPr, 80 mmHg) for short-term (6 h). Flow was the same (20 
ml/min). The p27 protein levels were similar between the low and high pressure groups. The error bar 
indicates SE of 5 independent experiments. 
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 Figure 4-26 Short-term (6 h) Src inhibition using PP1 in the media of high pressure cultures does 
not affect regulation of the p27 protein level by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg) with the Src inhibitor 
PP1 (10 μM), while the other segment was under low steady pressure (LPr, 80 mmHg) for short-term (6 h). 
Flow was the same (20 ml/min). The p27 protein levels were similar between the low and high pressure 
groups. The error bar indicates SE of 4 independent experiments.  
 
However, long-term (24 h) high steady pressure significantly reduced the p27 protein 
level (0.49±0.13-flod, P<0.05, Figure 4-27). Similarly, long-term (24 h) high mean pressure with 
pulsatility reduced the protein level of p27 (0.56±0.11-fold, n=3, P=0.056, Figure 4-28). 
Therefore, long-term (24 h) high pressure downregulates the protein level of p27. This regulation 
pattern is not altered by pressure pulsatility. It is thus expected that cells cultured under high 
pressure for 24 h have a stronger tendency of proliferating compared with those under low 
pressure. 
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 Figure 4-27 Long-term (24 h) regulation of the p27 protein level by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg), while the other 
segment was under low steady pressure (LPr, 80 mmHg) for long-term (24 h). Flow was the same (20 
ml/min). The protein levels of p27 were significantly decreased by long-term high pressure. Error bars 
indicate SE of 5 independent experiments. 
 
 
Figure 4-28 Long-term (24 h) regulation of the p27 protein level by mean pressure in the 
presence of pressure pulsatility.  
One segment of the DTA was cultured under high pulsatile pressure (HPr, mean pressure 150 mmHg, pulse 
pressure 30 mmHg, 192 cycles/min), while the other segment was under low pulsatile pressure (LPr, mean 
pressure 80 mmHg, pulse pressure 30 mmHg, 192 cycles/min) for long-term (24 h). Mean flow was the same 
(25 ml/min). The protein levels of p27 were decreased by long-term high pressure although it was not 
statistically significant. Error bars indicate SE of 3 independent experiments.  
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Other molecules-beta-catenin. Wnt proteins are a large family of secreted polypeptides 
that regulate cell-cell interactions both during embryogenesis and in adults. Beta-catenin is an 
important protein in the Wnt signaling pathway. Beta-catenin was involved in upregulation of 
Cx43 by Wnt in cardiac myocytes.342 Tyrosine phosphorylation of beta-catenin was increased by 
integrin, one of the sensors for mechanical forces.334 Therefore, the protein level of beta-catenin 
was quantified by Western blot to explore whether beta-catenin protein levels were altered by 
mechanical factors. The protein levels of beta-catenin were similar between these two pressure 
levels for short-term cultures (1.1±0.18-fold, Figure 4-29). Therefore, the protein level of beta-
catenin is not regulated by the short-term (6 h) pressure level. 
 
 
Figure 4-29 Short-term (6 h) regulation of the beta-catenin protein level by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg), while the other 
segment was under low steady pressure (LPr, 80 mmHg) for short-term (6 h). Flow was the same (20 
ml/min). The beta-catenin protein levels were similar between the low and high pressure groups. The error 
bar indicates SE of 5 independent experiments.  
 
Other molecules-CD31. The glycoprotein CD31 (or PECAM-1) mediates intercellular 
junctions between ECs. CD31 was also a mechanosensor.343 The level of CD31 may indicate the 
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integrity of the endothelium as well. The CD31 protein levels were not different between these 
two steady pressure levels at 24 h (Figure 4-30). Therefore, the protein level of CD31 is not 
differentially regulated by the long-term (24 h) steady pressure level. 
 
 
Figure 4-30 Long-term (24 h) regulation of the CD31 protein level by steady pressure. 
One segment of the DTA was cultured under high steady pressure (HPr, 150 mmHg), while the other 
segment was under low steady pressure (LPr, 80 mmHg) for long-term (24 h). Flow was the same (20 
ml/min). The CD31 protein levels were similar between the low and high pressure groups. The error bar 
indicates SE of 5 independent experiments.  
 
Other molecules-Akt. Protein kinase B (PKB) or Akt can be activated by static stretch in 
VSMCs in vitro.344 In an effort of identifying signaling molecules transducing mechanical forces 
in intact aortas, protein levels of active (phosphor-Ser473) and total Akt were quantified using 
Western blot. Akt was strongly activated by long-term (24 h) high mean pressure compared with 
low mean pressure (3.74±0.58-fold, n=3, P<0.05, Figure 4-31). However, the total Akt protein 
levels were similar between these two groups (0.97±0.14-fold). Moreover, the ratio of active to 
total Akt was significantly increased by high mean pressure (3.87±0.21-fold, P<0.01). Therefore, 
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high pressure regulates Akt through increasing the activation of Akt without affecting the total 
protein level of Akt. 
 
 
Figure 4-31 Long-term (24 h) regulation of Akt by mean pressure in the presence of pressure 
pulsatility. 
One segment of the DTA was cultured under high pulsatile pressure (HPr, mean pressure 150 mmHg, pulse 
pressure 30 mmHg, 192 cycles/min), while the other segment was under low pulsatile pressure (LPr, mean 
pressure 80 mmHg, pulse pressure 30 mmHg, 192 cycles/min) for long-term (24 h). Mean flow was the same 
(25 ml/min). The levels of active Akt were increased by long-term high pressure, although the levels of total 
Akt were similar. The ratios of active to total Akt were also increased by long-term high pressure. Error bars 
indicate SE of 3 independent experiments.  
 
In summary, both short- (6 h) and long-term (24 h) high steady pressures upregulate the 
mRNA level of Cx43. The protein level of Cx43 is also elevated by short-term high steady 
pressure. Src may regulate the increases in both mRNA and protein of Cx43 by short-term high 
steady pressure. Long-term high steady pressure does not increase the protein level of Cx43. This 
regulation pattern is the same in the presence of pressure pulsatility. Intraluminal flow also does 
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not alter this pattern. The mRNA level of Cx40 is not differentially regulated by steady pressure 
levels. Cells have a stronger tendency of proliferation after 24 h high pressure cultures. More Akt 
is activated by high pressure. 
4.3 REGULATION OF GAP JUNCTIONS BY CYCLIC STRETCH INDUCED BY 
PULSATILE PRESSURE 
4.3.1 Regulation of gap junction expression by pulsatile pressure 
Arteries are cyclically stretched by pulsatile pressure. The level of stretch depends on the 
compliance of a blood vessel, the mean blood pressure, and pulse pressure. The compliance of a 
blood vessel can be altered by hypertension, aging, etc. Cyclic stretch is important to vascular 
structure and function. However, the mechanisms of transducing cyclic stretch into biochemical 
signals by vascular cells are not well understood. Aortic segments from the same rabbit were 
cultured under pulsatile (pulse pressure 30 mmHg, mean pressure 80 mmHg, mean flow 25 
ml/min, 192 cycles/min) or steady (80 mmHg) pressure to study regulation of gap junctions by 
pulsatile pressure. 
Aortas under pulsatile pressure (Pul) had similar Cx43 mRNA levels to those under 
steady pressure (Ste) (0.74±0.15-fold, P=0.183, Figure 4-32) at 6 h. However, pulsatile pressure 
unexpectedly decreased the Cx43 total protein level at 6 h (0.63±0.05-fold, P<0.01). Aortas 
under pulsatile pressure had a larger ratio of phosphorylated to non-phosphorylated Cx43 
(2.03±0.43-fold, P<0.05, Figure 4-33). 
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 Figure 4-32 Short-term (6 h) regulation of Cx43 expression by pulsatile pressure. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) for short-term (6 h). Mean flow was the same (25 ml/min). The Cx43 
mRNA levels were not significantly altered by short-term pulsatile pressure. However, the Cx43 protein 
levels were significantly decreased by short-term pulsatile pressure. Error bars indicate SE of 5 independent 
experiments.  
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 Figure 4-33 Short-term (6 h) regulation of Cx43 phosphorylation by pulsatile pressure. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) for short-term (6 h). Mean flow was the same (25 ml/min). The ratios of 
phosphorylated to non-phosphorylated Cx43 were significantly increased by short-term pulsatile pressure. 
The error bar indicates SE of 5 independent experiments. 
 
Aortas were cultured for 24 h under the same conditions. Although the level of mRNA 
was increased slightly by pulsatile pressure at 24 h (1.63±0.45-fold, Figure 4-34), pulsatile 
pressure decreased the Cx43 protein level (0.49±0.09-fold, P<0.01). There were no significant 
differences in the ratios of phosphorylated to non-phosphorylated Cx43 protein (1.20±0.41-fold, 
Figure 4-35). Therefore, pulsatile pressure reduces the Cx43 protein level for both short- and 
long-term cultures. The decreased Cx43 protein level is not because of the decreased Cx43 
mRNA level. The relative level of phosphorylated to non-phosphorylated Cx43 is differentially 
regulated by short- and long-term pulsatile pressures. 
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 Figure 4-34 Long-term (24 h) regulation of Cx43 expression by pulsatile pressure. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was the same (25 ml/min). The Cx43 
mRNA levels were not significantly altered by long-term pulsatile pressure. However, the Cx43 protein 
levels were significantly decreased by long-term pulsatile pressure. Error bars indicate SE of 5 independent 
experiments.  
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 Figure 4-35 Long-term (24 h) regulation of Cx43 phosphorylation by pulsatile pressure. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was the same (25 ml/min). The ratios of 
phosphorylated to non-phosphorylated Cx43 were not significantly altered by long-term pulsatile pressure. 
The error bar indicates SE of 5 independent experiments. 
4.3.2 Regulation of Cx43 expression by long-term pulsatile pressure with a higher mean 
pressure – cyclic stretch regulates Cx43 expression  
The wall stress of arteries is changing cyclically under pulsatile pressure as well. To differentiate 
the effect of cyclic deformation in diameter (cyclic stretch) from cyclic change in wall stress 
(cyclic stress), both aortas from the same rabbit were cultured under a higher mean pressure (150 
versus 80 mmHg) for 24 h. The pulse pressure was the same (30 mmHg). Aortas had less cyclic 
stretch under a higher mean pressure (150) because of the nonlinear mechanical property of 
arteries.15 The Cx43 mRNA and protein levels were similar between pulsatile and steady 
perfusion conditions, respectively (Figure 4-36). Therefore, it was the cyclic stretch, instead of 
cyclic stress, that decreased the Cx43 protein level (Figure 4-34). The relative levels of 
phosphorylated to non-phosphorylated Cx43 were not significantly different (1.39±0.27-fold, 
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Figure 4-37). Thus, long-term (24 h) pulsatile pressure does not differentially regulate the ratio 
of phosphorylated to non-phosphorylated Cx43 compared with steady pressure (stretch). 
 
 
Figure 4-36 Long-term (24 h) regulation of Cx43 expression by pulsatile pressure under a higher 
mean pressure (150 mmHg). 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 150 mmHg, pulse 
pressure 30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, the same mean 
pressure 150 mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was the same (25 ml/min). 
The Cx43 mRNA and protein levels were not significantly different between these two culture conditions. 
Error bars indicate SE of 3 independent experiments.  
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 Figure 4-37 Long-term (24 h) regulation of Cx43 phosphorylation by pulsatile pressure under a 
higher mean pressure (150 mmHg). 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 150 mmHg, pulse 
pressure 30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, the same mean 
pressure 150 mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was the same (25 ml/min). 
The ratios of phosphorylated to non-phosphorylated Cx43 protein were not significantly different between 
these two culture conditions. The error bar indicates SE of 3 independent experiments.  
4.3.3 Potential mechanisms underlying the regulation of Cx43 by cyclic stretch 
Src regulation. Levels of active and total Src were quantified using Western blot to study 
whether Src was regulated differentially by pulsatile pressure compared to steady pressure. For 
short-term (6 h) cultures, active (1.11±0.21-fold) and total (1.03±0.08-fold) Src levels and the 
ratio of the two (active/total) were not different between the pulsatile and steady pressure groups 
(Figure 4-38). Therefore, Src is not differentially regulated by steady pressure (Figure 4-20) or 
pulsatile pressure for the short-term (6 h) culture duration. In contrast, active Src was less for 
pulsatile pressure (0.65±0.06-fold, P<0.01, Figure 4-39) in long-term (24 h) cultures. Total Src 
was also decreased (0.70±0.07-fold, P<0.05). The ratios of active to total Src were similar. 
Therefore, pulsatile pressure regulates Src by reducing the active and total Src without changing 
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the ratio of these two. However, active and total Src, and the ratios of these two were not 
significantly different between aortas cultured under the pulsatile pressure with a higher mean 
pressure (150 mmHg) and the same level of steady pressure (Figure 4-40). Hence, it is the cyclic 
stretch, instead of cyclic stress, that decreases the active and total protein levels of Src at 24 h 
(Figure 4-39). 
 
 
Figure 4-38 Short-term (6 h) regulation of Src by pulsatile pressure. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) for short-term (6 h). Mean flow was the same (25 ml/min). The levels of 
active and total Src, and the ratios of these two were not different between these two culture conditions. Error 
bars indicate SE of 5 independent experiments.  
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 Figure 4-39 Long-term (24 h) regulation of Src by pulsatile pressure. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was the same (25 ml/min). The levels of 
active and total Src were significantly reduced by pulsatile pressure. However, the ratios of these two were 
not different between these two culture conditions. Error bars indicate SE of 5 independent experiments. 
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 Figure 4-40 Long-term (24 h) regulation of Src by pulsatile pressure under a higher mean 
pressure (150 mmHg). 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 150 mmHg, pulse 
pressure 30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, the same mean 
pressure 150 mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was the same (25 ml/min). 
The levels of active and total Src, and the ratios of these two were not different between these two culture 
conditions. Error bars indicate SE of 3 independent experiments.  
 
Experiments with Src inhibition. We observed differential regulation Cx43 and Src by 
long-term (24 h) cyclic stretch. Because there was more active Src in aortas cultured under 
steady pressure (80 mmHg), the Src kinase inhibitor PP1 (10 μM) was added to the culture media 
of steady pressure cultures for 24 h at the onset of culturing to study the role of Src in mediating 
the regulation of Cx43 by cyclic stretch. There was more Cx43 mRNA (2.82±0.56-flod, P<0.05, 
Figure 4-41) in aortas cultured under cyclic stretch after Src inhibition. However, Cx43 protein 
was no longer significantly less after Src inhibition (0.72±0.14-fold, P=0.135). Thus, Src may 
mediate downregulation of Cx43 protein by cyclic stretch. Active Src was still less under cyclic 
stretch after Src inhibition (0.68±0.08-flod, P<0.05). Total Src was less as well (0.74±0.08-flod, 
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P=0.05). The ratios of active to total Src were similar. Therefore, long-term (24 h) inhibition of 
Src using PP1 does not alter the levels of active and total Src. It inhibits the function of Src. The 
ratios of phosphorylated to non-phosphorylated Cx43 were still similar after Src inhibition 
(Figure 4-42). Therefore, Src does not regulate the relative ratio of phosphorylated to non-
phosphorylated Cx43 between long-term (24 h) pulsatile and steady pressure cultures. 
 
 
Figure 4-41 Src may regulate downregulation of the Cx43 protein level by cyclic stretch. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) with the Src inhibitor PP1 (10 μM) for long-term (24 h). Mean flow was the 
same (25 ml/min). The Cx43 mRNA levels were higher in aortas under cyclic stretch after Src inhibition. 
However, the Cx43 protein levels were similar.  The active Src was still less in aortas under cyclic stretch 
after Src inhibition. The total Src was less as well. Error bars indicate SE of 4 independent experiments.  
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 Figure 4-42 Long-term (24 h) regulation of Cx43 phosphorylation by cyclic stretch after 
inhibition of Src in aortas cultured under steady pressure. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) with the Src inhibitor PP1 (10 μM) for long-term (24 h). Mean flow was the 
same (25 ml/min).The ratios of phosphorylated to non-phosphorylated Cx43 were similar. Error bars indicate 
SE of 4 independent experiments. 
 
Experiments with Reactive oxygen species inhibition. ROS mediated the regulation of 
Cx43 by static stretch in VSMCs.315 Aortas cultured under pulsatile perfusion had more ROS 
compared to those under steady perfusion.87 Therefore, ROS may mediate the differential 
regulation of Cx43 protein by cyclic and steady stretch. NADPH oxidase is the major enzyme 
that generates ROS in arteries. The NADPH oxidase inhibitor apocynin was planned to be used 
in this study. However, apocynin has been reported to have actually increased ROS in vascular 
fibroblasts.340 Levels of superoxide in rabbit aortic rings were thus measured using an L-012 
enhanced chemiluminescence method to test whether apocynin had the same effect on whole 
blood vessels. AngII has been known to increase superoxide production. The counts were 
increased following AngII addition to the buffer (Figure 4-43A). SOD can reduce the superoxide 
level, which was verified in a segment of rabbit aorta (Figure 4-43B). Therefore, we could 
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successfully measure ROS using our protocol. Apocynin (0.4 mM) immediately reduced the 
superoxide production (Figure 4-43C). This effect lasted for the measurement duration (75 
minutes). Therefore, apocynin is indeed an inhibitor of ROS. Apocynin (0.4 mM) was then 
added to the media of pulsatile perfusion at the onset of culturing for 24 h to elucidate the role of 
ROS in mediating the regulation of Cx43 by stretch. The Cx43 mRNA levels were not 
significantly different after inhibition (0.70±0.22-fold, Figure 4-44). The levels of Cx43 protein 
were also similar to the controls after ROS inhibition (0.90±0.2-fold). Thus, inhibition of ROS 
using apocynin increased the Cx43 protein level in aortas with cyclic stretch. Downregulation of 
the Cx43 protein level by long-term cyclic stretch may be mediated by ROS. Furthermore, 
inhibition of ROS elevated the ratio of phosphorylated to non-phosphorylated Cx43 in aortas 
with cyclic stretch (1.57±0.12-flod, P<0.05, Figure 4-45). Thus, a certain level of ROS is needed 
to maintain a similar level of phosphorylated Cx43 (Figure 4-35). Active Src was also increased 
in aortas under cyclic stretch by apocynin at 24 h, leading to a similar level of active Src (Figure 
4-44). The levels of total Src were similar as well. Again, there were no significant differences in 
the ratios of active to total Src (1.45±0.41-fold). Therefore, we observed interactions between 
ROS and Src. The elevated level of ROS in aortas under cyclic stretch may decrease the levels of 
active and total Src compared with aortas under steady stretch. 
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 Figure 4-43 Superoxide measurement using L-012 in aortic rings. 
The production of superoxide in aortas was increased after addition of AngII, decreased after addition of  
SOD. Apocynin (0.4 mM) also suppressed production of superoxide.  
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 Figure 4-44 Reactive oxygen species may mediate regulation of Cx43 by long-term (24 h) cyclic 
stretch. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min) with the ROS inhibitor apocynin (0.4 mM), while the other segment was under 
steady pressure (Ste, mean pressure 80 mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was 
the same (25 ml/min).The mRNA and protein levels of Cx43 were not significantly different. The levels of 
active and total Src, and the ratio of these two were similar as well after ROS inhibition. Error bars indicate 
SE of 4 independent experiments. 
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 Figure 4-45 Reactive oxygen species may mediate regulation of Cx43 phosphorylation by long-
term (24 h) cyclic stretch. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min) with the ROS inhibitor apocynin (0.4 mM), while the other segment was under 
steady pressure (Ste, mean pressure 80 mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was 
the same (25 ml/min). The ratios of phosphorylated to non-phosphorylated Cx43 were increased in aortas 
under cyclic stretch and ROS inhibition. The error bar indicates SE of 4 independent experiments.  
 
The effect of increasing the Cx43 protein level by apocynin was further studied by adding 
apocynin (0.4 mM) to aortas cultured in a relaxed state (without intraluminal pressure and flow) 
for 6 h. Apocycin significantly increased the Cx43 protein level (1.88±0.16-flod, P<0.05, Figure 
4-46). Active and total Src, and the ratio of these two were not different for this short duration, 
which was the same as short-term (6 h) steady pressure (Figure 4-20) and pulsatile pressure 
(Figure 4-38) cultures. 
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 Figure 4-46 Apocynin increases the Cx43 protein level in relaxed aortas at 6 h. 
Apocynin (0.4 mM) was added to aortas cultured in a relaxed state for 6 h. Apocycin significantly increased 
the Cx43 protein level. Active and total Src, and the ratio of these two were not different. Error bars indicate 
SE of 3 independent experiments. 
 
Other molecules-p27. The protein levels of p27 were quantified using Western blot to 
study whether there was a difference in proliferation between aortas cultured under pulsatile and 
steady stretch. There were no differences in the p27 protein levels between aortas under cyclic 
and steady stretch for short-term (6 h) (1.04±0.13-fold, Figure 4-47) or long-term (24 h) 
(1.08±0.11-fold, Figure 4-48) cultures. Inhibition of Src using PP1 in the media for aortas with 
steady stretch for 24 h did not alter the relative level of p27 protein (0.92±0.11-flod, Figure 4-49) 
as well. Therefore, the p27 protein level is not differentially regulated by any of these culture 
conditions. The proliferation status does not account for the difference in Cx43 protein 
expression between aortas cultured under pulsatile and steady stretch for up to 24 h. 
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 Figure 4-47 Short-term (6 h) regulation of the p27 protein level by cyclic stretch. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) for short-term (6 h). Mean flow was the same (25 ml/min). The p27 protein 
levels were similar. The error bar indicates SE of 5 independent experiments.  
 
 
Figure 4-48 Long-term (24 h) regulation of the p27 protein level by cyclic stretch. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was the same (25 ml/min). The p27 protein 
levels were similar. The error bar indicates SE of 5 independent experiments. 
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 Figure 4-49 Inhibition of Src in aortas under steady stretch for 24 h does not alter the relative 
level of p27 protein. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) with the Src inhibitor PP1 (10 μM) for long-term (24 h). Mean flow was the 
same (25 ml/min). The p27 protein levels were similar. The error bar indicates SE of 4 independent 
experiments. 
 
Other molecules-beta-catenin. The protein levels of beta-catenin were quantified using 
Western blot to study whether beta-catenin was differentially regulated by cyclic and steady 
stretch at the total protein level. There were no differences in the beta-catenin protein levels 
between aortas under cyclic and steady stretch for short-term (6 h) (1.09±0.18-fold, Figure 4-50) 
or long-term (24 h) (1.06±0.07-fold, Figure 4-51) cultures. Inhibition of Src using PP1 in the 
media for aortas with steady stretch for 24 h did not alter the relative levels of beta-catenin 
(0.97±0.07-flod, Figure 4-52) as well. Therefore, the relative levels of beta-catenin protein are 
not differentially regulated by any of these culture conditions. 
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 Figure 4-50 Short-term (6 h) regulation of the beta-catenin protein level by cyclic stretch. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) for short-term (6 h). Mean flow was the same (25 ml/min). The beta-catenin 
protein levels were similar. The error bar indicates SE of 5 independent experiments.  
 
 
Figure 4-51 Long-term (24 h) regulation of the beta-catenin protein level by cyclic stretch. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was the same (25 ml/min). The beta-
catenin protein levels were similar. The error bar indicates SE of 5 independent experiments. 
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 Figure 4-52 Inhibition of Src in aortas under steady stretch for 24 h does not alter the relative 
level of beta-catenin protein. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) with the Src inhibitor PP1 (10 μM) for long-term (24 h). Mean flow was the 
same (25 ml/min). The beta-catenin protein levels were similar. The error bar indicates SE of 4 independent 
experiments. 
 
Other molecules-Akt. Differential regulation of Akt by pulsatile and steady pressure in 
intact arteries has not been reported. Levels of active and total Akt were quantified by Western 
blot. Pulsatile pressure (mean 80 mmHg) for 6 h decreased the level of active Akt (0.47±0.14-
fold, P<0.05, Figure 4-53). However, the levels of total Akt were not different (0.91±0.13-fold). 
Therefore, short–term (6 h) pulsatile pressure decreased the ratio of active Akt to total Akt 
(0.33±0.11-fold, P<0.01). Similarly, pulsatile pressure for long-term (24 h) cultures decreased 
active Akt (0.52±0.06-fold, P<0.01, Figure 4-54). Again, the levels of total Akt were not 
different (1.10±0.11-fold). Long-term pulsatile pressure thus decreased the ratio of active Akt to 
total Akt (0.44±0.03-fold, P<0.001). However, the levels of active Akt and the ratios of active to 
total Akt were no longer different when aortas were cultured for 24 h under a higher mean 
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pressure (150 mmHg) (Figure 4-55). As discussed before, aortas were cyclically stretched much 
less at this high mean pressure level by the same pulse pressure (30 mmHg). Therefore, it was 
cyclic stretch, instead of cyclic stress, that decreases Akt activation compared to steady stretch. 
 
 
Figure 4-53 Short-term (6 h) regulation of Akt by cyclic stretch. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) for short-term (6 h). Mean flow was the same (25 ml/min). The levels of 
active Akt were reduced by cyclic stretch. However, the levels of total Akt were similar. Thus, the ratios of 
active to total Akt were reduced by cyclic stretch. Error bars indicate SE of 5 independent experiments. 
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 Figure 4-54 Long-term (24 h) regulation of Akt by cyclic stretch. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was the same (25 ml/min). The levels of 
active Akt were reduced cyclic stretch. However, the levels of total Akt were similar. Thus, the ratios of 
active to total Akt were reduced by cyclic stretch. Error bars indicate SE of 5 independent experiments. 
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 Figure 4-55 Long-term regulation of Akt by pulsatile pressure with a higher mean pressure (150 
mmHg). 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 150 mmHg, pulse 
pressure 30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, the same mean 
pressure 150 mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was the same (25 ml/min). 
The levels of active and total Akt, and the ratios of these two were not different between these two culture 
conditions. Error bars indicate SE of 3 independent experiments. 
 
There was more active Akt in aortas under cyclic stretch (Figure 4-54). Interestingly, 
inhibition of Src decreased the level of active Akt in aortas under steady stretch for 24 h, because 
there was more active Akt in aortas under cyclic stretch after Src inhibition (1.85±0.21-flod, 
P<0.05, Figure 4-56). However, the level of total Akt was not increased (0.69±0.15-flod, 
P=0.126). The ratio of active to total Akt was also higher in aortas under cyclic stretch after Src 
inhibition (3.05±0.66-flod, P=0.054). 
The effects of ROS inhibition by apocynin on Akt activation were studied. The level of 
active Akt was still less in aortas under cyclic stretch with apocynin for 24 h (0.63±0.13-fold, 
P<0.05, Figure 4-57). The levels of total Akt were not different (0.92±0.10-fold). The ratio of 
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active to total Akt was less in aortas under cyclic stretch (0.68±0.12-fold, P<0.05). Therefore, the 
level of ROS does not alter the regulatory pattern of Akt by long-term cyclic stretch. 
 
 
Figure 4-56 Src may regulate Akt activation by long-term (24 h) steady stretch. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min), while the other segment was under steady pressure (Ste, mean pressure 80 
mmHg, pulse pressure 0 mmHg) with the Src inhibitor PP1 (10 μM) for long-term (24 h). Mean flow was the 
same (25 ml/min). The levels of active Akt were more in aortas under cyclic stretch after Src inhibition. 
There were no differences in the levels of total Akt.The ratio of active to total Akt was larger in aortas under 
cyclic stretch after Src inhibition. The error bar indicates SE of 4 independent experiments.  
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 Figure 4-57 Inhibition of reactive oxygen species using apocynin does not alter the long-term 
(24 h) regulation pattern of Akt by cyclic stretch. 
One segment of the DTA was cultured under pulsatile pressure (Pul, mean pressure 80 mmHg, pulse pressure 
30 mmHg, 192 cycles/min) with the ROS inhibitor apocynin (0.4 mM), while the other segment was under 
steady pressure (Ste, mean pressure 80 mmHg, pulse pressure 0 mmHg) for long-term (24 h). Mean flow was 
the same (25 ml/min). The levels of active Akt were less in aortas under cyclic stretch. There were no 
differences in the levels of total Akt.The ratio of active to total Akt was smaller in aortas under cyclic stretch 
after ROS inhibition. Error bars indicate SE of 4 independent experiments. 
 
In summary, short- (6 h) or long-term (24 h) cyclic stretch downregulates the Cx43 
protein level compared to steady stretch. However, the mRNA level is not differentially 
regulated by cyclic and steady stretch for these two culture durations. Therefore, cyclic stretch 
regulates Cx43 protein, but not mRNA. There are no differences in cell proliferation between 
cyclic and steady stretch for these two culture durations, respectively. Thus, the differential 
regulation of the Cx43 protein level by cyclic stretch can not be explained by alterations in 
proliferation. There are no differences in the levels of active and total Src, and the ratios of these 
two for short-term cultures. However, there is less active Src in aortas under cyclic stretch for 24 
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h. The experiments using a Src specific inhibitor reveal Src as the possible mediator of the 
regulation of the Cx43 protein level by cyclic stretch. Another such potential mediator is ROS. 
Akt is also differentially regulated by cyclic stretch. Akt activation is reduced by both 
short- (6 h) and long-term (24 h) cyclic stretch compared to steady stretch, while the total protein 
level of Akt is not affected. Src inhibition in aortas under steady stretch reverses the relative 
level of active Akt, without affecting the total protein level of Akt. Therefore, activation of Akt 
is very sensitive to the activity of Src. In contrast, inhibition of ROS does not alter the relative 
level of active Akt between aortas under cyclic and steady stretch, demonstrating differential 
regulation of Cx43 and Akt by ROS. 
4.4 OTHER CONTROL EXPERIMENTS 
Proteins from fresh rabbit aortas that were frozen immediately after harvesting were extracted in 
some experiments. These fresh aortas represented the in vivo controls. Cx43 protein levels from 
these fresh aortas were quantified using Western blot along with protein samples from ex vivo 
cultured aortas. The Cx43 protein level was increased after culturing for 6 h under low steady 
pressure compared with the fresh aortas (4.27±0.61-fold, P<0.05, Figure 4-58). The Cx43 protein 
level in the aorta under cyclic stretch for 6 h relative to the fresh aorta was studied in one 
experiment. The ex vivo cultured aorta with cyclic stretch had more Cx43 protein (Figure 4-59). 
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 Figure 4-58 The Cx43 protein level is increased after 6 h under low steady pressure (80 mmHg) 
compared with fresh aortas (Fr). 
The Cx43 protein levels in aortas cultured under low steady pressure (LPr, 80 mmHg) for short-term (6 h) 
were compared with those in aortas just harvested from rabbits (fresh). The Cx43 protein level was increased 
after culture. The error bar indicates SE of 5 independent experiments. 
 
 
Figure 4-59 The Cx43protein level is increased after 6 h under cyclic stretch compared with the 
fresh aorta (Fre). 
 The Cx43 protein level in one aorta cultured under cyclic stretch for short-term (6 h) was compared with that 
in a fresh aorta. The Cx43 protein level was increased after culture. 
 
Rabbit aortas were also cultured in a relaxed state for 1 day (1D), 4 days and 7 days in 
order to see the effects of loss in mechanical factors. The Cx43 protein level was increased after 
1 day in a relaxed state as compared with the fresh aortas (Figure 4-60). The increase was more 
prominent after 4 days in a relaxed state. There was no further increase after 7 days. The protein 
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p27 followed a similar pattern (Figure 4-60). Therefore, proliferation of aortic cells in a relaxed 
state is inhibited. 
 
 
Figure 4-60 The protein levels of Cx43 and p27 are increased in aortas cultured in a relaxed 
state for up to 7 days (7D) as compared with fresh aortas. One typical example of three 
independent experiments is shown. 
 
The levels of active Src were not altered significantly compared to fresh aortas 
(1.10±0.28-fold for 1D, 0.66±0.14-fold for 4D, 0.82±0.21-fold for 7D in Figure 4-61). Similarly, 
the levels of total Src were close to that in fresh aortas (1.32±0.16-fold for 1D, 0.78±0.23-fold 
for 4D, 1.07±0.25-fold for 7D in Figure 4-61). The ratios of active to total Src were significantly 
different only after 7 days (0.80±0.11-fold for 1D, 0.91±0.13-fold for 4D, 0.72±0.03-fold for 7D 
in Figure 4-61). Therefore, less Src is activated after 7 days in a relaxed state. 
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 Figure 4-61 The Src levels in aortas cultured in a relaxed state for up to seven days. 
 
The active Akt level was significantly less than that in fresh aortas after 1 day in a 
relaxed state (0.21±0.04-fold, P=0.002, Figure 4-62). However, the active Akt levels were 
similar after 4 days (0.96±0.55-fold). Active Akt was slightly reduced after 7 days although the 
difference was not statistically significant (0.64±0.12-fold, P=0.089). The mean level of total 
Akt was elevated similarly for all three time points (around 1.5-fold), however, it was not 
statistically significant because of large variations. The ratio of active to total Akt was less after 
1 day, although it was not statistically significant (0.28±0.19-fold, P=0.066). The reduced ratio 
was significant after 4 days (0.65±0.05-fold, P<0.05). It was not significantly different after 7 
days (0.82±0.32-fold). Therefore, active Akt and the ratio of active to total Akt are dynamically 
regulated in aortas cultured under a relaxed state. 
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 Figure 4-62 The Akt levels in aortas cultured in a relaxed state for up to seven days. 
Levels of active and total Akt, and the ratios of these two were compared with those in fresh aortas. The 
active Akt level was significantly less than that in fresh aortas after 1 day in a relaxed state. However, it was 
similar after 4 days. Active Akt was slightly reduced after 7 days. The mean level of total Akt was non-
significantly increased similarly for all three time points. The ratio of active to total Akt was less after 1 day, 
although it was not statistically significant. The reduced ratio was significant after 4 days. It was not 
significantly different after 7 days.  
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5.0  DISCUSSION 
5.1 SUMMARY AND DISCUSSION OF RESULTS 
Using an ex vivo preparation, we have shown that Cx43 in arteries is regulated by the mean 
pressure level and this regulation is time-dependent. Short-term (6 h) high pressure upregulated 
both mRNA and protein of Cx43. However, only the mRNA level of Cx43 was increased by 
high pressure under a relatively longer (24 h) culture duration. The Cx43 protein level was 
similar between two culture conditions at 24 h. This regulatory pattern in Cx43 protein level was 
not affected by flow levels. It was also not affected by the presence of pressure pulsatility. Src 
may mediate upregulation of both mRNA and protein of Cx43 by short-term high pressure. 
We have also shown that Cx43 in arteries is regulated by pressure pulsatility and this 
regulation is time-independent. The Cx43protein level was downregulated by pulsatile pressure-
induced cyclic stretch as compared with steady stretch induced by steady intraluminal pressure 
for both 6 and 24 h in culture, although the mRNA level of Cx43 was not significantly different 
for either culture duration. Cyclic stretch for 24 h also reduced levels of active and total Src as 
compared to the steady stretch. Results from the inhibition experiments (inhibition of Src in 
cultures with steady stretch and inhibition of ROS in cultures with cyclic stretch) suggest a role 
of Src in mediating the upregulation of Cx43 protein by steady stretch and a role of ROS in 
mediating the downregulation of Cx43 protein by cyclic stretch. 
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5.1.1 Effects of mean pressure level on arterial gap junctions  
Hypertension is one of the most common cardiovascular diseases. Although changes in gap 
junction expression have been observed in vivo in various forms of hypertension,345 there is a 
great deal of variability in the patterns of responses. In addition, whether connexin expression is 
involved in the genesis and/or maintenance of hypertension is still an open question. Both 
upregulation and downregulation of Cx43 mRNA and protein levels in aortas have been 
reported.345 It appears that alteration of Cx43 expression depends on the specific hypertension 
model, where many factors may be differentially altered. Thus, use of in vivo hypertensive 
animal models can not establish a direct relation between blood pressure and gap junctions. In 
addition, both the mean blood pressure and pulse pressure are elevated in hypertensive subjects, 
making it difficult to identify individual effects. The ex vivo culture system used in the present 
study enables us to control mean and pulse pressures independently. We first studied the direct 
effects of the mean pressure level on gap junctions in arteries. 
Cx43. We found that the Cx43 mRNA level was upregulated by both short- (6 h) and 
long-term (24 h) high steady pressure cultures (Figures 4-9 and 4-12). However, the Cx43 
protein level was upregulated by short-term (6 h) high steady pressure only (Figure 4-9). The 
presence of pressure pulsatility did not alter this mean pressure-induced regulation pattern 
(Figure 4-18). Therefore, the mean pressure level per se does regulate Cx43 expression and this 
regulation appears to be time-dependent. 
There are two well-recognized phenotypes in VSMCs: contractile and synthetic. 
Connexin expression may be altered as cells change phenotypes. For example, the Cx43 protein 
level was upregulated as in vitro cultured VSMCs changed from a contractile to synthetic 
phenotype.346 Cx43 mRNA and protein were increased in human saphenous veins that were 
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cultured at a relaxed state for up to 14 days.347 Similarly, our results showed that aortas cultured 
in a relaxed state for 7 days had more Cx43 protein compared to fresh aortas (Figure 4-60). High 
pressure may promote growth, proliferation, and synthetic activity of VSMCs. Thus, high 
pressure was expected to increase the Cx43 protein level. However, such an increase was 
observed only for the 6 h culture; aortas cultured under high pressure for 24 h did not have more 
Cx43 protein compared to the low-pressure culture at the same time point. We wanted to 
examine whether the cell phenotype had been changed in these ex vivo cultured aortas. The 
protein p27 blocks activity of cyclin-dependent protein kinase2 (CDK2) /cyclin A and 
CDK2/cyclin E, which are complexes required for cell-cycle progression and cell proliferation. 
Therefore, levels of p27 were quantified to study the status of VSMCs cultured under high or 
low pressure. For 6 h cultures, the p27 protein level was not significantly different (Figure 4-25), 
which demonstrated that increases in Cx43 mRNA and protein by high steady pressure at 6 h 
were not because of a difference in cell proliferation. For 24 h cultures, the p27 protein level was 
less in aortas under high pressure (Figures 4-27 and 4-28), indicating that these cells under high 
pressure were moving towards proliferation although more studies are needed in order to test 
proliferation. The observation that the Cx43 prtein level was not affected by high pressure at 24 
h indicates longer cuture durations may be necessary to see the effect of decreased p27 on Cx43 
protein level. This conjecture is supported by a previous study wherein DNA synthesis, a 
hallmark of cell proliferation, was similar between aortas cultured  under high and low pressure 
levels for 3 days.332 Finally, there was more Cx43 mRNA in aortas under high pressure for 24 h. 
This observation, together with the known effect of high pressure on phenotypes of VSMCs, it is 
expected that chronic (i.e., many days) high pressure will upregulate the Cx43 protein level.  
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As mentioned before, aortas from L-NAME hypertensive rats have lower levels of Cx43 
mRNA and protein.327 This may be attributable to NO because the NO donor S-nitroso-N-
acetylpenicillamine increased Cx43 protein expression in mesangial cells.287 
Cx40. Cx40 mRNA levels were also quantified in aortas cultured under steady pressure 
for either 6 or 24 h (Figures 4-11 and 4-14). Either GAPDH or VE-cadherin was used as the 
reference gene. The Cx40 mRNA levels were not significantly different in any case. Therefore, 
Cx40 mRNA is not differentially regulated by the pressure level. The VE-cadherin mRNA level 
was not significantly different as well, which verified the validity of using VE-cadherin as the 
reference gene for Cx40.  
5.1.2 Effects of pulsatile pressure on arterial gap junctions 
Effects of pulsatile pressure on gap junctions of intact blood vessels have not been studied. 
Pulsatile pressure stretches a blood vessel cyclically. The level of stretch depends on the 
compliance of the blood vessel in addition to the level of pulse pressure, which has been 
recognized as a risk factor for cardiovascular diseases. Generally, a higher pulse pressure is 
related to the reduction in vascular compliance. However, the molecular mechanisms underlying 
effects of compliance and the associated cyclic stretch on remodeling of intact vascular tissues 
are poorly understood. We found cyclic stretch of intact aortas decreased the Cx43 protein level 
for both short- (6 h) and long-term (24 h) cultures, compared to the steady stretch controls. This 
result was unexpected because several cell culture studies have shown increased Cx43 protein by 
cyclic stretch as compared with static controls in ECs,12 neonatal rat cardiomyocytes,330 and 
osteoblasts.331 Nevertheless, there are several fundamental differences between ex vivo and in 
vitro studies. First, in vitro studies typically use relaxed or unstretched condition as the reference 
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state; all changes due to a test condition are compared with respect to this state. This may be 
problematic because blood vessels are constantly stretched due to the mean pressure, and 
therefore, one needs to use this steady-stretch condition as the reference state, not the relaxed or 
unstretched state when comparing the differential effects of cyclic and steady stretch. This is 
what we did in our ex vivo studies. Second, the intrinsic delicate three dimensional structural and 
compositional aspects of a blood vessel are maintained in an ex vivo culture. It has been shown 
that the components of extracellular matrix affect regulation of Cx43 protein by cyclic stretch in 
cardiac myocytes.330 Third, cells cultured in two dimensions (i.e., on a flat surface) may have 
altered phenotypes, which can affect responses to mechanical factors. Thus, results using whole-
vessels are more likely to reveal the in vivo situation. 
5.1.3 Possible role of Src in mediating the regulation of arterial Cx43 expression by 
pressure 
Src and Src-family proteins are non-receptor protein-tyrosine kinases playing prominent roles in 
cell proliferation, differentiation, growth, and migration.348 There are nine members in the Src 
kinase family.349 Among these members, Src, Fyn, Yes, and Yrk are ubiquitously expressed. 
Expression of other members (Blk, Fgr, Hck, Lck, and Lyn) is more restricted. However, it is not 
known how many members and at what levels these proteins are expressed in ECs and VSMCs. 
Although these members are functionally redundant, each member may also have specific roles. 
For example, all three members, Src, Yes and Fyn, were required for VEGF-induced growth of 
human retinal microvascular ECs studied using the small interference RNA gene knockdown 
technique.350 Interestingly, cell migration induced by VEGF was significantly increased in Fyn-
deficient cells; however, it was decreased in Yes-deficient cells. Furthermore, reduction in Fyn, 
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but not Src or Yes, impaired VEGF-induced tube formation. However, the specific roles of these 
members in arterial ECs and VSMCs are not known.  
Src can be activated, as quantified by the ratio of active to total Src, by stretch or shear 
stress, in addition to growth factors.351 Src was found to be involved in steady pressure-induced 
FAK phosphorylation using a Src-family kinase inhibitor PP2 for 24 h.83 The levels of active Src 
(Tyr-418) were measured using Western blot in rat mesentery arteries.352 Src was transiently 
(lasted for less than 5 minutes) activated by high steady pressure.352 However, activation of Src 
by steady or pulsatile pressure in elastic arteries has not been detected using Western blot. We 
found that there were no differences in the levels of Src activation at 6 h or 24 h between aortas 
under high and low steady pressure cultures (Figures 4-20 and 4-21), or cyclic and steady stretch 
cultures (Figures 4-38 and 4-39). Thus, it appears that the pressure-induced Src activation is 
short-lived (less than 5 minutes). Such transient Src activation has also been observed in ECs 
subjected to shear stress.353 Here, Src activation peaked after exposure to flow for 10 minutes. 
A recent finding may explain why the initial activation of Src by high pressure was 
transient. The Src family kinase Lyn was activated by erythropoietin in red blood cells.354 Lyn 
was found to interact with an adaptor protein Cbp (C-terminal Src kinase-binding protein), which 
recruited the negative regulator of Lyn, the complex of C-terminal Src kinase (Csk) and Csk-like 
protein-tyrosine kinase (Ctk). Activated Lyn phosphorylated Cbp on Tyr314, which recruited 
Csk/Ctk to suppress Lyn kinase activity. 
A diffent temporal pattern was observed for pressure-induced changes in total Src. While 
there were no pressure-induced changes in total Src at 6 h, it was altered at 24 h: high mean 
pressure had more total Src compared to low mean pressure (Figure 4-21), and steady stretch had 
more total Src compared to cyclic stretch with the same mean stretch (Figure 4-39). The increase 
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in total Src at 24 h may come from new synthesis of Src, which may explain why there was no 
difference at 6 h. This pattern of total Src regulation in aortic cells is different from that in 
pulmonary epithelial cells, in which cyclic stretch for 24 h did not increase total Src as compared 
to static control cells.355 
Although Western blot failed to detect the difference of active Src, the extensively used 
Src inhibitor PP1 eliminated the increase in both mRNA and protein of Cx43 by high pressure at 
6 h (Figure 4-23). The reason of this discrepancy may be that PP1 inhibited some members of the 
Src-family kinases (Fyn, Hck and Lck333, 349, 356) which could not be detected by the Src 
antibody, and these members played roles in transducing mechanical forces and deformation. 
The antibody for total Src (sc-18, Santa Cruz Biotechnology) can detect Src p60, Yes p62, Fyn 
p59 and c-Fgr p55 based on the product sheet from the company. However, there was only one 
single band around 60 kDa in our results. Thus, c-Fgr p55 was not detected because its molecular 
weight is far from 60 kDa. For the same reason, Yes p62 was most likely not detected. However, 
it is possible that Fyn p59 was also detected because its molecular weight was very close to 60 
kDa. We tried the antibody for Yes (sc-14, Santa Cruz Biotechnology) and Fyn (sc-434, Santa 
Cruz Biotechnology). Unfortunately, they did not work for rabbit aortic tissues. The antibody for 
active Src (nonphospho-Tyr-527, 2107, Cell Signaling Technology) may react with Yes p62 and 
Fyn p59 in addition to Src. Again, there was only one single band around 60 kDa in our results. 
Therefore, Yes p62 may not be detected. However, it is possible that Fyn p59 was also detected. 
Obviously, more studies are needed in order to explain definitely the discrepancy. 
To explore the role of Src in mediating differential activation of ERK1/2 by steady and 
cyclic stretch, PP2 was added to the culture media for aortas under cyclic stretch.83 Based on our 
results, it is not surprising that PP2 did not block differential activation of ERK1/2 because 
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aortas with steady stretch actually had more active Src. In our study, PP1 reduced the Cx43 
protein level in aortas under steady stretch, resulting in similar levels between cyclic and steady 
stretch cultures (Figure 4-41). PP1 also downregulated Cx43 mRNA, leading to more mRNA in 
aortas with cyclic stretch. Thus, a certain level of Src activity is necessary for maintaining Cx43 
mRNA. There were more Cx43 mRNA (Figure 4-12) and Src (Figure 4-21) in aortas under high 
pressure for 24 h. It is possible that Src was involved in upregulating Cx43 mRNA by high 
pressure. This role of Src may be revealed using the Src inhibitor PP1 in aortas under high 
pressure. 
Inhibition of Src using PP1 did not alter activation of Src by high pressure or cyclic 
stretch at 6 or 24 h. However, PP1 inhibited the rapid autophosphorylation and activation of Src 
by high pressure.352 Therefore, the mechanism of short-term inhibition of Src by PP1 is different 
from that of longer-term inhibition. It is known that PP1 binds to the ATP pocket of Hck and Lck, 
two other members of the Src-family kinases.356 Src has the same ATP binding domain as that of 
Hck. However, PP1 did not compete with ATP for the inhibition of Src because increasing the 
concentration of ATP did not affect the IC50 value of PP1 for Src inhibition.356 It is not known 
why the mechanism of short-term inhibition of Src by PP1 is different from that of long-term 
inhibition. 
5.1.4 Possible role of reactive oxygen species in mediating the regulation of Cx43 
expression by pressure 
In a previous study, ROS mediated upregulation of Cx43 mRNA and protein by static stretch 
(20%) in VSMCs.315 Arteries under higher steady pressure produced more superoxide.111 
Therefore, superoxide may have mediated increases of both Cx43 mRNA (6 and 24 h) and 
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protein (6 h) by high steady pressure in our study, which is analogous to the static stretch in the 
previous study.315 Experiments using inhibitors of ROS may reveal the role of ROS in mediating 
regulation of Cx43 by the mean pressure level. 
Rabbit aortas under cyclic stretch had more superoxide compared to steady stretch.87 
However, we found that there was less Cx43 protein in aortas under cyclic stretch. Inhibition of 
NADPH oxidase using apocynin elevated the Cx43 protein level in aortas under cyclic stretch. 
Furthermore, apocynin increased the Cx43 protein level in aortas cultured relaxed in Petri dishes 
(Figure 4-46). Thus, ROS may also reduce the Cx43 protein level. Taken together, ROS may 
play different roles in mediating mean pressure-induced and cyclic stretch-induced regulation of 
Cx43 expression, suggesting that factors other than ROS may be involved in this regulation. 
5.1.5 Interactions between Src and reactive oxygen species 
It is interesting to note that active and total Src were elevated by inhibition of ROS in aortas 
under cyclic stretch (Figure 4-44). It has been known that there are two-way interactions between 
Src and ROS. Src was required for the tyrosine phosphorylation of caveolin 1 in arterial ECs 
induced by H2O2.357 On the other hand, Src mediated ROS production induced by platelet-
derived growth factor (PDGF).358 Our data demonstrated, for the first time, that long-term (24 h) 
inhibition of ROS in aortas under cyclic stretch increased the protein level of Src. Considering 
the essential roles of ROS in the vasculature, this may be one compensatory response to 
inhibition of ROS. However, the role of Src in the increase of Cx43 protein by NADPH oxidase 
inhibition needs further investigation. Dual inhibition of ROS and Src may be able to reveal the 
consequences without effective compensation of Src. 
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5.1.6 Different regulatory patterns of Cx43 expression by the mean pressure level and 
cyclic stretch 
The regulatory patterns of Cx43 mRNA expression by the mean pressure level and cyclic stretch 
were different. The Cx43 mRNA level was increased by high steady pressure for both short- (6 
h) and long-term (24 h) cultures. However, the Cx43 mRNA levels were similar between aortas 
under cyclic and steady stretch cultures for these two durations. The differential regulatory 
patterns of Cx43 mRNA expression by the mean pressure level and cyclic stretch may be 
because of the different roles of Src. Src mediated the elevated Cx43 mRNA level by short-term 
high steady pressure because the Cx43 mRNA levels were similar after Src inhibition (Figure 4-
23). However, the elevated active Src level in aortas under steady stretch did not result in more 
Cx43 mRNA although Src is important for maintaining a certain level of Cx43 mRNA because 
inhibition of Src decreased Cx43 mRNA, leading to more Cx43 mRNA in aortas under cyclic 
stretch (Figure 4-41). 
The regulatory patterns of Cx43 protein expression by the mean pressure level and cyclic 
stretch were also different. The Cx43 protein level was increased by high steady pressure for 
short-term cultures (Figure 4-9). However, the Cx43 protein levels were similar after long-term 
(24 h) culture using the same culture conditions (Figure 4-12). Therefore, regulation of the Cx43 
protein level by the mean pressure level is culture duration dependent. In contrast, there was less 
Cx43 protein in aortas under cyclic stretch for both short- (6 h) and long-term (24 h) cultures. 
Hence, regulation of the Cx43 protein level by cyclic stretch is not culture duration dependent. 
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5.1.7 Dissociation of the Cx43 protein level from the mRNA level 
Our results showed that more Cx43 mRNA might not be associated with more Cx43 protein 
(Figures 4-12, 4-18 and 4-41). For example, although the Cx43 protein levels were similar, there 
was more mRNA at 24 h in aortas under high steady pressure (Figure 4-12) or aortas with cyclic 
stretch and Src inhibition (Figure 4-41). Protein levels depend on rates of protein synthesis and 
degradation. The rate of protein synthesis depends on the amount of the mRNA and the 
translational efficiency from mRNA to protein. The rate of protein degradation may not be 
related to the mRNA level at all. Hence, it is possible to observe a dissoacition between mRNA 
and protein levels. Cx43 protein is degraded rapidly.359 Therefore, it is necessary to study both 
the mRNA and protein levels of Cx43 in order to have a better understanding of Cx43 
regulation.345 Further studies are needed to clarify the exact mechanisms of this discrepancy. 
Inhibitors of protein synthesis and/or degradation can be used for this purpose. 
5.1.8 Cx43 phosphorylation 
Cx43 phosphorylation affects the trafficking, assembly, internalization, degradation and gating 
of Cx43 gap junction channels.160 Therefore, regulation of Cx43 is likely to include 
phosphorylation in addition to the mRNA and total protein levels. Ratios of phosphorylated 
(P1+P2+P3 in Figure 4-8) to non-phosphorylated (P0) Cx43 have been used to compare the 
status of phosphorylation of cardiac Cx43.296 Using this approach, we observed examples of both 
statistically significant changes (Figures 4-10 and 4-33) and no changes (Figures 4-13) in Cx43 
phosphorylation status. However, there are some concerns regarding the calculation of this ratio. 
Based on our Western blots, it is clear that most Cx43 proteins in aortic tissues were 
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phosphorylated; the amount of Cx43 protein in the P0 state (i.e., non-phosphorylated) was very 
small. Thus, there may be large errors in the calculation of the ratio which has the level of P0 (a 
small number) in the denominator. This issue needs further investigation. 
As introduced in Section 2.3.3, many amino acids of the Cx43 protein can be 
phosphorylated. The ratios mentioned above do not take into account the specifically 
phosphorylated amino acids. To fully understand regulation of Cx43 by mechanical forces, it is 
necessary to know the differential phosphorylation of these amino acids by mechanical factors, 
in addition to the regulation at the total protein level. For instance, long-term high pressure did 
not increase the total Cx43 protein level. However, there was more active Src in aortas with high 
pressure. Src has been reported to phosphorylate Tyr-247 and Tyr-265 of Cx43.170 Hence, it is 
possible that high pressure increases phosphorylation of these two sites, even in the absence of 
an increae in the total protein level. Antibodies for these specific amino acids are needed for this 
purpose. We have tried a few commercially available phospho-Cx43 antibodies. Unfortunately, 
none of them worked for rabbit aortic tissues. 
5.1.9 Regulation of Cx40 and Cx37 by pressure 
The mRNA levels of Cx40 were not significantly altered by different levels of steady pressure 
for both short- (Figure 4-11) and long-term (Figure 4-14) cultures. The Cx40 protein level may 
be regulated by pressure. However, the Cx40 antibodies we have tried did not have a sufficient 
affinity to the Cx40 protein. Therefore, Cx40 protein levels could not be measured using Western 
blot. En face immunostaining could also detect Cx40 protein expression in ECs. Unfortunately, 
the Cx40 staining of cultured aortas was much weaker compared with fresh aortas, which 
prevented us from doing quantitative comparison of the Cx40 protein levels in aortas cultured 
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under different conditions. The sequence of the rabbit Cx37 gene is known (Ensembl gene ID: 
ENSOCUG00000000325). Unfortunately, the Cx37 mRNA levels could not be detected using 
the TaqMan® gene expression assay (the following primers and probe were tried: forward 5’-
TGCCGCTGCCTCAGT-3’, reverse 5’-GTCGGCAGAAGGGTCTGA-3’; probe 5’- 
CCCTGGCCCTGCCGTG-3’). The protein levels of Cx37 could not be quantitatively analyzed 
for the same reasons as those for Cx40. 
5.1.10 Effects of flow on pressure-induced regulation of arterial gap junctions 
As discussed in Section 2.3.9, flow or fluid shear stress also regulates gap junctions. The flow 
rate used in this study was lower than the physiological value, just as in other ex vivo studies 
using rabbit aortas.83, 87, 332, 360 Low flow did not alter the integrity of ECs for 24 h cultures.360 
The major effects of flow have been assumed to be on ECs. However, the mRNA and protein of 
Cx43 analyzed in this study mostly came from VSMCs. Thus, we observed mainly the effects of 
pressure on gap junctions of VSMCs. Moreover, the same flow level was used for both aortic 
segments which were cultured under different mean pressure levels or pulse pressures. 
Therefore, the results of regulation of gap junctions by the mean pressure level or pulse pressures 
obtained under a flow level are expected to the same if another flow level is used. For example, 
regulation of the Cx43 protein level by long-term high steady pressure under low flow (Figure 4-
12) was not altered at high flow (Figure 4-15). 
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5.2 CLINICAL IMPLICATIONS 
We studied regulation of arterial Cx43 by pressure. Cx43 has been associated with 
cardiovascular diseases and cancer. However, interpretation of gap junctional studies in a clinical 
sense has been difficult. The possible causative roles of Cx43 in some diseases are under 
investigation (as revealed by searching CRISP, Computer Retrieval of Information on Scientific 
Projects). Because Cx43 is not the major connexin protein in arterial ECs, the possible role of 
endothelial Cx43 in vascular diseases may not be attributable to the chemical transfer function of 
gap junctions. Even though arterial VSMCs may express Cx43 as the only connexin protein, 
Cx43 is not absolutely required for VSMCs because mice with SMC-specific deletion of the 
Cx43 gene had normal blood pressure and heart rate.271  
The role of vascular Cx43 may be more prominent in pathological conditions, such as 
injuries. However, Cx43 may be both beneficial and detrimental. For example, the Cx43+/- mice 
had less neointima formation following balloon distension injuries as compared with Cx43+/+ 
controls.270 Moreover, there were smaller cardiac infarcts in Cx43+/- mice than wild-type 
controls following coronary ligation.361 In contrast, mice with SMC-specific knockout of Cx43 
had more neointima formation responding to injury induced by a wire.271 Loss of Cx43 blocked 
the protective effect of ischemia preconditioning on myocardial ischemia-reperfusion injury.362 
Furthermore, Cx43 was upregulated in rat carotid arteries following balloon catheter injuries.363 
However, the in vivo study of gap junctions has been hindered by the lack of specific inhibitors. 
Nevertheless, it is reasonable to think that a certain level of Cx43 is needed in VSMCs. 
Cx43 expression is altered in several animal models of hypertension. However, it is not 
known whether Cx43 expression is also altered in hypertensive humans. Even in the animal 
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models, it is not known whether Cx43 actively contributes to hypertension. The use of transgenic 
animals may help answer this question. 
Stiffer vasculature is considered to be a risk factor for cardiovascular diseases, although the 
molecular mechanisms are poorly understood. Increased vascular stiffness has been reported in 
several physiological (e.g., normal aging) and pathological (e.g., chronic hypertension, 
atherosclerosis, accelerated aging) conditions. The level of cyclic stretch of a stiffer blood vessel 
is less under the same pulse pressure. Our results showed that cyclic stretch reduced Cx43 
protein as compared with the steady stretch controls. Thus, it is speculated that stiffer vessels in 
vivo will have more Cx43 protein. Elevated Cx43 protein may play a role in mediating responses 
to injuries, inflammation, and other risk factors through its junctional and non-junctional 
functions. However, definitive data regarding this do not exist. 
5.3 ADVANTAGES OF METHODOLOGY 
Using the ex vivo culture method, we studied the effects of the mean pressure level and 
pulsatility on arterial gap junctions. The intrinsic delicate structure of arteries was maintained in 
our study. As the importance of extracellular matrix in regulating cellular processes is 
increasingly recognized, our method is advantageous over in vitro cell culture studies. We 
studied mainly the effects of stretch on VSMCs, which do not exist as a monolayer in vivo. Even 
though three dimensional cultures of VSMCs have been used to study vascular biology and 
engineering, the delicate structure of native blood vessels has not been recreated. The chemical 
components of native blood vessels are also different from those engineered constructs. We 
compared the effects of cyclic stretch versus steady stretch, which can be studied in vitro using 
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two dimensional culture of VSMCs as well. However, VSMCs that exist as a monolayer may 
respond to stretch differently from VSMCs in blood vessels. Moreover, there is intraluminal flow 
in our system. Therefore, we can also study the interaction of ECs with SMCs in arteries. 
Blood pressure and pulsatility can not be readily manipulated in vivo. It is not possible to 
just alter one single hemodynamic parameter in vivo without changing others. For example, the 
mean pressure proximal to a binding cast could be increased in vivo, however, the pulse pressure 
was also increased.364 Although casts can be placed around arteries to reduce cyclic stretch, wall 
stress may be altered as well. Moreover, this approach may interfere with arterial function and 
other organ systems, leading to responses to injuries. We were able to adjust mean and pulse 
pressures independently using the ex vivo method. Flow can also be independently adjusted. 
5.4 DISADVANTAGES OF METHODOLOGY 
We could investigate the effect of just one mechanical factor on intact arteries using the ex vivo 
method. However, ex vivo-cultured blood vessels are in an environment different from the in vivo 
situation. Although culture media have been optimized for cell culture, the medium is different 
from blood in many ways. For example, blood cells and many other chemicals are not in the 
culture medium. Using whole blood would be an alternative in this aspect. However, thrombosis 
will be rapidly formed in the perfusion system, and it is hard to clean the perfusion components. 
Anticoagulating reagents may reduce thrombosis. Nevertheless, these reagents may interfere 
with vascular responses to mechanical factors. 
One challenge relating to ex vivo culture of intact arteries is to maintain the integrity of 
the endothelium. Endothelial cells can be easily lost by any manipulation of arteries. We were 
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very careful in protecting ECs from loss. Aortic spasm could happen during harvesting aortas, 
which may damage ECs. Papaverine was applied frequently to the adventitia of aortas. However, 
it was not possible to completely prevent spasm when the chest was open during the procedure. 
Aortas contract after isolation, which may also damage ECs. The in vivo length was maintained 
using clamps. Aortas were prevented from collapse after isolation using a bag with Tyrode’s 
salts solution that was put at a higher position than that of aortas. These methods helped protect 
ECs. However, as the primary antigen presenting cells of the body, primary ECs are very 
sensitive to their environment. It is thus possible that ex vivo cultured ECs may behave 
differently after they are taken out of the body. In contrast, there are many layers of VSMCs in 
rabbit aortas. These cells are embedded between thick fibers, thus protected against injuries. 
Therefore, the ex vivo perfusion method is more suitable for studying effects of mechanical 
forces on VSMCs. 
Biological assays may be difficult to be performed on aortas. Most assays have been 
developed for in vitro cell culture studies. For example, measuring the dye transfer function of 
gap junctions in aortas was very difficult, as discussed in detail in Appendix A. Cultured 
HUVECs had good recovery after photobleaching. However, most bleaches did not have good 
recovery in ECs of aortas. It is also more difficult to do Western blot and PCR. As for studying 
the molecular mechanisms, there are fewer options when using tissues. Genes in cultured cells 
can be readily manipulated. The small interference RNA method has been widely used to 
knockdown specific genes in cells. However, using chemical inhibitors is the only option in most 
cases if using tissues. Moreover, most these commercially available chemicals target molecules 
that have been well studied, which means it is very difficult to study novel molecules in tissues. 
The volume of culture medium is also much larger than that of a typical culture dish, which 
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makes it expensive to use some chemicals. Ex vivo culture of blood vessels is also restricted by 
suitable animal models. Mice and rats have small blood vessels that are not the first choice for ex 
vivo culture. Larger animals are better for ex vivo culture. However, the genomes of large 
animals are either unknown or inferior in quality, which makes molecular analysis and 
manipulation of cultured tissues difficult. 
5.5 RECOMMENDATIONS FOR FUTURE WORK 
Regulation of arterial gap junctions by mechanical factors can be further studied in the future. 
We studied the effect of mean pressure on Cx43 for up to 24 h. Longer culture duration may be 
able to reveal the effects of high pressure, which induces hypertrophy and hyperplasia of 
vascular cells in vivo. For this chronic culture, it is better to culture both vessels under pulsatile 
conditions but with different mean pressure in order to avoid rapid adaptation of VSMCs to 
steady stretch. The exact duration will be determined by the days that are needed for VSMCs to 
synthesize significantly more proteins and/or DNA molecules. 
Cyclic stretch decreased the Cx43 protein levels, while the mRNA levels were not 
decreased. Studies can be done to investigate Cx43 translation and degradation to know the 
reasons of this regulatory pattern. Chemicals that inhibit protein translation and/or degradation 
can be added to the culture medium. Cx43 proteins are mainly degraded in lysosomes. Therefore, 
inhibitors of lysosomes can be used to study Cx43 degradation. 
We found that Src and ROS might mediate cyclic stretch-induced Cx43 protein reduction. 
More studies are needed to investigate the exact roles of Src and ROS in regulation of Cx43 by 
the pressure level and stretch. Src is related to integrins at focal adhesions. Therefore, Src is at 
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the upstream of the signaling pathway. The downstream signaling proteins need to be identified. 
Because there is very few information about the differentially regulated genes and proteins by 
cyclic versus steady stretch, high throughput gene and protein arrays may help identify those 
potential targets. Some growth factors and their receptors, such as EGF, FGF, and PDGF, may be 
involved in transducing mechanical forces. Since NADPH oxidase is the major source of ROS in 
blood vessels, NADPH oxidase may be regulated by cyclic stretch. More ROS in aortas under 
cyclic stretch may accelerate Cx43 protein degradation, which needs to be tested in the future. 
Cx43 protein is highly phosphorylated at many amino acids. Knowing the regulation in 
total protein level is just a small part of the story. More and better antibodies for the 
phosphorylated amino acids are needed for this task. Furthermore, the functions of these 
phosphorylation events need to be explored, which requires using multiple advanced techniques. 
The functional consequences of reduced Cx43 protein level by cyclic stretch need to be explored. 
One direction is to study the intracellular signaling role of Cx43, in addition to material transfer. 
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6.0  CONCLUSIONS 
One of the main findings of this dissertation is that arterial Cx43 is regulated by the mean 
pressure ex vivo. Short-term (6 h) high pressure upregulates both mRNA and protein of Cx43. 
However, a relatively longer (24 h) culture under high pressure only increases the mRNA level 
of Cx43. The protein level of Cx43 is not elevated by high pressure for 24 h under both low and 
high flow levels. This result is not affected when both segments are cultured under pulsatile 
pressure but with different mean pressure levels. Since chronic high pressure will promote 
hypertrophy and hyperplasia of VSMCs, and the Cx43 protein level is upregulated in VSMCs 
with a synthetic phenotype, chronic high pressure is expected to increase the Cx43 protein level 
in arteries. Src may mediate upregulation of both mRNA and protein of Cx43 by short-term high 
pressure. The mRNA level of Cx40 is not significantly altered by high pressure.  
Another finding is that arterial Cx43 is regulated by pressure pulsatility ex vivo. The 
protein level of Cx43 is downregulated by cyclic stretch as compared with steady stretch induced 
by a steady intraluminal pressure for both 6 and 24 h in culture, although the mRNA level of 
Cx43 is not significantly different at either duration. Levels of active and total Src are reduced in 
aortas under cyclic stretch for 24 h. Src may mediate downregulation of Cx43 protein by cyclic 
stretch. A certain level of active Src in aortas under steady stretch is required to maintain a 
comparable level of Cx43 mRNA to that in aortas under cyclic stretch. Downregulation of Cx43 
protein by cyclic stretch may be mediated by ROS. However, the mRNA level of Cx43 in aortas 
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under cyclic stretch is not affected by the level of ROS. There are interactions between Src and 
ROS. Inhibition of ROS in aortas under cyclic stretch increases the levels of active and total Src. 
Short-term (6 h) high pressure (150 mmHg) does not affect the cell cycle entry (the p27 
protein level). However, cells have a stronger tendency of entering the cell cycle after 24 h under 
high pressure. There is no significant difference in the tendency of entering the cell cycle 
between aortas cultured under steady and cyclic stretch for both short- (6 h) and long-term (24 
h). 
Pressure regulates activation of Akt. More Akt is activated in aortas under high pressure 
for 24 h. Both short- (6 h) and long-term (24 h) cyclic stretch reduce activation of Akt compare 
to steady stretch. Src, but not ROS, mediates differential activation of Akt by cyclic and steady 
stretch. The total protein level of Akt is not regulated by any of these conditions. Therefore, Src 
and Akt have different regulatory patterns by pressure. 
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APPENDIX A 
ENDEAVORS TO CHARACTERIZE ARTERIAL GAP JUNCTION FUNCTION 
The basic function of gap junctions is to provide a pathway for material transfer between 
adjacent cells. We tried several techniques to quantify this function in our aortic samples. 
Unfortunately, we could not acquire good dada for the quantitative comparison of the function of 
gap junctions in cultured aortas due to technical problems. 
A.1 SCRAPE LOADING/DYE TRANSFER ASSAY 
Scrape loading/dye transfer is the fastest and simplest method to evaluate gap junctional 
intercellular communication.365 It can simultaneously measure dye transfer in coupled cells. The 
fluorescent dye Lucifer Yellow (molecular weight 457 Da) is used most commonly in this 
technique. It can be easily transferred through gap junction channels. Lucifer Yellow can be 
visualized under a microscope using a UV light source (absorbance 428 nm, emission 536 nm). 
However, Lucifer Yellow can not enter cells through intact cell membranes. Scrape is thus used 
to break cell membranes and load Lucifer Yellow. Another fluorescent dye that is larger than the 
gap junction channel exclusion limit is used simultaneously as a control to show the scraped 
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position. Rhodamine–dextran conjugates (molecular weight 10,000 Da, absorbance 555 nm, 
emission 580 nm) are most commonly used for this purpose. The rate of dye transfer depends on 
the number of gap junctions and the conductance of individual channels. 
One aortic ring was cut open longitudinally. It was then put into the PBS solution with 
0.5 mg/ml Lucifer Yellow (L1177, Molecular Probes) and 1 mg/ml rhodamine–dextran 
conjugate (D1824, Molecular Probes). A surgical blade was used to gently scrape the luminal 
side of the aorta. After incubating for 3 minutes in dark, the aorta was washed in PBS and fixed 
in 4% paraformaldehyde PBS solution for 5 minutes. Images were taken under an Olympus wide 
field epifluorescence microscope. Unfortunately, Lucifer Yellow was everywhere along the 
surface of the aorta. The scrape line could not be identified. 
Scrape loading has been commonly used to study gap junctions of cultured cells on 
coverslips. It is very difficult to maintain the integrity of the endothelium of an elastic aorta 
during this procedure. 
A.2 CUT-END LOADING/DYE TRANSFER ASSAY 
One variation of scrape loading is cut-end loading of tissues. Aortic rings that were just cut from 
longer aortas were incubated in PBS with Lucifer Yellow (5 mg/ml) and rhodamine–dextran (3 
mg/ml) for 5 or 10 minutes. Aortas were quickly washed three times in PBS before fixation in 
4% paraformaldehyde PBS solution overnight. After washing, aortas were frozen in isopentane 
which had been cooled in liquid nitrogen. Aortas were embedded in OCT and sectioned. Images 
were taken using a confocal microscope. The elastic fibers were strongly stained by Lucifer 
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Yellow (Figure A-1). However, VSMCs did not have much staining even at the edges. This 
assay is thus not good for studying aortic gap junctions. 
 
                            
Figure A-1 Cut-end loading of Lucifer Yellow into aortas for 5 (left) or 10 (right) minutes. 
A.3 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP) 
FRAP is a more advanced technique to study the dye transfer function of gap junctions. The 
principle of FRAP is to observe the rate of recovery of fluorescence by diffusion of a fluorescent 
marker into an area which contains the same marker but has been rendered non-fluorescent via 
an intense pulse of photobleaching laser light.366 A rate constant of recovery can be obtained 
from the recorded recovery curve. Therefore, functions of gap junctions in different cells can be 
quantitatively compared. Calcein AM (Invitrogen) was commonly used as the fluorescent 
marker. Calcein AM is membrane-permeable and thus can be introduced into cells via 
incubation. Calcein AM is then hydrolyzed by endogenous esterases in live cells into the 
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negatively charged green fluorescent calcein, which is membrane-impermeable and retained in 
the cytoplasm. 
HUVECs cultured on a coverslip were used to test the FRAP technique. HUVECs were 
loaded with 6.25 μM calcein AM for 30 minutes at 37 °C and then washed 3 times with PBS. 
The DMEM medium and HUVECs were maintained at 37 °C using an incubated open chamber 
(Harvard Apparatus, MA). FRAP was performed on an inverted Olympus Fluoview 1000 
confocal microscope using a 40x oil, 1.3 NA objective. After initial imaging with a 488 nm laser 
line (0.4% laser output), an oval region was bleached for 2 seconds using a 405 nm laser line at 
its 100% intensity. Sequential images were taken every 30 seconds for 7 minutes. The control for 
photobleaching associated with imaging can be assessed by determining average intensity over 
time in regions far from the bleached region. Cells were successfully loaded with calcein (Figure 
A-2A). One area was just bleached (Figure A-2B). It was rapidly recovered a few minutes later 
(Figure A-2C). The time series of average intensity was shown in Figure A-2D. The control area 
had a stable intensity. Therefore, FRAP can be used to assess gap junctions in cultured HUVECs. 
FRAP was then used to detect the dye transfer function of endothelial cells in aortas. 
Aortic rings were opened longitudinally to lay flat in DMEM medium and loaded with 6.25 μM 
calcein AM for 30 minutes at 37 °C. Aortas were then washed 3 times with PBS. Aortas were 
held against the coverslip of a single-chamber Lab-Tek chamber slide system (Nalge Nunc 
International, NY) using a custom made plastic insert on the adventitia side of the aorta. 
Therefore, ECs could be visualized by an inverted Olympus Fluoview 1000 confocal microscope 
with a 40x oil, 1.3 NA objective (Figure A-3A). DMEM media and aortas were maintained at 37 
°C. After initial imaging with a 488 nm laser line (0.4% laser output), an oval region was 
bleached for 2 seconds using a 405 nm laser line at its 100% intensity. Sequential images were 
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taken every 30 seconds for 7 minutes. One example is shown in Figure A-4. Unlike HUVECs, 
the bleached area was not recovered well. 
Endothelial cells may not have a good environment when they are against a coverslip 
(Figure A-3A). A gap can be left between the coverslip and endothelial cells (Figure A-3B). A 
10X air objective was needed in this case in order to be focused. However, the image quality was 
much worse. A higher concentration of calcein may increase signal intensity. Unfortunately, high 
concentration of calcein is toxic to cells, and results in non-uniform loading in cells. 
 
 
 
Figure A-2 FRAP of HUVECs cultured on a coverslip. 
The arrow points to the bleaching area. 
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D 
 Figure A-3 Two setups of FRAP on aortas. 
 
 
Figure A-4 FRAP of rabbit aortas. 
 
There is another challenge of doing FRAP on aortas. There are many layers of SMCs in 
rabbit aortas. Therefore, an aorta may vigorously contract and relax, which leads to an alteration 
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in field of view, and loss of focus. The intensity in the designated area is thus altered by the 
movement. The parachute assay may overcome this limitation.367 It is a noninvasive technique to 
detect the diffusion of fluorescent dyes through gap junctions from pre-loaded cells to unlabelled 
cells. Some endothelial cells were loaded with calcein. Rabbit aortas were opened longitudinally 
and incubated with these preloaded cells. However, there was not much staining in rabbit 
endothelial cells after 1 h incubation. 
Gap junction channels are dynamically gated. Any perturbation, either mechanical or 
chemical, can thus alter the conductance of these channels. The assays that have been tested used 
aortas in a relaxed state. The properties of gap junctions in these cells may be different from 
those in aortas with physiological mechanical conditions. The best assay should use perfused 
aortas, which presents tremendous challenges. 
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APPENDIX B 
IN VITRO CONTROL OF PULSATILE PRESSURE AND FLOW 
The Vascular system is subjected to mechanical forces, such as blood shear stress and pressure. 
An in vitro system that has the capability of precisely manipulating these mechanical forces is an 
important supplement to in vivo and in vitro cell culture studies in which mechanical forces are 
not controlled. Specifically, we wanted to have a system wherein pressure and flow could be 
controlled independelty, both in terms of their magnitude and waveform morphology. Although 
we devoted a great deal of effort to this part of the project, we were only partially successful. Our 
efforts are described below; hopefully, this will be helpful for future attempts to fully implement 
the envisioned system. We will first discuss a model-based analysis that outlines the control 
strategy and also demonstrate its feasibility. 
B.1 MATHEMATICAL MODELING OF SIMULTANEOUSLY CONTROLLING 
PULSATILE PRESSURE AND FLOW 
Control strategy. There are two variables (pulsatile pressure and flow) that need to be 
dynamically controlled. For each of these two variables, there are two components. One is the 
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mean. The other is the pulse. The mean flow and pressure can be easily controlled. For example, 
the mean flow can be obtained using the combination of a Masterflex peristaltic pump and a 
dampener. The mean pressure can be achieved by adjusting a valve at the downstream of the 
blood vessel. Because the mean flow and pressure are constant, they do not need to be 
dynamically controlled. However, the pulse components of pressure and flow need to be 
dynamically controlled. One syringe pump at the upstream of the blood vessel can be used to 
mainly control the pulse flow. Another syringe pump at the downstream of the blood vessel can 
be used to mainly control the pulse pressure. Therefore, this is a multiple input-multiple output 
(MIMO) control problem. These two pumps can be controlled in real-time using PID 
(Proportional, Integral and Differential) controllers based on the difference between the desired 
and measured variables. 
The Model. A model was constructed using Simulink, one of the toolboxes in Matlab 
(Mathworks Inc.) using analogies between mechanical (pressure, flow, inertia and compliance) 
and electrical (voltage, current, conductance and capacitance) systems (Figure B-1). A limiter 
and a low pass filter were applied to the output of the upstream PID controller to take into 
account the fact that the pump is physically restrained (e.g., the maximal speed of the 
movement). 
Modeling results. The steady flow pump is always running for these simulations. The 
terminal load is also pre-adjusted to maintain the mean pressure. If both upstream and 
downstream pulsatile pumps do not work, only the mean pressure and flow are achieved (Figure 
B-2). However, when the upstream pulsatile pump is also working, the pulse flow is well 
controlled (Figure B-3). But the pressure waveform is different from the desired one. The pump 
runs smoothly. In contrast, when only the downstream pulsatile pump is working, the pressure is 
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well controlled (Figure B-4). However, the flow waveform is not desired. Both pulse flow and 
pressure are well controlled when both pulsatile pumps are running (Figure B-5). Therefore, it is 
possible to control both pressure and flow waveforms simultaneously using one upstream and 
one downstream pulsatile pump. 
 
 
Figure B-1 Diagram of the simulink model for pulsatile pressure and flow control. 
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 Figure B-2 Mathematical simulation when both pulsatile pumps are not working. 
For both pressure and flow, only the mean is achieved. Cyan - the desired waveforms. Magenta - the 
achieved values. Yellow - the error (the desired value – the achieved value). 
 
 
Figure B-3 Mathematical simulation when only the upstream pulsatile pump is working. 
Pressure is not controlled. Its shape is different from the desired one. Flow is achieved. Cyan - the desired 
waveforms. Magenta - the achieved values. Yellow - the error or the pulsatile pump flow. 
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 Figure B-4 Mathematical simulation when only the downstream pulsatile pump is working.  
Pressure is well controlled. Flow is not controlled. Its shape is different from the desired one. Cyan - the 
desired waveforms. Magenta - the achieved values. Yellow - the error or the pulatile pump flow. 
 
 
Figure B-5 Mathematical simulation when both pulsatile pumps are working. 
Pressure is well controlled. Flow is also well controlled. Therefore, this system maintains mean pressure, 
mean flow, pulse flow, and pulse pressure. Cyan - the desired waveforms in A and B. Magenta - the achieved 
values in A and B, the output of the downstream pulsatile pump in C. Yellow - the error in A and B, the 
output of the upstream pulsatile pump in C. 
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B.2 MODEL PREDICTIVE CONTROL OF PULSATILE FLOW IN AN IN VITRO 
SYSTEM 
In the idealized model (Figure B-1), parameters of the system are known. The pumps can also 
move very rapidly. However, these are not the case in reality. Therefore, we wanted to construct 
a model of the real system. Then, some control strategies were applied to control these variables. 
Model predictive control (MPC) has been used in chemical process control problems. Therefore, 
MPC was used to recreate the required flow waveform. 
 
Methods 
Perfusion system. A pulsatile flow has two components. One is the mean flow. The 
other is the pulsatile part. The current setup was aimed at the rabbit aortic flow waveform, which 
had negative flow. The mean flow was generated through a MasterFlex peristaltic pump (A in 
Figure B-6, Cole-Parmer) with a dampener (B, Cole-Parmer) filled with air in the upper part. A 
syringe pump (D) was used to generate the pulsatile part of the flow. This syringe pump was 
driven by a linear voice coil motor (LA25-42-000A, BEI Kimco Magnetics), which was 
controlled in real-time. A sensor was connected to the shaft of the motor to provide position 
information (DS16 displacement sensor, Equipment Solutions Inc.). A one-way valve (C, Cole-
Parmer) was used to prevent backflow. The in-line flow rate sensor (E) and pressure transducer 
(F) were connected upstream of the vessel culture chamber (G). The mean pressure was adjusted 
with a valve (H). The medium entered into a reservoir (I). Data acquisition was through the 
Quanser DAQ board (Quanser Inc., Canada). 
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Figure B-6 Schematic of the pulsatile perfusion system. 
A: MasterFlex peristaltic pump; B: dampener; C: one-way valve; D: syringe pump driven by a linear motor; 
E: in-line flow rate sensor; F: pressure transducer; G: culture chamber; H: manual valve; I: reservoir.  
 
Control strategy. MPC does not designate a specific control strategy but a very ample 
range of control methods which make an explicit use of a model of the process to obtain the 
control signal by minimizing an objective function. The model is used to predict the process 
output at future time instants. One specific algorithm, Dynamic Matrix Control (DMC), was used 
to control the movement of the linear motor in this project. DMC uses the step response model:  
 
Where, gi is the coefficient of the step response, u is the input to the system, y is the output.  
The linear motion of the motor changes the measured flow. The position change of the 
motor is the input to the system; flow is the output. Because it was not practical to have a perfect 
step change in the motor position, a ramp change of position was applied to derive the step 
response coefficients gi. The position control was through the Quanser system, which provided a 
real-time control platform. The Quanser system was based on Simulink. A PID loop was used to 
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control the position. The total position change was divided into W segments; the number of step 
response coefficients was M. The formula to calculate the step response coefficients matrix G is 
                G=(UTU)-1UTY, 
Where, U is the input (position) matrix, Y is the output (flow) matrix. An example of the 
step response model is shown in Figure B-7. 
 
 
 
 
 
 
 
DMC used the concepts of free and forced responses, which express the control sequence 
as the addition of the two signals: 
                u(t) = uf(t) + uc(t) 
Where, uf(t) corresponds to the past inputs; uc(t) is the control move in the future. 
The objective of a DMC controller is to control the output as close to the setpoint as 
possible in the lease-square sense with the possibility of the inclusion of a penalty term on the 
input moves. The objective function is 
 
 
Where,     is the predicted output, w is the output reference (desired flow rate), p is the 
prediction horizon, m is the control horizon, λ is the input penalty factor. 
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Figure B-7 One example of the step response. 
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If there are no constraints, the solution by minimizing J is 
             u=(GTG+λI)-1GT(w-f) 
Where, G is the system’s dynamic matrix, which has the step response coefficients as its 
elements, I is the unit matrix, f is the free response including disturbance terms. In this algorithm, 
m and λ can be adjusted. It should be mentioned that only the first element of u was actually sent 
to the controller as the input. The position input u was then used as the command in the inner 
PID position control loop. The output signal from the real-time program was input to a brush 
type PWM servo amplifier (MSA-12-80, Galil Motion Control) first before it reached the motor. 
 
Results 
Using one quarter of the measured rabbit aortic flow waveform as the command, the 
actual flow rate is shown in Figure B-8. These two waveforms matched pretty well.  
 
 
 
 
 
 
 
 
 
 
However, as simulated in B-3, the pressure waveform was not desired. Further efforts had 
been devoted to control the pressure waveform simultaneously. One method was to use a PID 
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Figure B-8 The command and actual flow rates generated using the DMC control. 
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controller to control the downstream pump. However, the movement of this downstream pump 
also changed the flow generated by the upstream pump. Therefore, there were interactions 
between these two pumps. The model (Figure B-7) generated when only the upstream pump was 
running was no longer valid.  It was necessary to construct a model when both pumps were 
running. However, the quality of the model was very poor for this two inputs-two outputs 
problem, especially for the pressure model. Without good models of flow and pressure for each 
of these two pumps, it is not possible to recreate pressure and flow waveforms which are very 
dynamic (steep slope, high frequency (3 Hz for rabbits)). 
A feasible method is to control flow dynamically using an upstream pump while 
manipulating the properties of the loop to match the impedance of the system, thus a reasonable 
good pressure waveform can be realized. One simulation example of changing the compliance of 
the downstream tubing is shown in Figure B-9. The pressure waveforms match well after 
increasing the compliance. 
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 Figure B-9 Mathematical simulation of the effects of changing the compliance of the 
downstream tubing when only the upstream pulsatile pump is working.  
Pressure is not actively controlled. Its shape is much different from the desired one when the compliance is 
low. However, the achieved pressure waveform is very close to the desired one by increasing the compliance 
from 0.3 to 1.6. Flow control is achieved in both cases. Cyan - the desired waveforms. Magenta - the 
achieved values. Yellow - the error. 
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APPENDIX C 
DRAWINGS OF THE VASCULAR STABILIZER 
Vascular stabilizers were cumtom-designed and manufactured to maintain the in vivo length of a 
rabbit aorta after havesting. A stabilizer has two parts: a clamp bar and a slider.  The pictures and 
drawings were generaged in SolidWorks (SolidWorks Corp.) and are shown here. 
 
 
Figure C-1 The stabilzer. 
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 Figure C-2 The three dimentional view of a vascular stabilizer showing the clamp bar and slider. 
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 Figure C-3 The isometric and front views of the clamp bar. 
 165 
 Figure C-4 The top and left views of the clamp bar. 
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 Figure C-5 The slider. 
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